[{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/NCAGoXdKlK","expanded_url":"http://bit.ly/1P4meIs","display_url":"bit.ly/1P4meIs"}],"hashtags":[{"start":19,"end":29,"tag":"medicines"},{"start":46,"end":53,"tag":"orphan"},{"start":73,"end":78,"tag":"COMP"}],"mentions":{},"annotations":{}},"id":"737955936480808960","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-06-01T10:36:20.000Z","conversation_id":"737955936480808960","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Find out about the #medicines recommended for #orphan designation by the #COMP in May: https://t.co/NCAGoXdKlK","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/yvOxMsp738","expanded_url":"http://bit.ly/1qZstHj","display_url":"bit.ly/1qZstHj"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":127,"end":131,"tag":"ICH"},{"start":132,"end":142,"tag":"guideline"}],"mentions":{},"annotations":{}},"id":"737569917759688704","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-31T09:02:26.000Z","conversation_id":"737569917759688704","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"#Consultation opens on Q&amp;A on toxicokinetics: assessment of systemic exposure in toxicity studies: https://t.co/yvOxMsp738 #ICH #guideline","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/b5ugkGXkXd","expanded_url":"http://bit.ly/1UicqyP","display_url":"bit.ly/1UicqyP"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":37,"end":48,"tag":"veterinary"}],"mentions":{},"annotations":{}},"id":"736224379558846464","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-27T15:55:45.000Z","conversation_id":"736224379558846464","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation on reflection paper on #veterinary non-spontaneous adverse event reports, incl. internet/social media: https://t.co/b5ugkGXkXd","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/0RxOvL02gJ","expanded_url":"http://bit.ly/1Z5LN1B","display_url":"bit.ly/1Z5LN1B"}],"hashtags":[{"start":20,"end":30,"tag":"guideline"},{"start":61,"end":72,"tag":"veterinary"},{"start":73,"end":83,"tag":"medicines"},{"start":109,"end":122,"tag":"consultation"}],"mentions":{},"annotations":{}},"id":"736222686679080960","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-27T15:49:01.000Z","conversation_id":"736222686679080960","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Comments invited on #guideline on plant testing strategy for #veterinary\n#medicines: https://t.co/0RxOvL02gJ #consultation","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/yagaQgp3Oa","expanded_url":"http://bit.ly/22rcbVE","display_url":"bit.ly/22rcbVE"}],"hashtags":[{"start":47,"end":63,"tag":"advancedtherapy"}],"mentions":{},"annotations":{}},"id":"736221774514388992","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-27T15:45:24.000Z","conversation_id":"736221774514388992","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":7,"quote_count":0},"lang":"en","text":"12 medicines recommended for classification as #advancedtherapy by committee for advanced therapies (CAT) this month https://t.co/yagaQgp3Oa","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/3SRUO1Ffhd","expanded_url":"http://bit.ly/1TNfQe8","display_url":"bit.ly/1TNfQe8"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":56,"end":63,"tag":"herbal"}],"mentions":{},"annotations":{}},"id":"736219509967708160","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-27T15:36:24.000Z","conversation_id":"736219509967708160","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #agenda of next week's meeting of our committee for #herbal medicines (HMPC) is available: https://t.co/3SRUO1Ffhd","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/e3hCUJNZeU","expanded_url":"http://bit.ly/20KnqqB","display_url":"bit.ly/20KnqqB"}],"hashtags":[{"start":32,"end":41,"tag":"Darzalex"},{"start":43,"end":55,"tag":"daratumumab"},{"start":61,"end":68,"tag":"orphan"},{"start":69,"end":78,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"736192739700813824","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-27T13:50:01.000Z","conversation_id":"736192739700813824","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Assessment report published for #Darzalex (#daratumumab), an #orphan #medicine to treat multiple myeloma: https://t.co/e3hCUJNZeU","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/r95HuiKwpb","expanded_url":"http://bit.ly/1VlAovu","display_url":"bit.ly/1VlAovu"}],"hashtags":[{"start":27,"end":36,"tag":"Idelvion"},{"start":38,"end":55,"tag":"albutrepenonacog"},{"start":66,"end":73,"tag":"orphan"},{"start":74,"end":83,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"736191973963538432","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-27T13:46:59.000Z","conversation_id":"736191973963538432","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"View assessment report for #Idelvion (#albutrepenonacog alfa), an #orphan #medicine for patients with haemophilia B: https://t.co/r95HuiKwpb","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/QlLQxWlbMY","expanded_url":"http://bit.ly/1TINm3O","display_url":"bit.ly/1TINm3O"}],"hashtags":[{"start":86,"end":91,"tag":"CHMP"},{"start":117,"end":127,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"736153229826854912","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-27T11:13:01.000Z","conversation_id":"736153229826854912","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"Two new combination therapies against chronic hepatitis C recommended for approval by #CHMP: https://t.co/QlLQxWlbMY #medicines","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/0QLJqingF9","expanded_url":"http://bit.ly/20JOyWA","display_url":"bit.ly/20JOyWA"},{"start":114,"end":137,"url":"https://t.co/JC5XxZhDop","expanded_url":"https://twitter.com/EMA_News/status/736152708252639232/photo/1","display_url":"pic.twitter.com/JC5XxZhDop"}],"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":23,"end":33,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"736152708252639232","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-27T11:10:57.000Z","conversation_id":"736152708252639232","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"#CHMP recommends 6 new #medicines for approval during May meeting – check out highlights: https://t.co/0QLJqingF9 https://t.co/JC5XxZhDop","attachments":{"media_keys":["3_736143108157624320"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":102,"end":125,"url":"https://t.co/OrFvN4K2RT","expanded_url":"http://bit.ly/22r1ZfO","display_url":"bit.ly/22r1ZfO"}],"hashtags":[{"start":15,"end":30,"tag":"clinicaltrials"}],"mentions":{},"annotations":{}},"id":"736124769880408064","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-27T09:19:56.000Z","conversation_id":"736124769880408064","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":7,"quote_count":0},"lang":"en","text":"First-in-human #clinicaltrials: EMA starts EU-wide reflection on necessary changes to best practices: https://t.co/OrFvN4K2RT","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/11TOkoohy8","expanded_url":"http://bit.ly/1TGJ6BT","display_url":"bit.ly/1TGJ6BT"}],"hashtags":[{"start":132,"end":136,"tag":"AMR"}],"mentions":{},"annotations":{}},"id":"735853682684796930","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-26T15:22:44.000Z","conversation_id":"735853682684796930","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Comment on the recommendation to reduce use of colistin in animals to manage risk of resistance by 26 June: https://t.co/11TOkoohy8 #AMR","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/oQcMoKqDfV","expanded_url":"http://bit.ly/1TLBVcY","display_url":"bit.ly/1TLBVcY"}],"hashtags":[{"start":26,"end":34,"tag":"Uptravi"},{"start":36,"end":46,"tag":"selexipag"},{"start":56,"end":65,"tag":"medicine"},{"start":128,"end":140,"tag":"RareDisease"}],"mentions":{},"annotations":{}},"id":"735849469477015552","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-26T15:05:59.000Z","conversation_id":"735849469477015552","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"See assessment report for #Uptravi (#selexipag), orphan #medicine for  pulmonary arterial hypertension: https://t.co/oQcMoKqDfV #RareDisease","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/20jIzlXaL5","expanded_url":"http://bit.ly/247rQbR","display_url":"bit.ly/247rQbR"}],"hashtags":[{"start":44,"end":58,"tag":"antimicrobial"},{"start":113,"end":119,"tag":"ESVAC"}],"mentions":{},"annotations":{}},"id":"735461617689894912","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-25T13:24:48.000Z","conversation_id":"735461617689894912","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Report on collecting data on consumption of #antimicrobial agents in pigs now available: https://t.co/20jIzlXaL5 #ESVAC","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/xYiiCD5OqW","expanded_url":"http://europa.eu/!qk77Vy","display_url":"europa.eu/!qk77Vy"}],"hashtags":[{"start":68,"end":73,"tag":"Zika"},{"start":117,"end":120,"tag":"EU"},{"start":121,"end":128,"tag":"health"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":86,"end":91,"probability":0.9778,"type":"Place","normalized_text":"Europe"}]},"id":"735156374242504704","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-24T17:11:52.000Z","conversation_id":"735156374242504704","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Low to moderate risk of locally transmitted cases of #Zika in parts of Europe https://t.co/xYiiCD5OqW #EU #health https://t.…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"735150604985716736"}]},{"source":"TweetDeck","entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/DNPRHbjNEh","expanded_url":"http://bit.ly/1TvdTEW","display_url":"bit.ly/1TvdTEW"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":42,"end":53,"tag":"paediatric"},{"start":65,"end":70,"tag":"PDCO"}],"mentions":{},"annotations":{}},"id":"735155245169401856","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-24T17:07:23.000Z","conversation_id":"735155245169401856","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #agenda of this week's meeting of our #paediatric committee (#PDCO) is available: https://t.co/DNPRHbjNEh","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/5bAL07FjdV","expanded_url":"http://bit.ly/1LJWKhX","display_url":"bit.ly/1LJWKhX"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":25,"end":35,"tag":"guideline"}],"mentions":{},"annotations":{}},"id":"735055458881417216","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-24T10:30:52.000Z","conversation_id":"735055458881417216","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation closing on #guideline on the conduct of efficacy studies for intramammary products for use in cattle: https://t.co/5bAL07FjdV","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/2viJJN9fDZ","expanded_url":"http://bit.ly/24t31Kl","display_url":"bit.ly/24t31Kl"}],"hashtags":[{"start":53,"end":64,"tag":"veterinary"},{"start":65,"end":75,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"735054947356684288","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-24T10:28:50.000Z","conversation_id":"735054947356684288","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One week to comment on paper on the authorisation of #veterinary #medicines containing PBT or vPvB substances: https://t.co/2viJJN9fDZ","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/lnYFivnxJw","expanded_url":"http://bit.ly/1TKnkhu","display_url":"bit.ly/1TKnkhu"}],"hashtags":[{"start":41,"end":59,"tag":"pharmacovigilance"},{"start":71,"end":75,"tag":"GVP"}],"mentions":{},"annotations":{}},"id":"735052612429611008","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-24T10:19:34.000Z","conversation_id":"735052612429611008","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"One week left to comment on revised good #pharmacovigilance practices (#GVP) module on risk management systems: https://t.co/lnYFivnxJw","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/IuB3ZroK5l","expanded_url":"http://bit.ly/22lF8SD","display_url":"bit.ly/22lF8SD"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":89,"end":94,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"734711225523834880","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-23T11:43:01.000Z","conversation_id":"734711225523834880","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week's meeting of our committee for human medicines (#CHMP): https://t.co/IuB3ZroK5l","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/rtLTZsSAN7","expanded_url":"http://bit.ly/27HJmrU","display_url":"bit.ly/27HJmrU"}],"hashtags":[{"start":48,"end":59,"tag":"veterinary"},{"start":71,"end":76,"tag":"CVMP"}],"mentions":{},"annotations":{}},"id":"733672039979098112","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-20T14:53:39.000Z","conversation_id":"733672039979098112","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the highlights from this week's #veterinary committee (#CVMP) meeting: https://t.co/rtLTZsSAN7","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/KjQtasKa2h","expanded_url":"http://bit.ly/1U3Bz07","display_url":"bit.ly/1U3Bz07"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":52,"end":63,"tag":"paediatric"},{"start":75,"end":80,"tag":"PDCO"}],"mentions":{},"annotations":{}},"id":"733649537290620928","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-20T13:24:14.000Z","conversation_id":"733649537290620928","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #minutes of the 30 March-1 April meeting of our #paediatric committee (#PDCO) are now available: https://t.co/KjQtasKa2h","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/0N8xgg4xA1","expanded_url":"http://bit.ly/1YHWjM2","display_url":"bit.ly/1YHWjM2"}],"hashtags":[{"start":22,"end":28,"tag":"guide"},{"start":71,"end":81,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"733599450296258560","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-20T10:05:13.000Z","conversation_id":"733599450296258560","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":7,"quote_count":0},"lang":"en","text":"We’ve published a new #guide on accessing key EMA information on human #medicines: https://t.co/0N8xgg4xA1","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/bn4OkEOtK4","expanded_url":"http://bit.ly/1XChtNu","display_url":"bit.ly/1XChtNu"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":78,"end":82,"tag":"CAT"},{"start":122,"end":138,"tag":"advancedtherapy"}],"mentions":{},"annotations":{}},"id":"733319976938033152","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-19T15:34:41.000Z","conversation_id":"733319976938033152","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"The #agenda for this month's meeting of our committee for advanced therapies (#CAT) is available: https://t.co/bn4OkEOtK4 #advancedtherapy","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/uReLaasdEm","expanded_url":"http://bit.ly/1sBJlpu","display_url":"bit.ly/1sBJlpu"}],"hashtags":[{"start":42,"end":52,"tag":"Empliciti"},{"start":54,"end":65,"tag":"elotuzumab"},{"start":70,"end":79,"tag":"medicine"},{"start":93,"end":101,"tag":"myeloma"},{"start":127,"end":134,"tag":"cancer"}],"mentions":{},"annotations":{}},"id":"733313552480620545","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-19T15:09:09.000Z","conversation_id":"733313552480620545","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Empliciti (#elotuzumab), a #medicine for multiple #myeloma: https://t.co/uReLaasdEm #cancer","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":25,"end":29,"tag":"CEP"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"id":"733227151043010561","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-19T09:25:50.000Z","conversation_id":"733227151043010561","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: Are you a #CEP holder, an applicant or simply want to know more about e-submissions?  This webinar is for you! https://t.co/…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"733217376896876544"}]},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/XHkYpkM3Uc","expanded_url":"http://bit.ly/1suNlY0","display_url":"bit.ly/1suNlY0"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":28,"end":39,"tag":"veterinary"},{"start":40,"end":50,"tag":"medicines"},{"start":62,"end":67,"tag":"CVMP"}],"mentions":{},"annotations":{}},"id":"733226452670386180","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-19T09:23:03.000Z","conversation_id":"733226452670386180","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #agenda of this month's #veterinary #medicines committee (#CVMP) meeting is available: https://t.co/XHkYpkM3Uc","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/QH97SwqmgO","expanded_url":"http://bit.ly/1WDSsCD","display_url":"bit.ly/1WDSsCD"}],"hashtags":[{"start":12,"end":19,"tag":"agenda"},{"start":36,"end":43,"tag":"orphan"},{"start":44,"end":53,"tag":"medicine"},{"start":65,"end":70,"tag":"COMP"}],"mentions":{},"annotations":{}},"id":"733225831099695104","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-19T09:20:35.000Z","conversation_id":"733225831099695104","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Here is the #agenda of this month's #orphan #medicine committee (#COMP) meeting: https://t.co/QH97SwqmgO","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/MUB1DVdgmg","expanded_url":"http://europa.eu/!Mn39qV","display_url":"europa.eu/!Mn39qV"},{"start":115,"end":138,"url":"https://t.co/wTXJQBnNDC","expanded_url":"https://twitter.com/H2020SME/status/732838283802247168/photo/1","display_url":"pic.twitter.com/wTXJQBnNDC"}],"hashtags":[{"start":14,"end":20,"tag":"H2020"},{"start":21,"end":35,"tag":"SMEInstrument"},{"start":70,"end":79,"tag":"nanotech"}],"mentions":[{"start":3,"end":12,"username":"H2020SME","id":"874591855626858496"}],"annotations":{}},"id":"732843449020481536","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-18T08:01:08.000Z","conversation_id":"732843449020481536","public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @H2020SME: #H2020 #SMEInstrument: €31.83 M to fund ~75 projects in #nanotech in 2016!   https://t.co/MUB1DVdgmg https://t.co/wTXJQBnNDC","attachments":{"media_keys":["3_732838281939984384"]},"referenced_tweets":[{"type":"retweeted","id":"732838283802247168"}]},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/uOJFUAmbEd","expanded_url":"http://bit.ly/1V7BScE","display_url":"bit.ly/1V7BScE"},{"start":105,"end":128,"url":"https://t.co/uJPneUrqAQ","expanded_url":"https://twitter.com/EMA_News/status/732591688628195328/photo/1","display_url":"pic.twitter.com/uJPneUrqAQ"}],"hashtags":{},"mentions":{},"annotations":[{"start":43,"end":45,"probability":0.4796,"type":"Organization","normalized_text":"EMA"}]},"id":"732591688628195328","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-17T15:20:44.000Z","conversation_id":"732591688628195328","public_metrics":{"retweet_count":51,"reply_count":0,"like_count":26,"quote_count":0},"lang":"en","text":"Progress in science, medicine and health - EMA publishes its 2015 annual report: https://t.co/uOJFUAmbEd https://t.co/uJPneUrqAQ","attachments":{"media_keys":["3_732591494197039104"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/u5kjA6014k","expanded_url":"http://bit.ly/1rK2gxy","display_url":"bit.ly/1rK2gxy"}],"hashtags":[{"start":63,"end":81,"tag":"pharmacovigilance"},{"start":93,"end":98,"tag":"PRAC"}],"mentions":{},"annotations":{}},"id":"731138684674822146","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-13T15:07:00.000Z","conversation_id":"731138684674822146","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've published the highlights from this week's meeting of our #pharmacovigilance committee (#PRAC): https://t.co/u5kjA6014k","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/TRdwhB2C8z","expanded_url":"http://bit.ly/1R13t8m","display_url":"bit.ly/1R13t8m"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":73,"end":81,"tag":"generic"}],"mentions":{},"annotations":{}},"id":"731138026534019072","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-13T15:04:24.000Z","conversation_id":"731138026534019072","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation on reflection paper on the dissolution specification for 6 #generic oral immediate release products: https://t.co/TRdwhB2C8z","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/tMevKDjsOx","expanded_url":"http://bit.ly/1s4UvlM","display_url":"bit.ly/1s4UvlM"}],"hashtags":[{"start":42,"end":49,"tag":"Evalon"},{"start":53,"end":64,"tag":"veterinary"},{"start":65,"end":73,"tag":"vaccine"}],"mentions":{},"annotations":{}},"id":"731043513572438016","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-13T08:48:50.000Z","conversation_id":"731043513572438016","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Evalon, a #veterinary #vaccine for chickens: https://t.co/tMevKDjsOx","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/Xs6zeNgqOq","expanded_url":"http://bit.ly/1qhI6cT","display_url":"bit.ly/1qhI6cT"}],"hashtags":[{"start":32,"end":40,"tag":"Lonsurf"},{"start":42,"end":55,"tag":"trifluridine"},{"start":58,"end":68,"tag":"tipiracil"},{"start":73,"end":82,"tag":"medicine"},{"start":92,"end":103,"tag":"colorectal"},{"start":104,"end":111,"tag":"cancer"}],"mentions":{},"annotations":{}},"id":"731043084713242624","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-13T08:47:08.000Z","conversation_id":"731043084713242624","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Assessment report published for #Lonsurf (#trifluridine / #tipiracil), a #medicine to treat #colorectal #cancer: https://t.co/Xs6zeNgqOq","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/0oZk520hVL","expanded_url":"http://bit.ly/1VUhIDY","display_url":"bit.ly/1VUhIDY"}],"hashtags":[{"start":4,"end":15,"tag":"regulators"},{"start":43,"end":53,"tag":"medicines"}],"mentions":[{"start":109,"end":114,"username":"NEJM","id":"25950355"}],"annotations":{}},"id":"730725160358182912","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-12T11:43:49.000Z","conversation_id":"730725160358182912","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":7,"quote_count":0},"lang":"en","text":"Can #regulators influence affordability of #medicines? See views from top EMA and national authority reps in @NEJM https://t.co/0oZk520hVL","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/yUcwSN7hwu","expanded_url":"http://bit.ly/1WpJJne","display_url":"bit.ly/1WpJJne"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":49,"end":60,"tag":"paediatric"},{"start":81,"end":93,"tag":"Respiratory"}],"mentions":{},"annotations":{}},"id":"730415504297447424","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-11T15:13:21.000Z","conversation_id":"730415504297447424","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#Consultation open until 11 July on Inventory of #paediatric therapeutic needs - #Respiratory: https://t.co/yUcwSN7hwu","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/7O2fniZ3FE","expanded_url":"http://bit.ly/1rFZr0m","display_url":"bit.ly/1rFZr0m"}],"hashtags":[{"start":51,"end":55,"tag":"SME"},{"start":89,"end":93,"tag":"EMA"}],"mentions":{},"annotations":{}},"id":"730371721392492545","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-11T12:19:22.000Z","conversation_id":"730371721392492545","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the 10th anniversary report on our #SME initiative. Learn more about how #EMA supports SMEs at: https://t.co/7O2fniZ3FE","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/Hhv7zc06mK","expanded_url":"http://bit.ly/1WnsTWn","display_url":"bit.ly/1WnsTWn"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":42,"end":60,"tag":"pharmacovigilance"},{"start":72,"end":77,"tag":"PRAC"}],"mentions":{},"annotations":{}},"id":"730083679725342720","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-10T17:14:48.000Z","conversation_id":"730083679725342720","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #agenda of this week's meeting of our #pharmacovigilance committee (#PRAC) is available: https://t.co/Hhv7zc06mK","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/zwzPmaoTC4","expanded_url":"http://bit.ly/1Npy8BC","display_url":"bit.ly/1Npy8BC"}],"hashtags":[{"start":42,"end":53,"tag":"Paediatric"},{"start":68,"end":78,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"730075820430135297","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-10T16:43:34.000Z","conversation_id":"730075820430135297","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Find out about the new PIPs agreed by our #Paediatric committee for #medicines for children under development: https://t.co/zwzPmaoTC4","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/QiinGk1VGg","expanded_url":"http://bit.ly/1QQHu4f","display_url":"bit.ly/1QQHu4f"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":49,"end":60,"tag":"veterinary"},{"start":61,"end":71,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"729982951925133312","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-10T10:34:32.000Z","conversation_id":"729982951925133312","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation ending on statements on developing #veterinary #medicines using stem cells or monoclonal antibodies: https://t.co/QiinGk1VGg","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":68,"end":91,"url":"https://t.co/fbULyEoFko","expanded_url":"http://bit.ly/1ogXYf2","display_url":"bit.ly/1ogXYf2"}],"hashtags":[{"start":24,"end":31,"tag":"herbal"},{"start":32,"end":42,"tag":"monograph"},{"start":92,"end":105,"tag":"consultation"}],"mentions":{},"annotations":{}},"id":"729982376785383424","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-10T10:32:15.000Z","conversation_id":"729982376785383424","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Consultation closing on #herbal #monograph on Origanum majorana L.: https://t.co/fbULyEoFko #consultation","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/Ld6e6bDqHW","expanded_url":"http://bit.ly/1VggC1x","display_url":"bit.ly/1VggC1x"}],"hashtags":[{"start":30,"end":37,"tag":"herbal"},{"start":38,"end":48,"tag":"monograph"},{"start":107,"end":120,"tag":"consultation"}],"mentions":{},"annotations":{}},"id":"729981961603846148","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-10T10:30:36.000Z","conversation_id":"729981961603846148","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"A few days left to comment on #herbal #monograph on Salvia officinalis L., folium: https://t.co/Ld6e6bDqHW #consultation","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/v6GVUvMtpO","expanded_url":"http://bit.ly/1mCv5ZJ","display_url":"bit.ly/1mCv5ZJ"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":24,"end":31,"tag":"herbal"},{"start":32,"end":42,"tag":"monograph"}],"mentions":{},"annotations":{}},"id":"729981326753927168","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-10T10:28:05.000Z","conversation_id":"729981326753927168","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"cy","text":"#Consultation ending on #herbal #monograph on Harpagophytum procumbens DC. and/or Harpagophytum zeheyri Decne.: https://t.co/v6GVUvMtpO","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/UlOZdV7q0m","expanded_url":"http://bit.ly/1UyAmjf","display_url":"bit.ly/1UyAmjf"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":34,"end":44,"tag":"guideline"},{"start":81,"end":91,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"727838607973699585","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-04T12:33:41.000Z","conversation_id":"727838607973699585","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"#Consultation open on revision of #guideline on environmental risk assessment of #medicines for human use: https://t.co/UlOZdV7q0m","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/WelpZZbvWv","expanded_url":"http://bit.ly/1WJLyKw","display_url":"bit.ly/1WJLyKw"}],"hashtags":[{"start":31,"end":43,"tag":"procurement"},{"start":48,"end":56,"tag":"finance"}],"mentions":{},"annotations":{}},"id":"727783989868675073","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-04T08:56:39.000Z","conversation_id":"727783989868675073","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Apply for a role as contracts, #procurement and #finance officer in our central sourcing office. Deadline 22 May: https://t.co/WelpZZbvWv","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/p2Y4waPFza","expanded_url":"http://europa.eu/!QY64py","display_url":"europa.eu/!QY64py"}],"hashtags":[{"start":51,"end":55,"tag":"DYK"},{"start":72,"end":75,"tag":"EU"},{"start":96,"end":103,"tag":"eprd16"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":21,"end":48,"probability":0.7943,"type":"Other","normalized_text":"European Patients Rights Day"}]},"id":"727772190800793601","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-04T08:09:46.000Z","conversation_id":"727772190800793601","public_metrics":{"retweet_count":65,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Happy European Patients Rights Day! #DYK the 10 benefits #EU brings to patients? #eprd16 https://t.co/p2Y4waPFza https://t.c…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"727769919790682113"}]},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/NI2WvNglvi","expanded_url":"http://bit.ly/1rtbmyz","display_url":"bit.ly/1rtbmyz"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"}],"mentions":{},"annotations":{}},"id":"727496440130494464","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-03T13:54:02.000Z","conversation_id":"727496440130494464","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #minutes of the March meeting of our committee for advanced therapies (CAT) are available: https://t.co/NI2WvNglvi","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":59,"end":82,"url":"https://t.co/aIkmEnEcJk","expanded_url":"http://bit.ly/1pXW6s6","display_url":"bit.ly/1pXW6s6"}],"hashtags":[{"start":22,"end":30,"tag":"minutes"},{"start":44,"end":49,"tag":"PRAC"}],"mentions":{},"annotations":{}},"id":"727475808529428480","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-03T12:32:03.000Z","conversation_id":"727475808529428480","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We have published the #minutes of our March #PRAC meeting: https://t.co/aIkmEnEcJk","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":63,"end":86,"url":"https://t.co/d8vwcA4wfO","expanded_url":"http://bit.ly/1SW7Tlg","display_url":"bit.ly/1SW7Tlg"}],"hashtags":[{"start":30,"end":35,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"727474864479690752","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-03T12:28:18.000Z","conversation_id":"727474864479690752","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The minutes of the March 2016 #CHMP meeting are now available: https://t.co/d8vwcA4wfO","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/fbULyEoFko","expanded_url":"http://bit.ly/1ogXYf2","display_url":"bit.ly/1ogXYf2"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":17,"end":24,"tag":"herbal"},{"start":38,"end":47,"tag":"Origanum"}],"mentions":{},"annotations":{}},"id":"727112015878193153","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-02T12:26:28.000Z","conversation_id":"727112015878193153","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#Consultation on #herbal monograph on #Origanum majorana L., herba open for 2 more weeks https://t.co/fbULyEoFko","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/Ld6e6bDqHW","expanded_url":"http://bit.ly/1VggC1x","display_url":"bit.ly/1VggC1x"}],"hashtags":[{"start":39,"end":52,"tag":"consultation"},{"start":56,"end":63,"tag":"herbal"},{"start":77,"end":84,"tag":"Salvia"}],"mentions":{},"annotations":{}},"id":"727111446350422020","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-02T12:24:12.000Z","conversation_id":"727111446350422020","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Send  your comments: 2 weeks to go for #consultation on #herbal monograph on #Salvia officinalis L., folium: https://t.co/Ld6e6bDqHW","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/Ld6e6bDqHW","expanded_url":"http://bit.ly/1VggC1x","display_url":"bit.ly/1VggC1x"}],"hashtags":[{"start":25,"end":32,"tag":"herbal"},{"start":46,"end":53,"tag":"Salvia"},{"start":102,"end":115,"tag":"consultation"}],"mentions":{},"annotations":{}},"id":"727110882241744900","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-05-02T12:21:58.000Z","conversation_id":"727110882241744900","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"fr","text":"Send us your comments on #herbal monograph on #Salvia officinalis L., folium: https://t.co/Ld6e6bDqHW #consultation","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/ZmRcBUg4bQ","expanded_url":"http://bit.ly/1Tafyte","display_url":"bit.ly/1Tafyte"}],"hashtags":[{"start":90,"end":101,"tag":"Veterinary"}],"mentions":{},"annotations":{}},"id":"726097288540635136","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-29T17:14:18.000Z","conversation_id":"726097288540635136","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Comments invited on concept paper on DNA vaccines non-amplifiable in eukaryotic cells for #Veterinary use: https://t.co/ZmRcBUg4bQ","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":67,"end":90,"url":"https://t.co/ZKoktjXU2n","expanded_url":"http://bit.ly/1VEHZWz","display_url":"bit.ly/1VEHZWz"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"726096690722299905","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-29T17:11:55.000Z","conversation_id":"726096690722299905","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Consultation opens on reflection paper on anthelmintic resistance: https://t.co/ZKoktjXU2n","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/fX4ACnT2Gm","expanded_url":"http://bit.ly/1WvyuYC","display_url":"bit.ly/1WvyuYC"}],"hashtags":[{"start":56,"end":71,"tag":"bioequivalence"},{"start":95,"end":105,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"726096272466296832","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-29T17:10:16.000Z","conversation_id":"726096272466296832","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Comments invited on revision of guideline on conduct of #bioequivalence studies for veterinary #medicines https://t.co/fX4ACnT2Gm","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/Q9K9dD0Hx2","expanded_url":"http://bit.ly/1XYaJaB","display_url":"bit.ly/1XYaJaB"}],"hashtags":[{"start":72,"end":76,"tag":"3Rs"},{"start":102,"end":112,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"726095616183554049","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-29T17:07:39.000Z","conversation_id":"726095616183554049","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Consultation on reflection paper on opportunities for implementation of #3Rs in testing of veterinary #medicines https://t.co/Q9K9dD0Hx2","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":63,"end":86,"url":"https://t.co/g0kxMNwWgI","expanded_url":"http://bit.ly/1SPiFtp","display_url":"bit.ly/1SPiFtp"}],"hashtags":[{"start":24,"end":42,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"726093945453862913","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-29T17:01:01.000Z","conversation_id":"726093945453862913","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"Check out what's new in #pharmacovigilance on our QPPV Update: https://t.co/g0kxMNwWgI","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/YEMzowmlvu","expanded_url":"http://bit.ly/1pO1nm0","display_url":"bit.ly/1pO1nm0"},{"start":117,"end":140,"url":"https://t.co/jYIlT1PQvR","expanded_url":"https://twitter.com/EMA_News/status/726014924036661248/photo/1","display_url":"pic.twitter.com/jYIlT1PQvR"}],"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":25,"end":35,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"726014924036661248","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-29T11:47:01.000Z","conversation_id":"726014924036661248","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"#CHMP recommends six new #medicines for approval during April meeting. Check out highlights: https://t.co/YEMzowmlvu https://t.co/jYIlT1PQvR","attachments":{"media_keys":["3_726014662404354048"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/sj8YZCygTw","expanded_url":"http://bit.ly/1VEv0nM","display_url":"bit.ly/1VEv0nM"},{"start":102,"end":125,"url":"https://t.co/OE0Kvg9RWK","expanded_url":"https://twitter.com/EMA_News/status/726014220748378112/photo/1","display_url":"pic.twitter.com/OE0Kvg9RWK"}],"hashtags":[{"start":43,"end":53,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"726014220748378112","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-29T11:44:13.000Z","conversation_id":"726014220748378112","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"See infographic on our procedure to review #medicines for use outside the EU: https://t.co/sj8YZCygTw https://t.co/OE0Kvg9RWK","attachments":{"media_keys":["3_726013953390817280"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/Sfc1MFg6hJ","expanded_url":"http://bit.ly/1WuPluI","display_url":"bit.ly/1WuPluI"}],"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":38,"end":47,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"726013870528167936","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-29T11:42:50.000Z","conversation_id":"726013870528167936","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#CHMP positive scientific opinion for #medicine to help prevent umbilical cord infection in countries outside the EU https://t.co/Sfc1MFg6hJ","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/YAtA0t9Bvs","expanded_url":"http://bit.ly/1VXsQ2x","display_url":"bit.ly/1VXsQ2x"}],"hashtags":[{"start":4,"end":13,"tag":"medicine"},{"start":43,"end":57,"tag":"antimicrobial"},{"start":97,"end":102,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"726011843957891073","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-29T11:34:46.000Z","conversation_id":"726011843957891073","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"New #medicine to help in the fight against #antimicrobial resistance recommended for approval by #CHMP: https://t.co/YAtA0t9Bvs","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":80,"end":103,"url":"https://t.co/WYblWT3FHG","expanded_url":"http://bit.ly/1WuOgmK","display_url":"bit.ly/1WuOgmK"}],"hashtags":[{"start":39,"end":48,"tag":"medicine"},{"start":58,"end":69,"tag":"follicular"},{"start":104,"end":109,"tag":"rare"},{"start":119,"end":124,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"726011433004195840","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-29T11:33:08.000Z","conversation_id":"726011433004195840","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Extension of indication for authorised #medicine to treat #follicular lymphoma: https://t.co/WYblWT3FHG #rare diseases #CHMP","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/2AkOPHwDGd","expanded_url":"http://bit.ly/1TA5gFP","display_url":"bit.ly/1TA5gFP"}],"hashtags":[{"start":11,"end":16,"tag":"CHMP"},{"start":118,"end":123,"tag":"COPD"}],"mentions":{},"annotations":{}},"id":"726010989141987328","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-29T11:31:23.000Z","conversation_id":"726010989141987328","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Outcome of #CHMP review of inhaled corticosteroids for chronic obstructive pulmonary disease: https://t.co/2AkOPHwDGd #COPD","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/uFTvmeJmzN","expanded_url":"http://bit.ly/1YW5M2e","display_url":"bit.ly/1YW5M2e"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"}],"mentions":{},"annotations":{}},"id":"725975013820616704","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-29T09:08:25.000Z","conversation_id":"725975013820616704","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#Consultation open on reflection paper on collecting and reporting information on off-label use in pharmacovigilance https://t.co/uFTvmeJmzN","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/atLqqqdz6u","expanded_url":"http://bit.ly/1YVrOlQ","display_url":"bit.ly/1YVrOlQ"}],"hashtags":[{"start":54,"end":65,"tag":"veterinary"},{"start":66,"end":81,"tag":"antimicrobials"},{"start":107,"end":113,"tag":"ESVAC"},{"start":114,"end":118,"tag":"AMR"}],"mentions":{},"annotations":{}},"id":"725678859824287744","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-28T13:31:37.000Z","conversation_id":"725678859824287744","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We’ve published standardised units of measurement for #veterinary #antimicrobials: https://t.co/atLqqqdz6u #ESVAC #AMR","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/SdLRM4Zfp1","expanded_url":"http://bit.ly/1UiQ5TB","display_url":"bit.ly/1UiQ5TB"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"725633028781920256","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-28T10:29:30.000Z","conversation_id":"725633028781920256","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Involving GPs in regulatory decisions on medicines: EMA workshop kicks off strengthened collaboration: https://t.co/SdLRM4Zfp1","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/PBqQ9rvmiV","expanded_url":"http://bit.ly/1QCmNIR","display_url":"bit.ly/1QCmNIR"}],"hashtags":[{"start":17,"end":27,"tag":"medicines"},{"start":44,"end":51,"tag":"orphan"},{"start":71,"end":76,"tag":"COMP"},{"start":111,"end":124,"tag":"rarediseases"}],"mentions":{},"annotations":{}},"id":"725626685136244741","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-28T10:04:17.000Z","conversation_id":"725626685136244741","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Check out the 14 #medicines recommended for #orphan designation by the #COMP in April: https://t.co/PBqQ9rvmiV #rarediseases","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/uH5dMpHLwj","expanded_url":"http://bit.ly/1Ueya0h","display_url":"bit.ly/1Ueya0h"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":42,"end":53,"tag":"paediatric"}],"mentions":{},"annotations":{}},"id":"724939874340626432","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-26T12:35:09.000Z","conversation_id":"724939874340626432","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"The #agenda of this week's meeting of our #paediatric commitee (PDCO) is available: https://t.co/uH5dMpHLwj","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/GmxJjjGwFO","expanded_url":"http://bit.ly/1pxKjRc","display_url":"bit.ly/1pxKjRc"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":89,"end":94,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"724572700451168256","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-25T12:16:08.000Z","conversation_id":"724572700451168256","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week's meeting of our committee for human medicines (#CHMP): https://t.co/GmxJjjGwFO","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/WelpZZbvWv","expanded_url":"http://bit.ly/1WJLyKw","display_url":"bit.ly/1WJLyKw"}],"hashtags":[{"start":31,"end":43,"tag":"procurement"},{"start":48,"end":56,"tag":"finance"}],"mentions":{},"annotations":{}},"id":"723511343064686592","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-22T13:58:41.000Z","conversation_id":"723511343064686592","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Apply for a role as contracts, #procurement and #finance officer in our central sourcing office. Deadline 22 May: https://t.co/WelpZZbvWv","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/pHHwFMgrGz","expanded_url":"http://bit.ly/26jriDy","display_url":"bit.ly/26jriDy"}],"hashtags":[{"start":61,"end":72,"tag":"veterinary"}],"mentions":{},"annotations":{}},"id":"723507110349254656","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-22T13:41:51.000Z","conversation_id":"723507110349254656","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the highlights of this week's meeting of our #veterinary committee (CVMP): https://t.co/pHHwFMgrGz","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/VpvlAuI8by","expanded_url":"http://bit.ly/1Wh6Z51","display_url":"bit.ly/1Wh6Z51"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"723504680135999488","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-22T13:32:12.000Z","conversation_id":"723504680135999488","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"First DNA vaccine for use in salmon recommended for approval in the EU: https://t.co/VpvlAuI8by","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/I93FVmZO9m","expanded_url":"http://bit.ly/1r3Mayr","display_url":"bit.ly/1r3Mayr"}],"hashtags":[{"start":82,"end":91,"tag":"oncology"}],"mentions":{},"annotations":{}},"id":"723489238034067456","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-22T12:30:50.000Z","conversation_id":"723489238034067456","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"We have published new guidance on the use of patient-reported outcome measures in #oncology studies: https://t.co/I93FVmZO9m","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/daULiOc7pA","expanded_url":"http://bit.ly/1qG4XiK","display_url":"bit.ly/1qG4XiK"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":120,"end":136,"tag":"advancedtherapy"}],"mentions":{},"annotations":{}},"id":"723454428372602880","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-22T10:12:31.000Z","conversation_id":"723454428372602880","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #agenda of the April meeting of our committee for advanced therapies (CAT): https://t.co/daULiOc7pA #advancedtherapy","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/RU8sUczoE6","expanded_url":"http://bit.ly/1V5XrHK","display_url":"bit.ly/1V5XrHK"}],"hashtags":[{"start":39,"end":49,"tag":"guideline"}],"mentions":{},"annotations":{}},"id":"723452022930968576","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-22T10:02:58.000Z","conversation_id":"723452022930968576","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to go to comment on the draft #guideline on the SmPC for human anti-D immunoglobulin for intravenous use: https://t.co/RU8sUczoE6","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/rgMShmwwxu","expanded_url":"http://bit.ly/1o63K3I","display_url":"bit.ly/1o63K3I"}],"hashtags":[{"start":38,"end":48,"tag":"guideline"}],"mentions":{},"annotations":{}},"id":"723451567702069249","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-22T10:01:09.000Z","conversation_id":"723451567702069249","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One week left to comment on the draft #guideline on the SmPC for human anti-D immunoglobulin for intramuscular use: https://t.co/rgMShmwwxu","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/QfxERFIDyv","expanded_url":"http://bit.ly/1YItcbn","display_url":"bit.ly/1YItcbn"}],"hashtags":[{"start":42,"end":55,"tag":"Palonosetron"},{"start":82,"end":90,"tag":"generic"},{"start":91,"end":100,"tag":"medicine"},{"start":104,"end":110,"tag":"Aloxi"}],"mentions":{},"annotations":{}},"id":"723105919878488064","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-21T11:07:40.000Z","conversation_id":"723105919878488064","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Palonosetron Hospira (palonosetron), a #generic #medicine of #Aloxi: https://t.co/QfxERFIDyv","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/aq5z8q0P8w","expanded_url":"http://bit.ly/1Qpkusz","display_url":"bit.ly/1Qpkusz"}],"hashtags":[{"start":40,"end":50,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"723104675097120768","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-21T11:02:43.000Z","conversation_id":"723104675097120768","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Find out about the applications for new #medicines currently under evaluation by EMA: https://t.co/aq5z8q0P8w","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/oIIF33C7vP","expanded_url":"http://bit.ly/1NCTvK5","display_url":"bit.ly/1NCTvK5"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":26,"end":36,"tag":"guideline"},{"start":64,"end":78,"tag":"antibacterial"},{"start":79,"end":89,"tag":"medicines"},{"start":94,"end":105,"tag":"paediatric"}],"mentions":{},"annotations":{}},"id":"723102811353944064","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-21T10:55:19.000Z","conversation_id":"723102811353944064","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#Consultation on need for #guideline addendum on development of #antibacterial #medicines for #paediatric use: https://t.co/oIIF33C7vP","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/E5MlPoGFF1","expanded_url":"http://bit.ly/1pk0q4M","display_url":"bit.ly/1pk0q4M"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":56,"end":63,"tag":"orphan"},{"start":64,"end":74,"tag":"medicines"},{"start":76,"end":81,"tag":"COMP"}],"mentions":{},"annotations":{}},"id":"723079699765837824","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-21T09:23:29.000Z","conversation_id":"723079699765837824","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"The #agenda of this week's meeting of our committee for #orphan #medicines (#COMP) is available: https://t.co/E5MlPoGFF1","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/u3w8hG4LHC","expanded_url":"http://bit.ly/22KEHA5","display_url":"bit.ly/22KEHA5"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":27,"end":38,"tag":"veterinary"},{"start":60,"end":65,"tag":"CVMP"}],"mentions":{},"annotations":{}},"id":"722412227333079040","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-19T13:11:11.000Z","conversation_id":"722412227333079040","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #agenda of this week's #veterinary medicines committee (#CVMP) is available: https://t.co/u3w8hG4LHC","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":16,"end":24,"username":"WEBRADR","id":"2797520425"}],"annotations":[{"start":94,"end":95,"probability":0.9922,"type":"Place","normalized_text":"UK"},{"start":118,"end":124,"probability":0.9956,"type":"Place","normalized_text":"Croatia"}]},"id":"722035262239453185","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-18T12:13:15.000Z","conversation_id":"722035262239453185","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @IMI_JU: The @WEBRADR app allows you to report side effects of medicines. Now available in UK &amp; NL, coming soon in Croatia... https://t.…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"721998804984164353"}]},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/llwmHQY1a8","expanded_url":"http://bit.ly/1VwlgMa","display_url":"bit.ly/1VwlgMa"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":58,"end":65,"tag":"herbal"}],"mentions":{},"annotations":{}},"id":"721988266497568768","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-18T09:06:31.000Z","conversation_id":"721988266497568768","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #minutes of the February meeting of our committee for #herbal medicines (HMPC) are available: https://t.co/llwmHQY1a8","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/ffsu4hOGqD","expanded_url":"http://bit.ly/265A1sW","display_url":"bit.ly/265A1sW"}],"hashtags":[{"start":66,"end":77,"tag":"Paediatric"}],"mentions":{},"annotations":{}},"id":"720987601621094400","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-15T14:50:14.000Z","conversation_id":"720987601621094400","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Registration opens for annual workshop of the European Network of #Paediatric Research at EMA (Enpr-EMA) on 2 June: https://t.co/ffsu4hOGqD","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/EoGFqIqwfL","expanded_url":"http://bit.ly/1YxffwG","display_url":"bit.ly/1YxffwG"}],"hashtags":[{"start":49,"end":59,"tag":"medicines"},{"start":61,"end":66,"tag":"PRAC"}],"mentions":{},"annotations":{}},"id":"720943615724425216","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-15T11:55:27.000Z","conversation_id":"720943615724425216","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Listening to the public’s views on the safety of #medicines: #PRAC adopts rules of procedure on public hearings https://t.co/EoGFqIqwfL","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":102,"end":125,"url":"https://t.co/Ufcq5nHzn7","expanded_url":"http://bit.ly/1NcCyvg","display_url":"bit.ly/1NcCyvg"}],"hashtags":[{"start":63,"end":81,"tag":"pharmacovigilance"},{"start":93,"end":98,"tag":"PRAC"}],"mentions":{},"annotations":{}},"id":"720943156225814528","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-15T11:53:37.000Z","conversation_id":"720943156225814528","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"We've published the highlights from this week's meeting of our #pharmacovigilance committee (#PRAC) : https://t.co/Ufcq5nHzn7","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/RU8sUczoE6","expanded_url":"http://bit.ly/1V5XrHK","display_url":"bit.ly/1V5XrHK"}],"hashtags":[{"start":35,"end":45,"tag":"guideline"}],"mentions":{},"annotations":{}},"id":"720902976135634944","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-15T09:13:57.000Z","conversation_id":"720902976135634944","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two weeks left to comment on draft #guideline on the SmPC for human anti-D immunoglobulin for intravenous use: https://t.co/RU8sUczoE6","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/rgMShmeVFW","expanded_url":"http://bit.ly/1o63K3I","display_url":"bit.ly/1o63K3I"}],"hashtags":[{"start":36,"end":46,"tag":"guideline"}],"mentions":{},"annotations":{}},"id":"720902590058405888","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-15T09:12:25.000Z","conversation_id":"720902590058405888","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two weeks to go to comment on draft #guideline on the SmPC for human anti-D immunoglobulin for intramuscular use: https://t.co/rgMShmeVFW","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/1rhUfFgyT9","expanded_url":"http://bit.ly/1RY814z","display_url":"bit.ly/1RY814z"}],"hashtags":{},"mentions":[{"start":0,"end":10,"username":"MarkDuman","id":"612922732"}],"annotations":{}},"id":"720900516193112065","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-15T09:04:11.000Z","conversation_id":"720873882953977856","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"@MarkDuman Thank you for your interest. You will find information on patient involvement in our activities here: https://t.co/1rhUfFgyT9","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"720873882953977856"}],"in_reply_to_user_id":"612922732"},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/CtlFxNZJEY","expanded_url":"http://bit.ly/1RVCPCZ","display_url":"bit.ly/1RVCPCZ"}],"hashtags":[{"start":35,"end":40,"tag":"HTAs"}],"mentions":[{"start":72,"end":81,"username":"EUnetHTA","id":"56493220"}],"annotations":{}},"id":"720559670549692416","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-14T10:29:47.000Z","conversation_id":"720559670549692416","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":8,"quote_count":0},"lang":"en","text":"Cooperation between regulators and #HTAs creates synergies: see ΕΜΑ and @EUnetHTA joint 2012-2015 work plan report https://t.co/CtlFxNZJEY","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/vy348bnDit","expanded_url":"http://bit.ly/1qI0U5T","display_url":"bit.ly/1qI0U5T"}],"hashtags":[{"start":29,"end":35,"tag":"Wakix"},{"start":37,"end":48,"tag":"pitolisant"},{"start":53,"end":62,"tag":"medicine"},{"start":84,"end":95,"tag":"narcolepsy"}],"mentions":{},"annotations":{}},"id":"720276191052226560","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-13T15:43:20.000Z","conversation_id":"720276191052226560","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"We've published the EPAR for #Wakix (#pitolisant), a #medicine to treat adults with #narcolepsy, a sleep disorder: https://t.co/vy348bnDit","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":120,"end":143,"url":"https://t.co/y2wk0jrDYn","expanded_url":"http://bit.ly/1RTKzoT","display_url":"bit.ly/1RTKzoT"}],"hashtags":[{"start":0,"end":10,"tag":"guideline"}],"mentions":{},"annotations":{}},"id":"720241792440995840","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-13T13:26:39.000Z","conversation_id":"720241792440995840","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"#guideline published on the sterilisation of the medicinal product, active substance, excipient &amp; primary container https://t.co/y2wk0jrDYn","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/uFDq0S7kUW","expanded_url":"http://bit.ly/1VlKNHK","display_url":"bit.ly/1VlKNHK"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":36,"end":47,"tag":"paediatric"},{"start":59,"end":64,"tag":"PDCO"}],"mentions":{},"annotations":{}},"id":"720239748170657792","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-13T13:18:32.000Z","conversation_id":"720239748170657792","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #minutes of our #paediatric committee (#PDCO) meeting in February: https://t.co/uFDq0S7kUW","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/FjSamdR47F","expanded_url":"http://bit.ly/1Nmhm0k","display_url":"bit.ly/1Nmhm0k"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":42,"end":60,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"719843118099501057","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-12T11:02:28.000Z","conversation_id":"719843118099501057","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"The #agenda of this week's meeting of our #pharmacovigilance committee (PRAC) is available: https://t.co/FjSamdR47F","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/ISMQYHk48U","expanded_url":"http://bit.ly/1Q2E9hx","display_url":"bit.ly/1Q2E9hx"}],"hashtags":[{"start":0,"end":11,"tag":"Paediatric"},{"start":44,"end":54,"tag":"medicines"},{"start":59,"end":68,"tag":"children"}],"mentions":{},"annotations":{}},"id":"719425319212597248","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-11T07:22:17.000Z","conversation_id":"719425319212597248","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":6,"quote_count":0},"lang":"en","text":"#Paediatric Committee agrees 8 new PIPs for #medicines for #children under development https://t.co/ISMQYHk48U","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":35,"end":58,"url":"https://t.co/Xu4xLh2HbY","expanded_url":"http://bit.ly/1oJfEQq","display_url":"bit.ly/1oJfEQq"}],"hashtags":[{"start":59,"end":66,"tag":"ribfp7"}],"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"}],"annotations":{}},"id":"718486273514717184","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-08T17:10:51.000Z","conversation_id":"718486273514717184","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @myCORDIS: Rapid drug discovery https://t.co/Xu4xLh2HbY #ribfp7","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"718485022425022464"}]},{"source":"TweetDeck","entities":{"urls":[{"start":74,"end":97,"url":"https://t.co/NV0cHsK8OZ","expanded_url":"http://bit.ly/1UHELB9","display_url":"bit.ly/1UHELB9"}],"hashtags":[{"start":49,"end":59,"tag":"shortages"},{"start":63,"end":73,"tag":"medicines"}],"mentions":[{"start":6,"end":17,"username":"DIA_Europe","id":"271864727"},{"start":23,"end":32,"username":"EMA_News","id":"116716199"}],"annotations":{}},"id":"718454773511536640","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-08T15:05:40.000Z","conversation_id":"718454773511536640","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Today @DIA_Europe what @EMA_news does to address #shortages of #medicines https://t.co/NV0cHsK8OZ","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":42,"end":65,"url":"https://t.co/AfQUZXocql","expanded_url":"http://bit.ly/1NdoU5H","display_url":"bit.ly/1NdoU5H"}],"hashtags":[{"start":18,"end":23,"tag":"PRAC"},{"start":33,"end":41,"tag":"minutes"}],"mentions":{},"annotations":{}},"id":"718418286015287296","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-08T12:40:41.000Z","conversation_id":"718418286015287296","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We have published #PRAC February #minutes https://t.co/AfQUZXocql","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/qOJN6MXnUP","expanded_url":"http://bit.ly/Flunews","display_url":"bit.ly/Flunews"}],"hashtags":[{"start":14,"end":24,"tag":"influenza"},{"start":74,"end":81,"tag":"Europe"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"annotations":{}},"id":"718417430171803648","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-08T12:37:17.000Z","conversation_id":"718417430171803648","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: #influenza indicators decreasing, but remains widespread in #Europe This week's data at: https://t.co/qOJN6MXnUP https://t.co…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"718417155679789056"}]},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/sEwymFRXfK","expanded_url":"http://bit.ly/1VDJeE3","display_url":"bit.ly/1VDJeE3"}],"hashtags":[{"start":35,"end":42,"tag":"cancer"},{"start":43,"end":59,"tag":"immunotherapies"}],"mentions":{},"annotations":{}},"id":"718416251031273473","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-08T12:32:36.000Z","conversation_id":"718416251031273473","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"Presentations from our workshop on #cancer #immunotherapies are now published https://t.co/sEwymFRXfK","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/qQPEjhbuuW","expanded_url":"http://bit.ly/20BJtk0","display_url":"bit.ly/20BJtk0"}],"hashtags":[{"start":70,"end":79,"tag":"academia"},{"start":124,"end":137,"tag":"consultation"}],"mentions":{},"annotations":{}},"id":"718402962096267266","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-08T11:39:48.000Z","conversation_id":"718402962096267266","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"One week left to respond to our questionnaire on our interaction with #academia, deadline 15 April: https://t.co/qQPEjhbuuW #consultation","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":9,"username":"ninawren","id":"20226444"}],"annotations":{}},"id":"718365908314533888","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-08T09:12:33.000Z","conversation_id":"718021276267319296","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"@ninawren The report is under preparation for publication in Q2","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"718021276267319296"}],"in_reply_to_user_id":"20226444"},{"source":"TweetDeck","entities":{"urls":[{"start":51,"end":74,"url":"https://t.co/vMoCVg45b4","expanded_url":"http://bit.ly/1SOX6sK","display_url":"bit.ly/1SOX6sK"}],"hashtags":[{"start":35,"end":50,"tag":"EudraVigilance"}],"mentions":[{"start":6,"end":17,"username":"DIA_Europe","id":"271864727"}],"annotations":{}},"id":"718360747479343104","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-08T08:52:03.000Z","conversation_id":"718360747479343104","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"Today @DIA_Europe planning for new #EudraVigilance https://t.co/vMoCVg45b4","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/2sUdJDRF0C","expanded_url":"http://bit.ly/1PWyidE","display_url":"bit.ly/1PWyidE"}],"hashtags":[{"start":32,"end":43,"tag":"antibiotic"},{"start":60,"end":73,"tag":"consultation"},{"start":83,"end":89,"tag":"ESVAC"},{"start":136,"end":140,"tag":"AMR"}],"mentions":{},"annotations":{}},"id":"718103749236015109","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-07T15:50:50.000Z","conversation_id":"718103749236015109","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Collecting high-quality data on #antibiotic use in animals: #consultation opens on #ESVAC strategy for 2016-20: https://t.co/2sUdJDRF0C #AMR","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":102,"end":125,"url":"https://t.co/vPQPzHFUbK","expanded_url":"http://bit.ly/1UEyfeX","display_url":"bit.ly/1UEyfeX"}],"hashtags":[{"start":39,"end":50,"tag":"Scientific"},{"start":91,"end":101,"tag":"medicines"}],"mentions":[{"start":6,"end":17,"username":"DIA_Europe","id":"271864727"}],"annotations":{}},"id":"717994219319783424","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-07T08:35:36.000Z","conversation_id":"717994219319783424","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"Today @DIA_Europe Joint Regulatory-HTA #Scientific Advice for more rational development of #medicines https://t.co/vPQPzHFUbK","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":67,"end":76,"tag":"diabetes"},{"start":81,"end":96,"tag":"WorldHealthDay"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":41,"end":55,"probability":0.2922,"type":"Place","normalized_text":"European Region"}]},"id":"717984278878019584","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-07T07:56:06.000Z","conversation_id":"717984278878019584","public_metrics":{"retweet_count":115,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO_Europe: 64 million people in the European Region live with #diabetes. On #WorldHealthDay join us to raise awareness https://t.co/nc…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"717983255832690688"}]},{"source":"TweetDeck","entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/iMxSjEt9hQ","expanded_url":"http://bit.ly/1QFnKRK","display_url":"bit.ly/1QFnKRK"}],"hashtags":[{"start":36,"end":42,"tag":"PRIME"}],"mentions":[{"start":71,"end":82,"username":"DIA_Europe","id":"271864727"}],"annotations":[{"start":57,"end":69,"probability":0.9824,"type":"Person","normalized_text":"Jordi Linares"}]},"id":"717983426108858368","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-07T07:52:42.000Z","conversation_id":"717983426108858368","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"“We’ve received 19 applications for #PRIME since launch” Jordi Linares @DIA_Europe https://t.co/iMxSjEt9hQ","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":70,"end":93,"url":"https://t.co/MJWkjPTFbm","expanded_url":"http://bit.ly/1RNe7kK","display_url":"bit.ly/1RNe7kK"}],"hashtags":[{"start":18,"end":24,"tag":"PRIME"}],"mentions":[{"start":6,"end":17,"username":"DIA_Europe","id":"271864727"}],"annotations":{}},"id":"717975258649726976","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-07T07:20:15.000Z","conversation_id":"717975258649726976","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Today @DIA_Europe #PRIME or how we support patient-focused innovation https://t.co/MJWkjPTFbm","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/AZSfOl89i8","expanded_url":"http://bit.ly/207Acj7","display_url":"bit.ly/207Acj7"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"}],"mentions":{},"annotations":{}},"id":"717733402993172480","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-06T15:19:12.000Z","conversation_id":"717733402993172480","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #minutes of the February meeting of our committee for advanced therapies (CAT) are available: https://t.co/AZSfOl89i8","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/EjWrbYSzey","expanded_url":"http://bit.ly/1TBPw79","display_url":"bit.ly/1TBPw79"},{"start":117,"end":140,"url":"https://t.co/jNm5SOA25Z","expanded_url":"http://bit.ly/150UJve","display_url":"bit.ly/150UJve"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"717709111723474945","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-06T13:42:41.000Z","conversation_id":"717709111723474945","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":10,"quote_count":0},"lang":"en","text":"Information for applicants applying for EU's Horizon 2020 - New therapies for rare diseases: https://t.co/EjWrbYSzey https://t.co/jNm5SOA25Z","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/RuZe8nAGJ3","expanded_url":"http://bit.ly/1WbVpZn","display_url":"bit.ly/1WbVpZn"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"}],"mentions":{},"annotations":{}},"id":"717675687939817472","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-06T11:29:52.000Z","conversation_id":"717675687939817472","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #minutes of the February meeting of our committee for human medicines (CHMP) are available: https://t.co/RuZe8nAGJ3","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/6S2l14FJPu","expanded_url":"http://bit.ly/1MRXWpp","display_url":"bit.ly/1MRXWpp"}],"hashtags":[{"start":32,"end":43,"tag":"Amlodipine"}],"mentions":{},"annotations":{}},"id":"717673546395291648","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-06T11:21:21.000Z","conversation_id":"717673546395291648","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Assessment report published for #Amlodipine / Valsartan Mylan, a generic medicine for essential hypertension: https://t.co/6S2l14FJPu","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/V8IJikMRzE","expanded_url":"http://bit.ly/1MNEaeH","display_url":"bit.ly/1MNEaeH"}],"hashtags":[{"start":45,"end":55,"tag":"Medicines"}],"mentions":[{"start":6,"end":17,"username":"DIA_Europe","id":"271864727"}],"annotations":[{"start":18,"end":37,"probability":0.4399,"type":"Organization","normalized_text":"Regulatory Town Hall"}]},"id":"717670778884513792","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-06T11:10:22.000Z","conversation_id":"717670778884513792","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Today @DIA_Europe Regulatory Town Hall on EU #Medicines Agencies Network Strategy to 2020: https://t.co/V8IJikMRzE","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/Hh1tyzDPqR","expanded_url":"http://bit.ly/1XgxnKS","display_url":"bit.ly/1XgxnKS"}],"hashtags":[{"start":22,"end":33,"tag":"Zonisamide"}],"mentions":{},"annotations":[{"start":34,"end":38,"probability":0.4606,"type":"Organization","normalized_text":"Mylan"}]},"id":"717652365575397377","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-06T09:57:11.000Z","conversation_id":"717652365575397377","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Assessment report for #Zonisamide Mylan, a generic medicine to treat patients with partial seizures, is available: https://t.co/Hh1tyzDPqR","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/momHmVbbeX","expanded_url":"http://bit.ly/1RWcNhv","display_url":"bit.ly/1RWcNhv"}],"hashtags":[{"start":3,"end":13,"tag":"medicines"},{"start":30,"end":37,"tag":"orphan"},{"start":57,"end":62,"tag":"COMP"},{"start":97,"end":110,"tag":"rarediseases"}],"mentions":{},"annotations":{}},"id":"717354751441125376","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-05T14:14:35.000Z","conversation_id":"717354751441125376","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"18 #medicines recommended for #orphan designation by the #COMP in March: https://t.co/momHmVbbeX #rarediseases","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/hwFfy4P6Ho","expanded_url":"http://bit.ly/1VqmBTx","display_url":"bit.ly/1VqmBTx"}],"hashtags":[{"start":13,"end":22,"tag":"Coagadex"},{"start":25,"end":34,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"717017340676845571","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-04T15:53:50.000Z","conversation_id":"717017340676845571","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"EPAR out for #Coagadex a #medicine for the prevention of bleeding episodes in patients with factor X deficiency: https://t.co/hwFfy4P6Ho","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/YxHH2iFUM4","expanded_url":"http://bit.ly/1SMfN0d","display_url":"bit.ly/1SMfN0d"}],"hashtags":[{"start":71,"end":82,"tag":"paediatric"}],"mentions":{},"annotations":{}},"id":"717009864292216832","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-04T15:24:07.000Z","conversation_id":"717009864292216832","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"How data extrapolation from adults to children can help development of #paediatric medicines: draft reflection paper https://t.co/YxHH2iFUM4","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/07Ku1ubXKr","expanded_url":"http://bit.ly/1TvYGlt","display_url":"bit.ly/1TvYGlt"}],"hashtags":[{"start":31,"end":39,"tag":"PROTECT"},{"start":93,"end":103,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"716993133448396800","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-04T14:17:38.000Z","conversation_id":"716993133448396800","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Find out how findings from the #PROTECT project are improving the benefit-risk monitoring of #medicines: https://t.co/07Ku1ubXKr","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/iDurI7MvMI","expanded_url":"http://bit.ly/1SMa0Yr","display_url":"bit.ly/1SMa0Yr"}],"hashtags":[{"start":58,"end":76,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"716983962334208005","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-04T13:41:12.000Z","conversation_id":"716983962334208005","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Sign up to attend our workshop on measuring the impact of #pharmacovigilance activities, 5-6 Dec 2016: https://t.co/iDurI7MvMI","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/kdT71M1wsh","expanded_url":"http://bit.ly/1RQ7uwS","display_url":"bit.ly/1RQ7uwS"}],"hashtags":[{"start":35,"end":51,"tag":"multiplemyeloma"},{"start":67,"end":72,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"715922804349222912","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-01T15:24:32.000Z","conversation_id":"715922804349222912","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"New treatment for EU patients with #multiplemyeloma recommended by #CHMP https://t.co/kdT71M1wsh","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":75,"end":98,"url":"https://t.co/rAn9cWXCNv","expanded_url":"http://bit.ly/1UYF8r3","display_url":"bit.ly/1UYF8r3"}],"hashtags":[{"start":25,"end":31,"tag":"Fabry"}],"mentions":{},"annotations":{}},"id":"715922306871259140","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-01T15:22:33.000Z","conversation_id":"715922306871259140","public_metrics":{"retweet_count":21,"reply_count":1,"like_count":10,"quote_count":0},"lang":"en","text":"First oral treatment for #Fabry disease recommended for approval in the EU https://t.co/rAn9cWXCNv","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/e3eRkegdBP","expanded_url":"http://bit.ly/1RRxUSb","display_url":"bit.ly/1RRxUSb"}],"hashtags":[{"start":4,"end":16,"tag":"genetherapy"},{"start":69,"end":73,"tag":"ADA"},{"start":74,"end":79,"tag":"SCID"},{"start":108,"end":113,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"715921822856949760","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-01T15:20:38.000Z","conversation_id":"715921822856949760","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"New #genetherapy for treatment of children with rare immune disorder #ADA #SCID recommended for approval by #CHMP\nhttps://t.co/e3eRkegdBP","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/yInpRTcCKD","expanded_url":"http://bit.ly/22Vfatf","display_url":"bit.ly/22Vfatf"},{"start":115,"end":138,"url":"https://t.co/12Bh7kgiG7","expanded_url":"https://twitter.com/EMA_News/status/715921314427617280/photo/1","display_url":"pic.twitter.com/12Bh7kgiG7"}],"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":23,"end":33,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"715921314427617280","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-01T15:18:37.000Z","conversation_id":"715921314427617280","public_metrics":{"retweet_count":19,"reply_count":1,"like_count":3,"quote_count":0},"lang":"en","text":"#CHMP recommends 7 new #medicines for approval during March meeting – check out highlights https://t.co/yInpRTcCKD https://t.co/12Bh7kgiG7","attachments":{"media_keys":["3_715912166294073344"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/qQPEjhbuuW","expanded_url":"http://bit.ly/20BJtk0","display_url":"bit.ly/20BJtk0"}],"hashtags":[{"start":53,"end":62,"tag":"academia"},{"start":107,"end":120,"tag":"consultation"}],"mentions":{},"annotations":{}},"id":"715820743146213376","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-01T08:38:59.000Z","conversation_id":"715820743146213376","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Respond to our questionnaire on our interaction with #academia, deadline 15 April: https://t.co/qQPEjhbuuW #consultation","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":74,"end":97,"url":"https://t.co/aejlaw3C9F","expanded_url":"http://bit.ly/1UH04mH","display_url":"bit.ly/1UH04mH"}],"hashtags":[{"start":23,"end":38,"tag":"herbalmedicine"}],"mentions":{},"annotations":{}},"id":"715817760375312384","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-04-01T08:27:07.000Z","conversation_id":"715817760375312384","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Agenda for next week's #herbalmedicine committee meeting is now available https://t.co/aejlaw3C9F","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/vPQPzHFUbK","expanded_url":"http://bit.ly/1UEyfeX","display_url":"bit.ly/1UEyfeX"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.6001,"type":"Organization","normalized_text":"EMA"}]},"id":"715501158232690689","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-31T11:29:04.000Z","conversation_id":"715501158232690689","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"EMA publishes report on pilot on parallel scientific advice with HTA bodies. Read our press release here: https://t.co/vPQPzHFUbK","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":70,"end":93,"url":"https://t.co/jWbirN31ng","expanded_url":"http://bit.ly/1Tir6iE","display_url":"bit.ly/1Tir6iE"}],"hashtags":[{"start":4,"end":15,"tag":"paediatric"}],"mentions":{},"annotations":{}},"id":"715170567272448001","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-30T13:35:25.000Z","conversation_id":"715170567272448001","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Our #paediatric committee is meeting this week. Check out the agenda: https://t.co/jWbirN31ng","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/s85txoM1fL","expanded_url":"http://bit.ly/1XZTRjk","display_url":"bit.ly/1XZTRjk"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":34,"end":43,"tag":"medicine"},{"start":55,"end":60,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"714796423733190656","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-29T12:48:42.000Z","conversation_id":"714796423733190656","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #agenda for this week's human #medicine committee (#CHMP) meeting is available: https://t.co/s85txoM1fL","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/iSp8G6dnmi","expanded_url":"http://ec.europa.eu/eipp","display_url":"ec.europa.eu/eipp"}],"hashtags":[{"start":119,"end":128,"tag":"investEU"}],"mentions":[{"start":3,"end":17,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"id":"712185764935823362","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-22T07:54:52.000Z","conversation_id":"712185764935823362","public_metrics":{"retweet_count":51,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Commission: Do you have a project idea and are looking for funds? Let investors know at https://t.co/iSp8G6dnmi #investEU https://t.…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"712184556271620096"}]},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":36,"end":44,"tag":"vaccine"}],"mentions":[{"start":3,"end":18,"username":"WHO_Europe_VPI","id":"561122363"},{"start":24,"end":28,"username":"WHO","id":"14499829"}],"annotations":{}},"id":"712182514106966016","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-22T07:41:57.000Z","conversation_id":"712182514106966016","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO_Europe_VPI: New @WHO global #vaccine development tracker brings together info on candidate vaccines in devt for 7 diseases https://…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"712182395991150592"}]},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/cKzErSX65C","expanded_url":"http://bit.ly/1ScZ1ab","display_url":"bit.ly/1ScZ1ab"}],"hashtags":[{"start":42,"end":54,"tag":"Caspofungin"},{"start":66,"end":77,"tag":"antifungal"},{"start":78,"end":86,"tag":"generic"},{"start":87,"end":96,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"711928537989648384","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-21T14:52:45.000Z","conversation_id":"711928537989648384","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Caspofungin Accord, an #antifungal #generic #medicine: https://t.co/cKzErSX65C","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":46,"end":69,"url":"https://t.co/nTWaLae2uX","expanded_url":"http://bit.ly/1RuzIn9","display_url":"bit.ly/1RuzIn9"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"711870141345169408","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-21T11:00:42.000Z","conversation_id":"711870141345169408","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Highlights from the Management Board meeting: https://t.co/nTWaLae2uX","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/MkX8VZJDUi","expanded_url":"http://bit.ly/1SYbwbR","display_url":"bit.ly/1SYbwbR"}],"hashtags":[{"start":42,"end":51,"tag":"Feraccru"},{"start":71,"end":80,"tag":"medicine"},{"start":85,"end":93,"tag":"anaemia"}],"mentions":{},"annotations":{}},"id":"710837316907081728","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-18T14:36:37.000Z","conversation_id":"710837316907081728","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Feraccru (ferric maltol), a #medicine for #anaemia: https://t.co/MkX8VZJDUi","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/XLFtzPwDUx","expanded_url":"http://bit.ly/21yZNRb","display_url":"bit.ly/21yZNRb"}],"hashtags":[{"start":0,"end":5,"tag":"PRAC"},{"start":75,"end":91,"tag":"corticosteroids"},{"start":96,"end":101,"tag":"COPD"}],"mentions":{},"annotations":{}},"id":"710804643186647040","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-18T12:26:47.000Z","conversation_id":"710804643186647040","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#PRAC has concluded its review of the known risk of pneumonia with inhaled #corticosteroids for #COPD: https://t.co/XLFtzPwDUx","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/snlLKJHnCm","expanded_url":"http://bit.ly/1PfZNyz","display_url":"bit.ly/1PfZNyz"}],"hashtags":[{"start":0,"end":5,"tag":"PRAC"},{"start":41,"end":48,"tag":"cancer"},{"start":58,"end":66,"tag":"Zydelig"}],"mentions":{},"annotations":{}},"id":"710804049801641984","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-18T12:24:26.000Z","conversation_id":"710804049801641984","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"#PRAC recommends new safety measures for #cancer medicine #Zydelig while its review is ongoing: https://t.co/snlLKJHnCm","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/xRCQR6nkG3","expanded_url":"http://bit.ly/1pQbkA8","display_url":"bit.ly/1pQbkA8"}],"hashtags":[{"start":55,"end":73,"tag":"pharmacovigilance"},{"start":85,"end":90,"tag":"PRAC"}],"mentions":{},"annotations":{}},"id":"710803328620503040","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-18T12:21:34.000Z","conversation_id":"710803328620503040","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Check out the highlights of this week’s meeting of our #pharmacovigilance committee (#PRAC): https://t.co/xRCQR6nkG3","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/NnwujKk4NU","expanded_url":"http://bit.ly/1SVtprT","display_url":"bit.ly/1SVtprT"},{"start":114,"end":137,"url":"https://t.co/yMxuzH02Db","expanded_url":"https://twitter.com/EMA_News/status/710776792420884480/photo/1","display_url":"pic.twitter.com/yMxuzH02Db"}],"hashtags":{},"mentions":{},"annotations":[{"start":19,"end":28,"probability":0.5103,"type":"Person","normalized_text":"Guido Rasi"},{"start":66,"end":82,"probability":0.8435,"type":"Person","normalized_text":"Christa Wirthumer"}]},"id":"710776792420884480","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-18T10:36:07.000Z","conversation_id":"710776792420884480","public_metrics":{"retweet_count":14,"reply_count":2,"like_count":7,"quote_count":0},"lang":"en","text":"Executive Director Guido Rasi welcomes new Management Board chair Christa Wirthumer-Hoche https://t.co/NnwujKk4NU https://t.co/yMxuzH02Db","attachments":{"media_keys":["3_710776526749503489"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":68,"end":91,"url":"https://t.co/NnwujKk4NU","expanded_url":"http://bit.ly/1SVtprT","display_url":"bit.ly/1SVtprT"},{"start":92,"end":115,"url":"https://t.co/wmSVMdDyvL","expanded_url":"https://twitter.com/EMA_News/status/710478136866164736/photo/1","display_url":"pic.twitter.com/wmSVMdDyvL"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":16,"probability":0.9709,"type":"Person","normalized_text":"Christa Wirthumer"}]},"id":"710478136866164736","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-17T14:49:22.000Z","conversation_id":"710478136866164736","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":8,"quote_count":0},"lang":"en","text":"Christa Wirthumer-Hoche elected as chair of EMA's Management Board: https://t.co/NnwujKk4NU https://t.co/wmSVMdDyvL","attachments":{"media_keys":["3_710477727451779075"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/6J0SAPxCQO","expanded_url":"http://bit.ly/1muLgci","display_url":"bit.ly/1muLgci"}],"hashtags":[{"start":58,"end":70,"tag":"biosimilars"}],"mentions":{},"annotations":{}},"id":"710425023668953088","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-17T11:18:19.000Z","conversation_id":"710425023668953088","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"2 weeks to comment on revision of paper on development of #biosimilars containing recombinant interferon alpha: https://t.co/6J0SAPxCQO","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":74,"end":97,"url":"https://t.co/f7fmjO6urJ","expanded_url":"http://bit.ly/1UC5vBI","display_url":"bit.ly/1UC5vBI"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":33,"tag":"guideline"},{"start":62,"end":72,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"710420436056674305","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-17T11:00:05.000Z","conversation_id":"710420436056674305","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#Consultation opens on #guideline on evaluation of anticancer #medicines: https://t.co/f7fmjO6urJ","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/0KhhyXtbHy","expanded_url":"http://bit.ly/1pLOadX","display_url":"bit.ly/1pLOadX"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":124,"end":137,"tag":"rarediseases"}],"mentions":{},"annotations":{}},"id":"710161070460178432","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-16T17:49:28.000Z","conversation_id":"710161070460178432","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"The #agenda of next week's meeting of our committee for orphan medicines (COMP) has been published: https://t.co/0KhhyXtbHy #rarediseases","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/0JchYnTqx2","expanded_url":"http://bit.ly/1U8h9Wt","display_url":"bit.ly/1U8h9Wt"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"}],"mentions":{},"annotations":{}},"id":"710160589553799168","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-16T17:47:33.000Z","conversation_id":"710160589553799168","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"The #agenda for our Management Board meeting tomorrow is now available: https://t.co/0JchYnTqx2","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/kEZjef7QnX","expanded_url":"http://bit.ly/1U3vzaf","display_url":"bit.ly/1U3vzaf"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":43,"end":61,"tag":"pharmacovigilance"},{"start":73,"end":78,"tag":"PRAC"}],"mentions":{},"annotations":{}},"id":"709672163037597696","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-15T09:26:43.000Z","conversation_id":"709672163037597696","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #agenda for this week's meeting of the #pharmacovigilance committee (#PRAC) is available: https://t.co/kEZjef7QnX","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/zrQccY8H3q","expanded_url":"http://bit.ly/1RhvDCB","display_url":"bit.ly/1RhvDCB"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":43,"end":54,"tag":"veterinary"}],"mentions":{},"annotations":{}},"id":"709442451195498496","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-14T18:13:55.000Z","conversation_id":"709442451195498496","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"The #agenda for this week's meeting of the #veterinary medicines committee (CVMP) is available: https://t.co/zrQccY8H3q","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/NOGDGVd8mS","expanded_url":"http://bit.ly/2238jdr","display_url":"bit.ly/2238jdr"}],"hashtags":[{"start":11,"end":20,"tag":"Zurampic"},{"start":23,"end":33,"tag":"lesinurad"},{"start":66,"end":75,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"707624866028122112","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-09T17:51:29.000Z","conversation_id":"707624866028122112","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"EPAR out - #Zurampic  (#lesinurad) used in combination with other #medicine in adults with gout to reduce uric acid: https://t.co/NOGDGVd8mS","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"Twitter Web Client","entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/Y3hVk6R4uc","expanded_url":"http://bit.ly/antivirals","display_url":"bit.ly/antivirals"}],"hashtags":[{"start":61,"end":72,"tag":"antivirals"},{"start":114,"end":124,"tag":"influenza"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":29,"end":37,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"id":"707570895770890241","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-09T14:17:02.000Z","conversation_id":"707570895770890241","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_Flu: One week left: @ECDC_EU public consultation on #antivirals. Deadline 16 Mar https://t.co/Y3hVk6R4uc #influenza https://t.co/B…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"707516617744392192"}]},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/D6xX8V16u6","expanded_url":"http://bit.ly/1VN9Roi","display_url":"bit.ly/1VN9Roi"}],"hashtags":[{"start":81,"end":90,"tag":"colistin"},{"start":127,"end":140,"tag":"consultation"}],"mentions":{},"annotations":{}},"id":"707177731679772672","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-08T12:14:44.000Z","conversation_id":"707177731679772672","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to comment: call for scientific data to update our advice on the use of #colistin in animals: https://t.co/D6xX8V16u6 #consultation","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/2z8l1JSLUf","expanded_url":"http://bit.ly/1Qx8loU","display_url":"bit.ly/1Qx8loU"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.5787,"type":"Organization","normalized_text":"EMA"}]},"id":"706835737044492290","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-07T13:35:46.000Z","conversation_id":"706835737044492290","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":6,"quote_count":0},"lang":"en","text":"EMA publishes its work programme for 2016 – Read about our priorities for this year: https://t.co/2z8l1JSLUf","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/pHdB1wFaNf","expanded_url":"http://bit.ly/1QBqvHd","display_url":"bit.ly/1QBqvHd"}],"hashtags":[{"start":13,"end":22,"tag":"Kovaltry"},{"start":24,"end":32,"tag":"octocog"},{"start":42,"end":51,"tag":"medicine"},{"start":101,"end":113,"tag":"haemophilia"}],"mentions":{},"annotations":{}},"id":"706834782471262209","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-07T13:31:59.000Z","conversation_id":"706834782471262209","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"EPAR out for #Kovaltry (#octocog alfa), a #medicine to prevent &amp; treat bleeding in patients with #haemophilia A: https://t.co/pHdB1wFaNf","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/iMxSjEt9hQ","expanded_url":"http://bit.ly/1QFnKRK","display_url":"bit.ly/1QFnKRK"},{"start":116,"end":139,"url":"https://t.co/NHesyYfhKE","expanded_url":"https://twitter.com/EMA_News/status/706800418211426304/photo/1","display_url":"pic.twitter.com/NHesyYfhKE"}],"hashtags":[{"start":47,"end":57,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"706800418211426304","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-07T11:15:26.000Z","conversation_id":"706800418211426304","public_metrics":{"retweet_count":58,"reply_count":1,"like_count":16,"quote_count":0},"lang":"en","text":"Launch of PRIME – paving the way for promising #medicines for patients. See our info sheet: https://t.co/iMxSjEt9hQ https://t.co/NHesyYfhKE","attachments":{"media_keys":["3_706800196601188353"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/yAc8GyZRog","expanded_url":"http://bit.ly/1X6oLq0","display_url":"bit.ly/1X6oLq0"}],"hashtags":[{"start":69,"end":79,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"706799597126066176","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-07T11:12:10.000Z","conversation_id":"706799597126066176","public_metrics":{"retweet_count":24,"reply_count":1,"like_count":8,"quote_count":0},"lang":"en","text":"Read more about our new PRIME (PRIority MEdicines) scheme to support #medicines that address an unmet medical need: https://t.co/yAc8GyZRog","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/mT5Yg3bNZd","expanded_url":"http://bit.ly/1RMEglr","display_url":"bit.ly/1RMEglr"}],"hashtags":[{"start":10,"end":20,"tag":"guideline"},{"start":52,"end":59,"tag":"autism"},{"start":90,"end":103,"tag":"consultation"}],"mentions":{},"annotations":{}},"id":"705758165850259456","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-04T14:13:53.000Z","conversation_id":"705758165850259456","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"First EMA #guideline on evaluation of medicines for #autism launched for a 6-month public #consultation : https://t.co/mT5Yg3bNZd","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/QiinGk1VGg","expanded_url":"http://bit.ly/1QQHu4f","display_url":"bit.ly/1QQHu4f"}],"hashtags":[{"start":0,"end":12,"tag":"Consulation"},{"start":46,"end":57,"tag":"veterinary"},{"start":58,"end":68,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"705703214549704704","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-04T10:35:32.000Z","conversation_id":"705703214549704704","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"#Consulation open on statements on developing #veterinary #medicines using stem cells or monoclonal antibodies: https://t.co/QiinGk1VGg","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/8oX7lCREBd","expanded_url":"http://bit.ly/1TSO0Or","display_url":"bit.ly/1TSO0Or"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":43,"end":54,"tag":"paediatric"},{"start":66,"end":71,"tag":"PDCO"}],"mentions":{},"annotations":{}},"id":"705426997422505984","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-03T16:17:57.000Z","conversation_id":"705426997422505984","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #minutes of the January meeting of our #paediatric committee (#PDCO) are available: https://t.co/8oX7lCREBd","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/vOIOwUU6l2","expanded_url":"http://bit.ly/1TViCxm","display_url":"bit.ly/1TViCxm"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":68,"end":78,"tag":"medicines"},{"start":90,"end":95,"tag":"COMP"}],"mentions":{},"annotations":{}},"id":"705426854484824064","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-03T16:17:22.000Z","conversation_id":"705426854484824064","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've published the #minutes from the January meeting of our orphan #medicines committee (#COMP): https://t.co/vOIOwUU6l2","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/RuYBSTh38o","expanded_url":"http://bit.ly/1QOo3sG","display_url":"bit.ly/1QOo3sG"}],"hashtags":[{"start":8,"end":16,"tag":"minutes"},{"start":24,"end":42,"tag":"pharmacovigilance"},{"start":54,"end":59,"tag":"PRAC"}],"mentions":{},"annotations":{}},"id":"705426572736634880","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-03T16:16:15.000Z","conversation_id":"705426572736634880","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"See the #minutes of our #pharmacovigilance committee (#PRAC) meeting in January: https://t.co/RuYBSTh38o","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/UNe9w7xVF7","expanded_url":"http://bit.ly/1SktIfD","display_url":"bit.ly/1SktIfD"}],"hashtags":[{"start":8,"end":17,"tag":"guidance"}],"mentions":{},"annotations":{}},"id":"705358878431694849","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-03-03T11:47:16.000Z","conversation_id":"705358878431694849","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":9,"quote_count":0},"lang":"en","text":"See EMA #guidance for industry on the requirements to comply with our policy on publication of clinical data: https://t.co/UNe9w7xVF7","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/D6xX8V16u6","expanded_url":"http://bit.ly/1VN9Roi","display_url":"bit.ly/1VN9Roi"}],"hashtags":[{"start":78,"end":87,"tag":"colistin"},{"start":124,"end":137,"tag":"consultation"}],"mentions":{},"annotations":{}},"id":"704355404243996672","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-29T17:19:49.000Z","conversation_id":"704355404243996672","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"lang":"en","text":"We've published a call for scientific data to update our advice on the use of #colistin in animals: https://t.co/D6xX8V16u6 #consultation","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/jW0IL1HfEW","expanded_url":"http://europa.eu/!gK66gp","display_url":"europa.eu/!gK66gp"}],"hashtags":[{"start":50,"end":53,"tag":"EU"},{"start":116,"end":131,"tag":"RareDiseaseDay"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"id":"704311704897916928","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-29T14:26:10.000Z","conversation_id":"704311704897916928","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: 117 orphan medicines authorized by #EU 4 rare diseases: state of play report https://t.co/jW0IL1HfEW #RareDiseaseDay https:/…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"704311060363407361"}]},{"source":"TweetDeck","entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/lnYFivnxJw","expanded_url":"http://bit.ly/1TKnkhu","display_url":"bit.ly/1TKnkhu"}],"hashtags":[{"start":34,"end":52,"tag":"pharmacovigilance"},{"start":64,"end":68,"tag":"GVP"}],"mentions":{},"annotations":{}},"id":"704304494063054848","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-29T13:57:31.000Z","conversation_id":"704304494063054848","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":6,"quote_count":0},"lang":"en","text":"Consultation open on revised good #pharmacovigilance practices (#GVP) module on risk management systems: https://t.co/lnYFivnxJw","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/nBhWNZ1gSk","expanded_url":"http://bit.ly/16Zy2IA","display_url":"bit.ly/16Zy2IA"}],"hashtags":[{"start":59,"end":69,"tag":"medicines"},{"start":113,"end":128,"tag":"RareDiseaseDay"}],"mentions":{},"annotations":{}},"id":"704284372682346499","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-29T12:37:34.000Z","conversation_id":"704284372682346499","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":11,"quote_count":0},"lang":"en","text":"Find out how EMA supports development and authorisation of #medicines for rare diseases: https://t.co/nBhWNZ1gSk #RareDiseaseDay","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/b4bYjebqqi","expanded_url":"http://europa.eu/!Bv38Xb","display_url":"europa.eu/!Bv38Xb"}],"hashtags":[{"start":15,"end":30,"tag":"RareDiseaseDay"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":81,"end":96,"username":"V_Andriukaitis","id":"575269517"},{"start":103,"end":110,"username":"Moedas","id":"20058825"}],"annotations":{}},"id":"704283028051402752","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-29T12:32:13.000Z","conversation_id":"704283028051402752","public_metrics":{"retweet_count":105,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: #RareDiseaseDay 8000 rare diseases affect 27-36 million Europeans @V_Andriukaitis &amp; @Moedas https://t.co/b4bYjebqqi https://…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"704247350986936320"}]},{"source":"TweetDeck","entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/dCXA2yn5td","expanded_url":"http://bit.ly/1TDqGCP","display_url":"bit.ly/1TDqGCP"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":61,"end":72,"tag":"veterinary"},{"start":84,"end":89,"tag":"CVMP"}],"mentions":{},"annotations":{}},"id":"703257804438683648","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-26T16:38:21.000Z","conversation_id":"703257804438683648","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #minutes from the January meeting of our #veterinary committee (#CVMP): https://t.co/dCXA2yn5td","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/of65RsBE5i","expanded_url":"http://bit.ly/1Rt2AbK","display_url":"bit.ly/1Rt2AbK"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":59,"end":66,"tag":"safety"},{"start":91,"end":102,"tag":"veterinary"},{"start":103,"end":112,"tag":"vaccines"}],"mentions":{},"annotations":[{"start":17,"end":25,"probability":0.335,"type":"Person","normalized_text":"VICH GL50"}]},"id":"703254952630730752","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-26T16:27:01.000Z","conversation_id":"703254952630730752","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation on VICH GL50: Criteria to waive animal batch #safety testing for inactivated #veterinary #vaccines: https://t.co/of65RsBE5i","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/SNOp3LLNwR","expanded_url":"http://bit.ly/1LJXS5g","display_url":"bit.ly/1LJXS5g"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":83,"end":94,"tag":"veterinary"},{"start":95,"end":104,"tag":"vaccines"},{"start":130,"end":140,"tag":"guideline"}],"mentions":{},"annotations":[{"start":17,"end":25,"probability":0.2798,"type":"Person","normalized_text":"VICH GL55"}]},"id":"703254453311430657","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-26T16:25:02.000Z","conversation_id":"703254453311430657","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation on VICH GL55: Criteria to waive animal batch safety testing for live #veterinary #vaccines: https://t.co/SNOp3LLNwR #guideline","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/5bAL07FjdV","expanded_url":"http://bit.ly/1LJWKhX","display_url":"bit.ly/1LJWKhX"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":33,"tag":"guideline"},{"start":73,"end":86,"tag":"intramammary"},{"start":87,"end":97,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"703254196980736000","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-26T16:24:01.000Z","conversation_id":"703254196980736000","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#Consultation opens on #guideline on the conduct of efficacy studies for #intramammary #medicines for use in cattle: https://t.co/5bAL07FjdV","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/2viJJN9fDZ","expanded_url":"http://bit.ly/24t31Kl","display_url":"bit.ly/24t31Kl"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":32,"end":43,"tag":"veterinary"},{"start":44,"end":54,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"703253714375733248","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-26T16:22:05.000Z","conversation_id":"703253714375733248","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation opens on paper on #veterinary #medicines containing persistent, bioaccumulative &amp; toxic substances:https://t.co/2viJJN9fDZ","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/qm6cmXk3R4","expanded_url":"http://bit.ly/1LhZLet","display_url":"bit.ly/1LhZLet"}],"hashtags":[{"start":32,"end":45,"tag":"ketoacidosis"},{"start":77,"end":86,"tag":"diabetes"}],"mentions":{},"annotations":{}},"id":"703200650209800193","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-26T12:51:14.000Z","conversation_id":"703200650209800193","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":4,"quote_count":0},"lang":"et","text":"EMA recommendations to minimise #ketoacidosis risk with SGLT2 inhibitors for #diabetes: https://t.co/qm6cmXk3R4","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/HpYEppDER5","expanded_url":"http://bit.ly/1QhUi7Q","display_url":"bit.ly/1QhUi7Q"}],"hashtags":[{"start":84,"end":93,"tag":"medicine"},{"start":94,"end":102,"tag":"Tysabri"}],"mentions":{},"annotations":{}},"id":"703199809033744384","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-26T12:47:53.000Z","conversation_id":"703199809033744384","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"EMA recommendations to minimise risk of brain infection PML with multiple sclerosis #medicine #Tysabri: https://t.co/HpYEppDER5","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/FPETgMZvW4","expanded_url":"http://bit.ly/1OA413G","display_url":"bit.ly/1OA413G"}],"hashtags":[{"start":8,"end":13,"tag":"CHMP"},{"start":56,"end":63,"tag":"Opdivo"},{"start":77,"end":84,"tag":"kidney"},{"start":85,"end":92,"tag":"cancer"}],"mentions":{},"annotations":{}},"id":"703198081865502720","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-26T12:41:02.000Z","conversation_id":"703198081865502720","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"See the #CHMP press release on the new approved use for #Opdivo for advanced #kidney #cancer: \nhttps://t.co/FPETgMZvW4","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/Wrxc93lMXl","expanded_url":"http://bit.ly/1OA2LNT","display_url":"bit.ly/1OA2LNT"}],"hashtags":[{"start":2,"end":12,"tag":"medicines"},{"start":72,"end":77,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"703197941251477504","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-26T12:40:28.000Z","conversation_id":"703197941251477504","public_metrics":{"retweet_count":22,"reply_count":1,"like_count":9,"quote_count":0},"lang":"en","text":"6 #medicines, including 2 orphan medicines, recommended for approval by #CHMP this month. See meeting’s highlights:https://t.co/Wrxc93lMXl","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/Tw3LuZOrY4","expanded_url":"http://bit.ly/1R1v2Ph","display_url":"bit.ly/1R1v2Ph"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"702534800628965376","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-24T16:45:23.000Z","conversation_id":"702534800628965376","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Check out the 17 positive opinions for orphan designations from this month's orphan medicines committee meeting: https://t.co/Tw3LuZOrY4","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/e9kYOgilxl","expanded_url":"https://shar.es/1CHemp","display_url":"shar.es/1CHemp"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":[{"start":24,"end":25,"probability":0.497,"type":"Organization","normalized_text":"Ph"}]},"id":"702498836372180992","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-24T14:22:29.000Z","conversation_id":"702498836372180992","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: Join the Ph. Eur. network! CALL FOR EXPERTS: Appointment of experts to prepare for the 10th Edition https://t.co/e9kYOgilxl …","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"702491935299264513"}]},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":13,"end":23,"tag":"ZikaVirus"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"id":"702204374177738752","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-23T18:52:23.000Z","conversation_id":"702204374177738752","public_metrics":{"retweet_count":31,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: #ZikaVirus &amp; potential association with microcephaly &amp; Guillain–Barré syndrome - updated ECDC risk assessment: https://t.co/eQ…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"702184837487132672"}]},{"source":"TweetDeck","entities":{"urls":[{"start":49,"end":72,"url":"https://t.co/RBy2XnwFY3","expanded_url":"http://bit.ly/1SMDTdF","display_url":"bit.ly/1SMDTdF"}],"hashtags":[{"start":0,"end":5,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"701737619206578177","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-22T11:57:40.000Z","conversation_id":"701737619206578177","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#CHMP is meeting this week. Check out the agenda https://t.co/RBy2XnwFY3","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/9e18IlXfld","expanded_url":"http://bit.ly/1QoKtH0","display_url":"bit.ly/1QoKtH0"}],"hashtags":[{"start":48,"end":59,"tag":"veterinary"},{"start":60,"end":70,"tag":"medicines"},{"start":90,"end":95,"tag":"CVMP"}],"mentions":{},"annotations":{}},"id":"700692268836118528","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-19T14:43:49.000Z","conversation_id":"700692268836118528","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the highlights from this week's #veterinary #medicines committee meeting (#CVMP): https://t.co/9e18IlXfld","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/rgAuCiDPCU","expanded_url":"http://europa.eu/!UT98MG","display_url":"europa.eu/!UT98MG"}],"hashtags":[{"start":53,"end":66,"tag":"HorizonPrize"},{"start":84,"end":96,"tag":"Antibiotics"},{"start":122,"end":128,"tag":"H2020"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":129,"end":138,"username":"EU_H2020","id":"920249612329504768"}],"annotations":{}},"id":"700328604387909632","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-18T14:38:45.000Z","conversation_id":"700328604387909632","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Just six months left to crack the €1m #HorizonPrize on Better Use of #Antibiotics https://t.co/rgAuCiDPCU  #H2020 @EU_H2020 …","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"700327436400123904"}]},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/iQdOZSJ7wx","expanded_url":"https://twitter.com/EFSA_EU/status/700248902075871232/video/1","display_url":"pic.twitter.com/iQdOZSJ7wx"}],"hashtags":[{"start":27,"end":48,"tag":"AntibioticResistance"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":66,"end":74,"username":"ECDC_EU","id":"204752573"},{"start":79,"end":88,"username":"EMA_News","id":"116716199"}],"annotations":{}},"id":"700253686568742912","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-18T09:41:03.000Z","conversation_id":"700253686568742912","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Fight against #AntibioticResistance: learn how EFSA, @ECDC_EU and @EMA_News are working together https://t.co/iQdOZSJ7wx","attachments":{"media_keys":["7_700248444196274176"]},"referenced_tweets":[{"type":"retweeted","id":"700248902075871232"}]},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/XfwChPEy37","expanded_url":"http://bit.ly/1SSscCG","display_url":"bit.ly/1SSscCG"}],"hashtags":[{"start":91,"end":101,"tag":"medicines"}],"mentions":{},"annotations":[{"start":57,"end":57,"probability":0.5255,"type":"Organization","normalized_text":""}]},"id":"699988074231701504","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-17T16:05:36.000Z","conversation_id":"699988074231701504","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Jan 2016 report on application procedures, guidelines and\nrelated documents for veterinary #medicines now available: https://t.co/XfwChPEy37","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":35,"end":56,"tag":"AntibioticResistance"},{"start":93,"end":96,"tag":"EU"},{"start":118,"end":130,"tag":"AMRPOLITICO"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":15,"end":32,"probability":0.6917,"type":"Person","normalized_text":"Xavier Prats Monné"}]},"id":"699954196209078273","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-17T13:50:59.000Z","conversation_id":"699954196209078273","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Xavier Prats Monné: #AntibioticResistance is an important challenge where the #EU added value can help #AMRPOLITICO https://…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"699946439007473664"}]},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/W73EkxREVF","expanded_url":"http://bit.ly/1SSeXll","display_url":"bit.ly/1SSeXll"}],"hashtags":[{"start":19,"end":28,"tag":"Tagrisso"},{"start":30,"end":42,"tag":"osimertinib"},{"start":47,"end":56,"tag":"medicine"},{"start":81,"end":92,"tag":"lungcancer"}],"mentions":{},"annotations":{}},"id":"699953769979760641","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-17T13:49:17.000Z","conversation_id":"699953769979760641","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"EPAR published for #Tagrisso (#osimertinib), a #medicine to treat non-small cell #lungcancer: https://t.co/W73EkxREVF","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/EHA9p0QA7C","expanded_url":"http://bit.ly/1TlstfF","display_url":"bit.ly/1TlstfF"}],"hashtags":[{"start":28,"end":39,"tag":"veterinary"}],"mentions":{},"annotations":{}},"id":"699611226444324866","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-16T15:08:09.000Z","conversation_id":"699611226444324866","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Committee for medicines for #veterinary use is meeting this week. Check out the agenda https://t.co/EHA9p0QA7C","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/vw323Piabc","expanded_url":"http://bit.ly/1ok9QwV","display_url":"bit.ly/1ok9QwV"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"699598906846486528","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-16T14:19:11.000Z","conversation_id":"699598906846486528","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"We have a strong working relationship with healthcare professionals. Find out more  https://t.co/vw323Piabc","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":68,"end":91,"url":"https://t.co/CEVbubTbrO","expanded_url":"http://bit.ly/1i7LoH5","display_url":"bit.ly/1i7LoH5"}],"hashtags":[{"start":22,"end":31,"tag":"patients"},{"start":36,"end":45,"tag":"consumer"}],"mentions":{},"annotations":{}},"id":"699598812952797184","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-16T14:18:49.000Z","conversation_id":"699598812952797184","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":6,"quote_count":0},"lang":"en","text":"We work actively with #patients and #consumer groups. Find out more https://t.co/CEVbubTbrO","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/MYypFoY08B","expanded_url":"http://bit.ly/1TlyiLs","display_url":"bit.ly/1TlyiLs"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"}],"mentions":{},"annotations":{}},"id":"699274372368965634","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-15T16:49:36.000Z","conversation_id":"699274372368965634","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #minutes of last December Management Board meeting are now available on our website: https://t.co/MYypFoY08B","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/fbULyEoFko","expanded_url":"http://bit.ly/1ogXYf2","display_url":"bit.ly/1ogXYf2"}],"hashtags":[{"start":22,"end":29,"tag":"herbal"},{"start":43,"end":52,"tag":"Origanum"},{"start":97,"end":110,"tag":"consultation"}],"mentions":{},"annotations":{}},"id":"699271795648634882","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-15T16:39:22.000Z","conversation_id":"699271795648634882","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"fr","text":"We invite comments on #herbal monograph on #Origanum majorana L., herba: https://t.co/fbULyEoFko #consultation","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/p03MQUL8nG","expanded_url":"http://bit.ly/1Tj5IJc","display_url":"bit.ly/1Tj5IJc"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":70,"end":75,"tag":"COMP"}],"mentions":{},"annotations":{}},"id":"699270401030037505","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-15T16:33:50.000Z","conversation_id":"699270401030037505","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week’s orphan medicine committee (#COMP) meeting: https://t.co/p03MQUL8nG","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/XOzGQadayS","expanded_url":"http://bit.ly/1Ssh9zr","display_url":"bit.ly/1Ssh9zr"}],"hashtags":[{"start":14,"end":22,"tag":"opinion"},{"start":54,"end":64,"tag":"biomarker"},{"start":109,"end":116,"tag":"trials"}],"mentions":{},"annotations":{}},"id":"699268693340114944","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-15T16:27:02.000Z","conversation_id":"699268693340114944","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Qualification #opinion on ingestible sensor system as #biomarker for measuring patient adherence in clinical #trials:https://t.co/XOzGQadayS","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/v6GVUvMtpO","expanded_url":"http://bit.ly/1mCv5ZJ","display_url":"bit.ly/1mCv5ZJ"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":30,"tag":"herbal"},{"start":44,"end":58,"tag":"Harpagophytum"}],"mentions":{},"annotations":{}},"id":"699199417124024320","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-15T11:51:46.000Z","conversation_id":"699199417124024320","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"fr","text":"#Consultation opens on #herbal monograph on #Harpagophytum procumbens DC. and/or Harpagophytum zeheyri Decne., radix:https://t.co/v6GVUvMtpO","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/Ld6e6bDqHW","expanded_url":"http://bit.ly/1VggC1x","display_url":"bit.ly/1VggC1x"}],"hashtags":[{"start":25,"end":32,"tag":"herbal"},{"start":46,"end":53,"tag":"Salvia"},{"start":102,"end":115,"tag":"consultation"}],"mentions":{},"annotations":{}},"id":"699199194695921664","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-15T11:50:53.000Z","conversation_id":"699199194695921664","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"lang":"fr","text":"Send us your comments on #herbal monograph on #Salvia officinalis L., folium: https://t.co/Ld6e6bDqHW #consultation","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":75,"end":98,"url":"https://t.co/oiJ3cpNSiM","expanded_url":"http://bit.ly/244Mufx","display_url":"bit.ly/244Mufx"}],"hashtags":[{"start":30,"end":35,"tag":"CVMP"},{"start":48,"end":63,"tag":"antimicrobials"},{"start":99,"end":110,"tag":"veterinary"},{"start":111,"end":124,"tag":"consultation"}],"mentions":{},"annotations":{}},"id":"699169077957423104","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-15T09:51:12.000Z","conversation_id":"699169077957423104","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks to go to comment on #CVMP strategy on #antimicrobials 2016-2020: https://t.co/oiJ3cpNSiM #veterinary #consultation","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/68CqHwg3ck","expanded_url":"http://bit.ly/1NL0P5E","display_url":"bit.ly/1NL0P5E"}],"hashtags":[{"start":59,"end":74,"tag":"EudraVigilance"},{"start":75,"end":86,"tag":"veterinary"},{"start":117,"end":135,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"699167470616252417","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-15T09:44:49.000Z","conversation_id":"699167470616252417","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks to comment on recommendation for surveillance of #EudraVigilance #veterinary data: https://t.co/68CqHwg3ck #pharmacovigilance","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/wJMa3EqC9s","expanded_url":"https://shar.es/14XW5H","display_url":"shar.es/14XW5H"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"id":"698167503944552448","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-12T15:31:18.000Z","conversation_id":"698167503944552448","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: Get the latest info on our certification activities with our monthly Report of Activities https://t.co/wJMa3EqC9s  via @shar…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"698163813334519808"}]},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/ilckU5K7JH","expanded_url":"http://bit.ly/1KKdH0z","display_url":"bit.ly/1KKdH0z"}],"hashtags":[{"start":14,"end":35,"tag":"AntibioticResistance"}],"mentions":[{"start":47,"end":55,"username":"EFSA_EU","id":"84582815"},{"start":57,"end":65,"username":"ECDC_EU","id":"204752573"}],"annotations":{}},"id":"698147934219718657","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-12T14:13:33.000Z","conversation_id":"698147934219718657","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":7,"quote_count":0},"lang":"en","text":"Fight against #AntibioticResistance: learn how @EFSA_EU, @ECDC_EU and EMA are working together. https://t.co/ilckU5K7JH","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/kV7U3gonLG","expanded_url":"http://bit.ly/1PQWLpB","display_url":"bit.ly/1PQWLpB"}],"hashtags":[{"start":48,"end":66,"tag":"pharmacovigilance"},{"start":86,"end":91,"tag":"PRAC"}],"mentions":{},"annotations":{}},"id":"698115423947120640","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-12T12:04:22.000Z","conversation_id":"698115423947120640","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"We've published the highlights from this week's #pharmacovigilance committee meeting (#PRAC): https://t.co/kV7U3gonLG","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/tsuYAgkD3e","expanded_url":"http://bit.ly/1PqTcF7","display_url":"bit.ly/1PqTcF7"},{"start":114,"end":137,"url":"https://t.co/9e0sXuvdOG","expanded_url":"https://twitter.com/EFSA_EU/status/698103024280018944/photo/1","display_url":"pic.twitter.com/9e0sXuvdOG"}],"hashtags":[{"start":25,"end":49,"tag":"AntimicrobialResistance"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"annotations":{}},"id":"698103289267798016","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-12T11:16:08.000Z","conversation_id":"698103289267798016","public_metrics":{"retweet_count":41,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EFSA_EU: Overview of #AntimicrobialResistance levels in the EU. View our infographic. https://t.co/tsuYAgkD3e https://t.co/9e0sXuvdOG","attachments":{"media_keys":["3_698103022166138881"]},"referenced_tweets":[{"type":"retweeted","id":"698103024280018944"}]},{"source":"TweetDeck","entities":{"urls":[{"start":75,"end":98,"url":"https://t.co/GnAPHZXtdL","expanded_url":"http://bit.ly/1o1OCDH","display_url":"bit.ly/1o1OCDH"}],"hashtags":[{"start":7,"end":17,"tag":"medicines"},{"start":54,"end":64,"tag":"ZikaVirus"}],"mentions":{},"annotations":{}},"id":"697758017593413633","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-11T12:24:09.000Z","conversation_id":"697758017593413633","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Global #medicines regulators pledge support to tackle #ZikaVirus disease: \nhttps://t.co/GnAPHZXtdL","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/RU8sUczoE6","expanded_url":"http://bit.ly/1V5XrHK","display_url":"bit.ly/1V5XrHK"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":33,"tag":"guideline"}],"mentions":{},"annotations":{}},"id":"697753168969596929","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-11T12:04:53.000Z","conversation_id":"697753168969596929","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation opens on #guideline on the SmPC for human anti-D immunoglobulin for intravenous use: https://t.co/RU8sUczoE6","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/rgMShmeVFW","expanded_url":"http://bit.ly/1o63K3I","display_url":"bit.ly/1o63K3I"}],"hashtags":[{"start":35,"end":45,"tag":"guideline"}],"mentions":{},"annotations":{}},"id":"697752278434975744","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-11T12:01:21.000Z","conversation_id":"697752278434975744","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Send us your comments on the draft #guideline on the SmPC for human anti-D immunoglobulin for intramuscular use: https://t.co/rgMShmeVFW","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/XFZzjgphOR","expanded_url":"http://bit.ly/1Kdktfi","display_url":"bit.ly/1Kdktfi"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":62,"end":72,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"697749809436950528","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-11T11:51:32.000Z","conversation_id":"697749809436950528","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"#Consultation opens on guideline on clinical investigation of #medicines for treatment of chronic heart failure: https://t.co/XFZzjgphOR","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"Twitter Web Client","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/0LxZsbDPDa","expanded_url":"http://europa.eu/!XY97Nf","display_url":"europa.eu/!XY97Nf"}],"hashtags":[{"start":15,"end":18,"tag":"EU"},{"start":41,"end":48,"tag":"safety"},{"start":62,"end":72,"tag":"medicines"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"id":"697082731512131584","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-09T15:40:49.000Z","conversation_id":"697082731512131584","public_metrics":{"retweet_count":41,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: #EU introduces obligatory #safety features for #medicines: unique ID &amp; anti-tampering device https://t.co/0LxZsbDPDa https:/…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"697019180919492609"}]},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/D7OyAHFUSb","expanded_url":"http://bit.ly/1SFTL1U","display_url":"bit.ly/1SFTL1U"}],"hashtags":[{"start":84,"end":94,"tag":"falsified"},{"start":95,"end":105,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"697080164258283520","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-09T15:30:36.000Z","conversation_id":"697080164258283520","public_metrics":{"retweet_count":20,"reply_count":1,"like_count":9,"quote_count":0},"lang":"en","text":"New safety features introduced on medicines packaging to help protect patients from #falsified #medicines: https://t.co/D7OyAHFUSb","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/X1ssHHEduB","expanded_url":"http://bit.ly/1Qn8TL9","display_url":"bit.ly/1Qn8TL9"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"}],"mentions":{},"annotations":{}},"id":"696748478299574273","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-08T17:32:36.000Z","conversation_id":"696748478299574273","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #minutes of the December meeting of our committee for human medicines (CHMP) are available: https://t.co/X1ssHHEduB","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/KDXoEruqlD","expanded_url":"http://bit.ly/1SEk74d","display_url":"bit.ly/1SEk74d"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":42,"end":60,"tag":"pharmacovigilance"},{"start":72,"end":77,"tag":"PRAC"}],"mentions":{},"annotations":{}},"id":"696744664557350912","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-08T17:17:27.000Z","conversation_id":"696744664557350912","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #agenda of this week's meeting of our #pharmacovigilance committee (#PRAC) is available: https://t.co/KDXoEruqlD","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/y4b8gTxehy","expanded_url":"http://bit.ly/1nSziJu","display_url":"bit.ly/1nSziJu"}],"hashtags":{},"mentions":{},"annotations":[{"start":26,"end":29,"probability":0.4217,"type":"Place","normalized_text":"Zika"}]},"id":"696674917371273217","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-08T12:40:18.000Z","conversation_id":"696674917371273217","public_metrics":{"retweet_count":30,"reply_count":0,"like_count":10,"quote_count":0},"lang":"en","text":"EMA sets up task force on Zika virus to provide support to global response on the emerging epidemic: https://t.co/y4b8gTxehy","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/n7RKIiFNTp","expanded_url":"http://bit.ly/1SOWKmF","display_url":"bit.ly/1SOWKmF"}],"hashtags":[{"start":63,"end":71,"tag":"Xarelto"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.5286,"type":"Organization","normalized_text":"EMA"}]},"id":"695616788730667009","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-05T14:35:41.000Z","conversation_id":"695616788730667009","public_metrics":{"retweet_count":21,"reply_count":1,"like_count":19,"quote_count":0},"lang":"en","text":"EMA concludes defective device in ROCKET study does not impact #Xarelto’s safety: https://t.co/n7RKIiFNTp","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/NALPzKyrbd","expanded_url":"http://bit.ly/1TIA3S8","display_url":"bit.ly/1TIA3S8"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":121,"end":137,"tag":"advancedtherapy"}],"mentions":{},"annotations":{}},"id":"695601810132897792","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-05T13:36:09.000Z","conversation_id":"695601810132897792","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #minutes of the December meeting of the Committee for Advanced Therapies (CAT) are available:https://t.co/NALPzKyrbd #advancedtherapy","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/zrN6tiUuMN","expanded_url":"http://bit.ly/1X2FcnL","display_url":"bit.ly/1X2FcnL"}],"hashtags":[{"start":15,"end":30,"tag":"WorldCancerDay"},{"start":96,"end":105,"tag":"Eurostat"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"id":"695215811930255360","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-04T12:02:20.000Z","conversation_id":"695215811930255360","public_metrics":{"retweet_count":81,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: #WorldCancerDay: most common fatal cancer - men lung cancer, women breast cancer #Eurostat https://t.co/zrN6tiUuMN https://t…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"695204082722717696"}]},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/lWo0vMdSXW","expanded_url":"http://bit.ly/1KUtCnA","display_url":"bit.ly/1KUtCnA","status":429,"unwound_url":"https://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/02/news_detail_002464.jsp&mid=WC0b01ac058004d5c1"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"695208659975069696","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-04T11:33:55.000Z","conversation_id":"695208659975069696","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Watch today the live broadcast of our workshop on challenges for the approval of immunotherapy medicines for cancer: https://t.co/lWo0vMdSXW","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/vSi9EbMzY7","expanded_url":"http://bit.ly/1nMJzYj","display_url":"bit.ly/1nMJzYj"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":33,"tag":"guideline"},{"start":79,"end":90,"tag":"veterinary"},{"start":91,"end":101,"tag":"medicines"},{"start":106,"end":111,"tag":"MUMS"}],"mentions":{},"annotations":{}},"id":"694889860079992832","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-03T14:27:07.000Z","conversation_id":"694889860079992832","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation opens on #guideline on safety &amp; residue data requirements of #veterinary #medicines for #MUMS: https://t.co/vSi9EbMzY7","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":120,"end":143,"url":"https://t.co/bXcpitrUya","expanded_url":"http://bit.ly/1PRLscn","display_url":"bit.ly/1PRLscn"}],"hashtags":[{"start":29,"end":39,"tag":"guideline"},{"start":86,"end":97,"tag":"veterinary"},{"start":98,"end":108,"tag":"medicines"},{"start":113,"end":118,"tag":"MUMS"}],"mentions":{},"annotations":{}},"id":"694887367170224128","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-03T14:17:13.000Z","conversation_id":"694887367170224128","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Send us your comments on our #guideline on efficacy &amp; safety data requirements of #veterinary #medicines for #MUMS: https://t.co/bXcpitrUya","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/DmOr3lu4Ra","expanded_url":"http://bit.ly/1mcVOM2","display_url":"bit.ly/1mcVOM2"}],"hashtags":[{"start":28,"end":38,"tag":"guideline"},{"start":71,"end":82,"tag":"veterinary"},{"start":83,"end":93,"tag":"medicines"},{"start":98,"end":103,"tag":"MUMS"}],"mentions":{},"annotations":{}},"id":"694885374817124352","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-03T14:09:18.000Z","conversation_id":"694885374817124352","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We invite comments on draft #guideline on quality data requirements of #veterinary #medicines for #MUMS: https://t.co/DmOr3lu4Ra","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/fYltc3QZSo","expanded_url":"http://bit.ly/1SsDrBp","display_url":"bit.ly/1SsDrBp"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":33,"tag":"guideline"},{"start":58,"end":72,"tag":"immunological"},{"start":73,"end":84,"tag":"veterinary"},{"start":85,"end":95,"tag":"medicines"},{"start":100,"end":105,"tag":"MUMS"}],"mentions":{},"annotations":{}},"id":"694882537009778692","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-03T13:58:01.000Z","conversation_id":"694882537009778692","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation opens on #guideline on data requirements of #immunological #veterinary #medicines for #MUMS: https://t.co/fYltc3QZSo","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/2YZdRSFKFQ","expanded_url":"http://bit.ly/1mcTO6u","display_url":"bit.ly/1mcTO6u"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":35,"end":45,"tag":"guideline"},{"start":65,"end":81,"tag":"pharmacokinetic"},{"start":100,"end":107,"tag":"animal"}],"mentions":{},"annotations":{}},"id":"694881278504648704","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-03T13:53:01.000Z","conversation_id":"694881278504648704","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation opens on revision of #guideline for the conduct of #pharmacokinetic studies in target #animal species: https://t.co/2YZdRSFKFQ","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/lWo0vMdSXW","expanded_url":"http://bit.ly/1KUtCnA","display_url":"bit.ly/1KUtCnA"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"694565475683061760","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-02T16:58:08.000Z","conversation_id":"694565475683061760","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Workshop on challenges for the approval of immunotherapy medicines for cancer to be broadcast live on 4-5 February: https://t.co/lWo0vMdSXW","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/M8UBfErqsX","expanded_url":"http://bit.ly/1JTCO0L","display_url":"bit.ly/1JTCO0L"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":22,"end":26,"tag":"ICH"},{"start":40,"end":48,"tag":"genomic"}],"mentions":{},"annotations":{}},"id":"694183518272905217","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-01T15:40:22.000Z","conversation_id":"694183518272905217","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"#Consultation open on #ICH guideline on #genomic sampling and management of genomic data: https://t.co/M8UBfErqsX","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/GE0AMD3m1x","expanded_url":"http://bit.ly/20iLFAl","display_url":"bit.ly/20iLFAl"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":31,"end":41,"tag":"guideline"},{"start":45,"end":55,"tag":"medicines"},{"start":65,"end":75,"tag":"Alzheimer"}],"mentions":{},"annotations":{}},"id":"694170902460813312","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-01T14:50:14.000Z","conversation_id":"694170902460813312","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation opens on revised #guideline on #medicines to treat #Alzheimer’s disease and other dementias: https://t.co/GE0AMD3m1x","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/qQPEjhbuuW","expanded_url":"http://bit.ly/20BJtk0","display_url":"bit.ly/20BJtk0"}],"hashtags":[{"start":53,"end":62,"tag":"academia"},{"start":107,"end":120,"tag":"consultation"}],"mentions":{},"annotations":{}},"id":"694169496861446144","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-02-01T14:44:39.000Z","conversation_id":"694169496861446144","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Respond to our questionnaire on our interaction with #academia, deadline 15 April: https://t.co/qQPEjhbuuW #consultation","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/fLX5Rj5Kw1","expanded_url":"http://bit.ly/23xR4Tk","display_url":"bit.ly/23xR4Tk"}],"hashtags":[{"start":32,"end":41,"tag":"Oncaspar"},{"start":43,"end":56,"tag":"pegaspargase"},{"start":65,"end":74,"tag":"medicine"},{"start":99,"end":109,"tag":"leukaemia"}],"mentions":{},"annotations":{}},"id":"693090572844847104","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-29T15:17:24.000Z","conversation_id":"693090572844847104","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Assessment report published for #Oncaspar (#pegaspargase), a new #medicine for acute lymphoblastic #leukaemia: https://t.co/fLX5Rj5Kw1","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/8qty1jlSbD","expanded_url":"http://bit.ly/1VvhwqH","display_url":"bit.ly/1VvhwqH"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":56,"end":63,"tag":"herbal"}],"mentions":{},"annotations":{}},"id":"693077410804318208","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-29T14:25:06.000Z","conversation_id":"693077410804318208","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #agenda of next week's meeting of our committee for #herbal medicinal products (HMPC) is available: https://t.co/8qty1jlSbD","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/Qvi07wXWs6","expanded_url":"http://bit.ly/1PmKTv7","display_url":"bit.ly/1PmKTv7"}],"hashtags":[{"start":4,"end":11,"tag":"orphan"},{"start":12,"end":21,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"693045281005400065","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-29T12:17:25.000Z","conversation_id":"693045281005400065","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"New #orphan #medicine for factor X deficiency recommended after accelerated assessment: https://t.co/Qvi07wXWs6","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/ErQuEKgosb","expanded_url":"http://bit.ly/1nsfug0","display_url":"bit.ly/1nsfug0"}],"hashtags":[{"start":4,"end":11,"tag":"orphan"},{"start":12,"end":21,"tag":"medicine"},{"start":35,"end":43,"tag":"myeloma"}],"mentions":{},"annotations":{}},"id":"693044822404374528","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-29T12:15:36.000Z","conversation_id":"693044822404374528","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"New #orphan #medicine for multiple #myeloma recommended after accelerated assessment: https://t.co/ErQuEKgosb","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/yOeLrI6zZs","expanded_url":"http://bit.ly/1NFgsL7","display_url":"bit.ly/1NFgsL7"},{"start":113,"end":136,"url":"https://t.co/C5kAolWIYC","expanded_url":"https://twitter.com/EMA_News/status/693044377934041088/photo/1","display_url":"pic.twitter.com/C5kAolWIYC"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"693044377934041088","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-29T12:13:50.000Z","conversation_id":"693044377934041088","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"6 new medicines recommended for approval at this week's CHMP. Highlights available here: https://t.co/yOeLrI6zZs https://t.co/C5kAolWIYC","attachments":{"media_keys":["3_693040389708779520"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/MXkpHpI0c4","expanded_url":"http://bit.ly/1KHK6zl","display_url":"bit.ly/1KHK6zl"}],"hashtags":[{"start":32,"end":42,"tag":"Spectrila"},{"start":44,"end":57,"tag":"asparaginase"},{"start":62,"end":71,"tag":"medicine"},{"start":101,"end":111,"tag":"leukaemia"}],"mentions":{},"annotations":{}},"id":"692760788734496768","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-28T17:26:57.000Z","conversation_id":"692760788734496768","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Assessment report published for #Spectrila (#asparaginase), a #medicine to treat acute lymphoblastic #leukaemia: https://t.co/MXkpHpI0c4","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/SZzUEnLpEO","expanded_url":"http://bit.ly/1nRwFbh","display_url":"bit.ly/1nRwFbh"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"692757804927565824","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-28T17:15:06.000Z","conversation_id":"692757804927565824","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published guidance on the labelling of centrally authorised pandemic vaccines: https://t.co/SZzUEnLpEO","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":121,"end":144,"url":"https://t.co/oPz8KQp8Id","expanded_url":"http://bit.ly/1TpTYoJ","display_url":"bit.ly/1TpTYoJ"}],"hashtags":[{"start":10,"end":21,"tag":"Pemetrexed"},{"start":33,"end":42,"tag":"medicine"},{"start":113,"end":120,"tag":"cancer"}],"mentions":{},"annotations":{}},"id":"692753888454299648","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-28T16:59:32.000Z","conversation_id":"692753888454299648","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"EPAR out: #Pemetrexed Actavis, a #medicine for malignant pleural mesothelioma &amp; advanced non-small-cell lung #cancer:https://t.co/oPz8KQp8Id","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/xt1spVO1Ju","expanded_url":"http://bit.ly/1SMgrgi","display_url":"bit.ly/1SMgrgi"}],"hashtags":[{"start":32,"end":41,"tag":"Benepali"},{"start":43,"end":54,"tag":"etanercept"},{"start":59,"end":70,"tag":"biosimilar"},{"start":71,"end":76,"tag":"anti"},{"start":90,"end":99,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"692745988247830529","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-28T16:28:08.000Z","conversation_id":"692745988247830529","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Assessment report published for #Benepali (#etanercept), a #biosimilar #anti-inflammatory #medicine: https://t.co/xt1spVO1Ju","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/yKE7Tvkvbf","expanded_url":"http://bit.ly/1nAjQlT","display_url":"bit.ly/1nAjQlT"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":58,"end":69,"tag":"paediatric"}],"mentions":{},"annotations":{}},"id":"692679858481164288","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-28T12:05:22.000Z","conversation_id":"692679858481164288","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week's meeting of our #paediatric committee (PDCO): https://t.co/yKE7Tvkvbf","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/XU7zkczy6e","expanded_url":"http://bit.ly/1OPBue2","display_url":"bit.ly/1OPBue2"}],"hashtags":[{"start":13,"end":22,"tag":"workshop"},{"start":26,"end":41,"tag":"immunogenicity"}],"mentions":{},"annotations":{}},"id":"692676826439745536","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-28T11:53:19.000Z","conversation_id":"692676826439745536","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Register for #workshop on #immunogenicity assessment of biotechnological therapeutic proteins: https://t.co/XU7zkczy6e","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/WamzL4kcOD","expanded_url":"http://bit.ly/1UpWY2M","display_url":"bit.ly/1UpWY2M"},{"start":106,"end":129,"url":"https://t.co/PPQBDFajio","expanded_url":"https://twitter.com/EMA_News/status/692322976339988480/photo/1","display_url":"pic.twitter.com/PPQBDFajio"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"692322976339988480","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-27T12:27:14.000Z","conversation_id":"692322976339988480","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Highlights of 2015: check out EMA’s key recommendations for veterinary medicines: https://t.co/WamzL4kcOD https://t.co/PPQBDFajio","attachments":{"media_keys":["3_692322576341864448"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/hD6bTMeo1E","expanded_url":"http://bit.ly/1WKnS6Y","display_url":"bit.ly/1WKnS6Y"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":49,"end":60,"tag":"veterinary"}],"mentions":{},"annotations":{}},"id":"691672037010608128","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-25T17:20:38.000Z","conversation_id":"691672037010608128","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #minutes of the December 2015 meeting of our #veterinary committee are now available: https://t.co/hD6bTMeo1E","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":59,"end":82,"url":"https://t.co/q6VXWjBzjz","expanded_url":"http://bit.ly/1S5C3Vb","display_url":"bit.ly/1S5C3Vb"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":27,"end":32,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"691592566823915521","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-25T12:04:51.000Z","conversation_id":"691592566823915521","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #agenda of this week's #CHMP meeting is now available: https://t.co/q6VXWjBzjz","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":120,"end":143,"url":"https://t.co/a5qA2clv7D","expanded_url":"http://bit.ly/1PwJamM","display_url":"bit.ly/1PwJamM"}],"hashtags":[{"start":0,"end":13,"tag":"consultation"},{"start":37,"end":47,"tag":"guideline"}],"mentions":{},"annotations":{}},"id":"690510263309697024","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-22T12:24:10.000Z","conversation_id":"690510263309697024","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"#consultation closing on revision of #guideline on the assessment of clinical safety &amp; efficacy of herbal medicines:https://t.co/a5qA2clv7D","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/Niii1WXMO0","expanded_url":"http://bit.ly/1SinfC9","display_url":"bit.ly/1SinfC9"}],"hashtags":[{"start":29,"end":32,"tag":"IT"},{"start":33,"end":42,"tag":"workshop"}],"mentions":{},"annotations":{}},"id":"690507360683593728","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-22T12:12:38.000Z","conversation_id":"690507360683593728","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"1 week left to register- for #IT #workshop on the implementation of ISO standards for individual case safety reports:https://t.co/Niii1WXMO0","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/2TEgBr6mv7","expanded_url":"http://bit.ly/1PkDjD9","display_url":"bit.ly/1PkDjD9"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":120,"end":136,"tag":"advancedtherapy"}],"mentions":{},"annotations":{}},"id":"690224247675998208","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-21T17:27:39.000Z","conversation_id":"690224247675998208","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #agenda for this week's meeting of our committee for advanced therapies (CAT) is available: https://t.co/2TEgBr6mv7 #advancedtherapy","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/r1YxdFmv3q","expanded_url":"http://bit.ly/1KrgiqE","display_url":"bit.ly/1KrgiqE"}],"hashtags":[{"start":52,"end":63,"tag":"paediatric"}],"mentions":{},"annotations":{}},"id":"689867852019531776","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-20T17:51:27.000Z","conversation_id":"689867852019531776","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've published a new qualification opinion \non the #paediatric ulcerative colitis activity index: https://t.co/r1YxdFmv3q","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"will_iamchin","id":"2539867801"}],"annotations":[{"start":73,"end":88,"probability":0.5913,"type":"Organization","normalized_text":"EU Member States"}]},"id":"689843705310744576","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-20T16:15:30.000Z","conversation_id":"689740857898090496","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@will_iamchin Approval and conduct of clinical trials is in the remit of EU Member States. Please contact the French authorities for info","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"689740857898090496"}],"in_reply_to_user_id":"2539867801"},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/VMeNaS0O4S","expanded_url":"http://bit.ly/1N6WDON","display_url":"bit.ly/1N6WDON"}],"hashtags":[{"start":29,"end":39,"tag":"guideline"},{"start":112,"end":116,"tag":"GCP"},{"start":117,"end":130,"tag":"consultation"}],"mentions":{},"annotations":{}},"id":"689790148586897408","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-20T12:42:41.000Z","conversation_id":"689790148586897408","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on #guideline for good clinical practice E6(R2) 4 - Step 2b: https://t.co/VMeNaS0O4S  #GCP #consultation","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/96fwbytHyT","expanded_url":"http://bit.ly/1M8O3BX","display_url":"bit.ly/1M8O3BX"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":47,"end":57,"tag":"guideline"}],"mentions":{},"annotations":{}},"id":"689789234501271552","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-20T12:39:03.000Z","conversation_id":"689789234501271552","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation closing on application of ICH M7 #guideline to calculation of compound-specific acceptable intakes: https://t.co/96fwbytHyT","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/9ZCYysLQ8H","expanded_url":"http://bit.ly/1Q8ZPfe","display_url":"bit.ly/1Q8ZPfe"}],"hashtags":[{"start":19,"end":32,"tag":"Eptifibatide"},{"start":43,"end":51,"tag":"generic"},{"start":52,"end":61,"tag":"medicine"},{"start":73,"end":79,"tag":"heart"}],"mentions":{},"annotations":{}},"id":"689050675179876353","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-18T11:44:17.000Z","conversation_id":"689050675179876353","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"EPAR published for #Eptifibatide Accord, a #generic #medicine to prevent #heart attack in adults:https://t.co/9ZCYysLQ8H","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/bvORgk2Cx9","expanded_url":"http://bit.ly/1Q2Ty4D","display_url":"bit.ly/1Q2Ty4D"}],"hashtags":[{"start":127,"end":140,"tag":"consultation"}],"mentions":{},"annotations":{}},"id":"688016062458257408","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-15T15:13:06.000Z","conversation_id":"688016062458257408","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Comments invited on Q&amp;A\non mentioning solvents in the product information of veterinary medicines: https://t.co/bvORgk2Cx9 #consultation","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/DiFjnqG4xm","expanded_url":"http://bit.ly/1nnFWYk","display_url":"bit.ly/1nnFWYk"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"688015100238794753","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-15T15:09:17.000Z","conversation_id":"688015100238794753","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"ca","text":"Consultation on concept paper on statistical principles for clinical trials for immunological \nveterinary medicines: https://t.co/DiFjnqG4xm","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/bErKIFJnei","expanded_url":"http://bit.ly/1RK8gBg","display_url":"bit.ly/1RK8gBg"}],"hashtags":[{"start":45,"end":63,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"687969765810409472","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-15T12:09:08.000Z","conversation_id":"687969765810409472","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"The highlights of this week's meeting of our #pharmacovigilance committee (PRAC) are available: https://t.co/bErKIFJnei","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/WAaKeYNJ4X","expanded_url":"http://bit.ly/1hA6XEv","display_url":"bit.ly/1hA6XEv"}],"hashtags":[{"start":78,"end":87,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"687703690988355584","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-14T18:31:51.000Z","conversation_id":"687703690988355584","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"Registration open for our workshop on extrapolation of efficacy and safety in #medicine development in May 2016: https://t.co/WAaKeYNJ4X","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":76,"end":99,"url":"https://t.co/p74KW1jYAd","expanded_url":"http://bit.ly/EUEbFs","display_url":"bit.ly/EUEbFs"},{"start":100,"end":123,"url":"https://t.co/IJaW00rlhe","expanded_url":"https://twitter.com/eu_echo/status/687631169396031488/photo/1","display_url":"pic.twitter.com/IJaW00rlhe"}],"hashtags":[{"start":13,"end":19,"tag":"Ebola"}],"mentions":[{"start":3,"end":11,"username":"eu_echo","id":"470099591"}],"annotations":{}},"id":"687669181312024576","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-14T16:14:43.000Z","conversation_id":"687669181312024576","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @eu_echo: #Ebola | The EU's contribution to getting to a resilient zero: https://t.co/p74KW1jYAd https://t.co/IJaW00rlhe","attachments":{"media_keys":["3_687631168179712001"]},"referenced_tweets":[{"type":"retweeted","id":"687631169396031488"}]},{"source":"TweetDeck","entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/hlF60VGFwt","expanded_url":"http://bit.ly/1Ok7Mh1","display_url":"bit.ly/1Ok7Mh1"}],"hashtags":{},"mentions":{},"annotations":[{"start":15,"end":17,"probability":0.3974,"type":"Organization","normalized_text":"EMA"}]},"id":"687638954900848640","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-14T14:14:37.000Z","conversation_id":"687638954900848640","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Find out about EMA's revised policy on handling competing interests for members of its Management Board: https://t.co/hlF60VGFwt","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/Niii1WXMO0","expanded_url":"http://bit.ly/1SinfC9","display_url":"bit.ly/1SinfC9"}],"hashtags":[{"start":9,"end":12,"tag":"IT"},{"start":31,"end":40,"tag":"workshop"}],"mentions":{},"annotations":{}},"id":"687312734241865729","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-13T16:38:20.000Z","conversation_id":"687312734241865729","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Call for #IT experts to attend #workshop on the implementation of ISO standards for individual case safety reports: https://t.co/Niii1WXMO0","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/kDk0QHGulW","expanded_url":"http://bit.ly/200ozuT","display_url":"bit.ly/200ozuT"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":118,"end":131,"tag":"rarediseases"}],"mentions":{},"annotations":{}},"id":"687298203503452160","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-13T15:40:35.000Z","conversation_id":"687298203503452160","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #agenda of next week's meeting of our committee for orphan medicines (COMP) is available: https://t.co/kDk0QHGulW #rarediseases","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":3,"end":12,"username":"ICH_news","id":"305434870"},{"start":49,"end":58,"username":"TGAgovau","id":"3800463014"},{"start":66,"end":75,"username":"ICH_news","id":"305434870"}],"annotations":[{"start":39,"end":47,"probability":0.9635,"type":"Place","normalized_text":"Australia"}]},"id":"687295438882496512","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-13T15:29:36.000Z","conversation_id":"687295438882496512","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ICH_news: Pleased to announce that Australia @TGAgovau is new @ICH_News Observer. Joins SADC, GCC, ANVISA, PANDRH &amp; APEC. See https://t…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"687281364392099840"}]},{"source":"TweetDeck","entities":{"urls":[{"start":76,"end":99,"url":"https://t.co/10ddtScvHG","expanded_url":"http://bit.ly/1RzjUyO","display_url":"bit.ly/1RzjUyO"},{"start":100,"end":123,"url":"https://t.co/kOIiXgg39I","expanded_url":"https://twitter.com/EMA_News/status/686855957318610944/photo/1","display_url":"pic.twitter.com/kOIiXgg39I"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"686855957318610944","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-12T10:23:16.000Z","conversation_id":"686855957318610944","public_metrics":{"retweet_count":72,"reply_count":1,"like_count":26,"quote_count":0},"lang":"en","text":"Highlights of 2015: check out EMA’s key recommendations for human medicines:https://t.co/10ddtScvHG https://t.co/kOIiXgg39I","attachments":{"media_keys":["3_686850169669812224"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/VkMc7dUlSu","expanded_url":"http://bit.ly/1ZnB2vG","display_url":"bit.ly/1ZnB2vG"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":58,"end":76,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"686599086187917313","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-11T17:22:33.000Z","conversation_id":"686599086187917313","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week's meeting of the #pharmacovigilance committee (PRAC): https://t.co/VkMc7dUlSu","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/Z7tuyld9kd","expanded_url":"http://bit.ly/1VZHNyc","display_url":"bit.ly/1VZHNyc"}],"hashtags":[{"start":17,"end":26,"tag":"colistin"},{"start":103,"end":107,"tag":"AMR"}],"mentions":{},"annotations":{}},"id":"686573098888462336","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-11T15:39:17.000Z","conversation_id":"686573098888462336","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"Advice on use of #colistin in animals to be updated following detection of colistin-resistant bacteria #AMR: https://t.co/Z7tuyld9kd","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/c3GJveryrD","expanded_url":"http://bit.ly/1LkabVe","display_url":"bit.ly/1LkabVe"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":41,"end":48,"tag":"herbal"},{"start":63,"end":75,"tag":"Helichrysum"}],"mentions":{},"annotations":{}},"id":"685433501752147969","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-08T12:10:56.000Z","conversation_id":"685433501752147969","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation closing in 1 week on draft #herbal monograph for #Helichrysum arenarium (Sandy everlasting): https://t.co/c3GJveryrD","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/jkSAoJZPpU","expanded_url":"http://bit.ly/1jyhrFJ","display_url":"bit.ly/1jyhrFJ"}],"hashtags":[{"start":50,"end":57,"tag":"herbal"}],"mentions":{},"annotations":{}},"id":"685433241634009088","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-08T12:09:54.000Z","conversation_id":"685433241634009088","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Call for scientific data to support the review of #herbal monographs – One week left to comment: https://t.co/jkSAoJZPpU","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/4rVkTqfuOP","expanded_url":"http://bit.ly/1OKp19S","display_url":"bit.ly/1OKp19S"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"685073202100461568","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-07T12:19:14.000Z","conversation_id":"685073202100461568","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Check out the presentations from our workshop on PK/PD measurements for anticoagulants in November https://t.co/4rVkTqfuOP","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/6J0SAPxCQO","expanded_url":"http://bit.ly/1muLgci","display_url":"bit.ly/1muLgci"}],"hashtags":[{"start":0,"end":13,"tag":"consultation"},{"start":64,"end":76,"tag":"biosimilars"}],"mentions":{},"annotations":{}},"id":"683989880062504960","author_id":"116716199","possibly_sensitive":false,"created_at":"2016-01-04T12:34:29.000Z","conversation_id":"683989880062504960","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"#consultation on revision of reflection paper on development of #biosimilars containing recombinant interferon alpha https://t.co/6J0SAPxCQO","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":59,"end":82,"url":"https://t.co/er6YjFQdrf","expanded_url":"http://bit.ly/1J1Mdmf","display_url":"bit.ly/1J1Mdmf"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.3706,"type":"Organization","normalized_text":"EMA"}]},"id":"679250397156913153","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-22T10:41:29.000Z","conversation_id":"679250397156913153","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"EMA will be closed from 23 December 2015 to 3 January 2016 https://t.co/er6YjFQdrf","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/CMG5uAFdvp","expanded_url":"http://bit.ly/1NGYbhF","display_url":"bit.ly/1NGYbhF"}],"hashtags":[{"start":22,"end":30,"tag":"elderly"},{"start":55,"end":62,"tag":"trials"}],"mentions":{},"annotations":{}},"id":"679250153870495744","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-22T10:40:31.000Z","conversation_id":"679250153870495744","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":12,"quote_count":0},"lang":"en","text":"How to better include #elderly populations in clinical #trials? Send your comments https://t.co/CMG5uAFdvp","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/VGSRrJzvH4","expanded_url":"http://bit.ly/1NGWlNQ","display_url":"bit.ly/1NGWlNQ"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"679249956994023424","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-22T10:39:44.000Z","conversation_id":"679249956994023424","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Send your comments on draft guidance for developers of medicines against pain https://t.co/VGSRrJzvH4","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/QgkwGtP2EB","expanded_url":"http://bit.ly/1OkBGSZ","display_url":"bit.ly/1OkBGSZ"}],"hashtags":[{"start":21,"end":34,"tag":"Consultation"}],"mentions":{},"annotations":{}},"id":"679228142590947329","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-22T09:13:03.000Z","conversation_id":"679228142590947329","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"One week to comment: #Consultation on Common technical document for registration of pharmaceuticals for human use: https://t.co/QgkwGtP2EB","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/OqlWwQ7Swj","expanded_url":"http://bit.ly/1Ikmi9k","display_url":"bit.ly/1Ikmi9k"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":122,"end":138,"tag":"advancedtherapy"}],"mentions":{},"annotations":{}},"id":"678987886281101312","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-21T17:18:21.000Z","conversation_id":"678987886281101312","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"The #minutes of the November meeting of the committee for advanced therapies (CAT) are available: https://t.co/OqlWwQ7Swj #advancedtherapy","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/2iU4I7BGvs","expanded_url":"http://bit.ly/1MqTCq0","display_url":"bit.ly/1MqTCq0"}],"hashtags":[{"start":4,"end":14,"tag":"guideline"},{"start":86,"end":90,"tag":"ALS"}],"mentions":{},"annotations":{}},"id":"678946286859501568","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-21T14:33:03.000Z","conversation_id":"678946286859501568","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"New #guideline out for developers of medicines to treat amyotrophic lateral sclerosis #ALS https://t.co/2iU4I7BGvs. Applies from 1 June 2016","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/jqL6TqQVE6","expanded_url":"http://bit.ly/1UVnBNB","display_url":"bit.ly/1UVnBNB"}],"hashtags":[{"start":4,"end":14,"tag":"guideline"},{"start":71,"end":76,"tag":"DBMD"}],"mentions":{},"annotations":{}},"id":"678946004008173571","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-21T14:31:56.000Z","conversation_id":"678946004008173571","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"New #guideline on clinical investigation of medicines for treatment of #DBMD adopted https://t.co/jqL6TqQVE6. Applies from 1 July 2016","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/3ISmQOYd5F","expanded_url":"http://bit.ly/1kcfb75","display_url":"bit.ly/1kcfb75"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"678911342330298368","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-21T12:14:12.000Z","conversation_id":"678911342330298368","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"Commitment to patients’ welfare to guide EMA’s work - message from the Executive Director: https://t.co/3ISmQOYd5F","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/bdrT6QLzKo","expanded_url":"http://bit.ly/1MlaFtz","display_url":"bit.ly/1MlaFtz"}],"hashtags":[{"start":49,"end":59,"tag":"medicines"}],"mentions":{},"annotations":[{"start":70,"end":89,"probability":0.8364,"type":"Organization","normalized_text":"EMA Management Board"}]},"id":"677856540448178176","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-18T14:22:47.000Z","conversation_id":"677856540448178176","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":7,"quote_count":0},"lang":"en","text":"Better access to reports on adverse reactions to #medicines agreed by EMA Management Board https://t.co/bdrT6QLzKo","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":45,"end":68,"url":"https://t.co/sSrLjZAMGH","expanded_url":"http://bit.ly/1Ntkny4","display_url":"bit.ly/1Ntkny4"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"677856348097396737","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-18T14:22:02.000Z","conversation_id":"677856348097396737","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Highlights from the Management Board meeting https://t.co/sSrLjZAMGH","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/JNYYm66Y0Q","expanded_url":"http://bit.ly/1T5VSIO","display_url":"bit.ly/1T5VSIO"},{"start":108,"end":131,"url":"https://t.co/iETI2lgSXq","expanded_url":"https://twitter.com/EMA_News/status/677856203733639172/photo/1","display_url":"pic.twitter.com/iETI2lgSXq"}],"hashtags":{},"mentions":{},"annotations":[{"start":22,"end":23,"probability":0.7971,"type":"Organization","normalized_text":"EU"},{"start":67,"end":68,"probability":0.4642,"type":"Organization","normalized_text":"EU"}]},"id":"677856203733639172","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-18T14:21:27.000Z","conversation_id":"677856203733639172","public_metrics":{"retweet_count":24,"reply_count":1,"like_count":6,"quote_count":0},"lang":"en","text":"A common strategy for EU medicines agencies to shape the future of EU public health https://t.co/JNYYm66Y0Q https://t.co/iETI2lgSXq","attachments":{"media_keys":["3_677836149759545344"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/1S64ZpoHyN","expanded_url":"http://bit.ly/1MkTtUX","display_url":"bit.ly/1MkTtUX"},{"start":106,"end":129,"url":"https://t.co/fQFsZMi3Ph","expanded_url":"https://twitter.com/EMA_News/status/677825821567016960/photo/1","display_url":"pic.twitter.com/fQFsZMi3Ph"}],"hashtags":[{"start":6,"end":16,"tag":"medicines"},{"start":45,"end":50,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"677825821567016960","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-18T12:20:43.000Z","conversation_id":"677825821567016960","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":7,"quote_count":0},"lang":"en","text":"9 new #medicines recommended for approval by #CHMP this month, 93 overall in 2015 https://t.co/1S64ZpoHyN https://t.co/fQFsZMi3Ph","attachments":{"media_keys":["3_677825621955878912"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/if1u2lZhVL","expanded_url":"http://bit.ly/1IYkHWI","display_url":"bit.ly/1IYkHWI"}],"hashtags":[{"start":9,"end":18,"tag":"medicine"},{"start":38,"end":49,"tag":"lungcancer"},{"start":90,"end":95,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"677825517870063617","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-18T12:19:31.000Z","conversation_id":"677825517870063617","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"New oral #medicine for non-small cell #lungcancer recommended for conditional approval by #CHMP https://t.co/if1u2lZhVL","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/QgkwGu6E3b","expanded_url":"http://bit.ly/1OkBGSZ","display_url":"bit.ly/1OkBGSZ"}],"hashtags":[{"start":19,"end":32,"tag":"Consultation"}],"mentions":{},"annotations":{}},"id":"677467025271300096","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-17T12:35:00.000Z","conversation_id":"677467025271300096","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"2 weeks to comment #Consultation on Common technical document for registration of pharmaceuticals for human use:https://t.co/QgkwGu6E3b","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/YLvJlwNcLE","expanded_url":"http://bit.ly/1NUK783","display_url":"bit.ly/1NUK783"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"}],"mentions":{},"annotations":{}},"id":"677426041426681856","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-17T09:52:08.000Z","conversation_id":"677426041426681856","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #agenda for the Management Board meeting of 16 &amp; 17 December is now available: https://t.co/YLvJlwNcLE","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/CCBwqew01E","expanded_url":"http://bit.ly/1Qp4n48","display_url":"bit.ly/1Qp4n48"}],"hashtags":[{"start":21,"end":27,"tag":"PRIME"}],"mentions":{},"annotations":{}},"id":"677068793902968832","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-16T10:12:34.000Z","conversation_id":"677068793902968832","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"7 days to comment on #PRIME: new scheme to optimise development of priority medicines and facilitate patient access: https://t.co/CCBwqew01E","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/jkSAoJZPpU","expanded_url":"http://bit.ly/1jyhrFJ","display_url":"bit.ly/1jyhrFJ"}],"hashtags":[{"start":68,"end":75,"tag":"herbal"}],"mentions":{},"annotations":{}},"id":"676807501090856961","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-15T16:54:17.000Z","conversation_id":"676807501090856961","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Calls for scientific data to support the ongoing review of certain  #herbal substances published: https://t.co/jkSAoJZPpU","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/DLAse5IVmj","expanded_url":"http://bit.ly/1NsK3Zt","display_url":"bit.ly/1NsK3Zt"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"676442498860982272","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-14T16:43:54.000Z","conversation_id":"676442498860982272","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Check out the 8 positive opinions for orphan designations from this month's orphan medicines committee meeting: https://t.co/DLAse5IVmj","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":58,"end":81,"url":"https://t.co/acaZqaHV07","expanded_url":"http://bit.ly/1Nlf3fY","display_url":"bit.ly/1Nlf3fY"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":43,"end":48,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"676433327562358784","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-14T16:07:27.000Z","conversation_id":"676433327562358784","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week's #CHMP meeting: https://t.co/acaZqaHV07","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/WAaKeYNJ4X","expanded_url":"http://bit.ly/1hA6XEv","display_url":"bit.ly/1hA6XEv"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"676355029725519872","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-14T10:56:19.000Z","conversation_id":"676355029725519872","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Workshop on extrapolation of efficacy and safety in medicine development in May 2016. Registration starts in January https://t.co/WAaKeYNJ4X","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/BxkqmnnZiA","expanded_url":"http://bit.ly/1O4AfKJ","display_url":"bit.ly/1O4AfKJ"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"676344278696742912","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-14T10:13:36.000Z","conversation_id":"676344278696742912","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Report from our risk minimisation workshop with patients and doctors now available: https://t.co/BxkqmnnZiA","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/pSFK1pv8GP","expanded_url":"http://bit.ly/1OWjj88","display_url":"bit.ly/1OWjj88"}],"hashtags":[{"start":48,"end":59,"tag":"veterinary"},{"start":71,"end":76,"tag":"CVMP"}],"mentions":{},"annotations":{}},"id":"675353220294799360","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-11T16:35:29.000Z","conversation_id":"675353220294799360","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We've published the highlights from this week's #veterinary committee (#CVMP) meeting: https://t.co/pSFK1pv8GP","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/HszDYLTVuM","expanded_url":"http://bit.ly/1NZNIDE","display_url":"bit.ly/1NZNIDE"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":62,"end":73,"tag":"veterinary"},{"start":85,"end":90,"tag":"CVMP"}],"mentions":{},"annotations":{}},"id":"675318822174371844","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-11T14:18:48.000Z","conversation_id":"675318822174371844","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #minutes from the November meeting of our #veterinary committee (#CVMP): https://t.co/HszDYLTVuM","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/dyMavhMhMP","expanded_url":"http://bit.ly/1M6OHdJ","display_url":"bit.ly/1M6OHdJ"}],"hashtags":[{"start":13,"end":20,"tag":"Elocta"},{"start":22,"end":35,"tag":"efmoroctocog"},{"start":45,"end":54,"tag":"medicine"},{"start":90,"end":102,"tag":"haemophilia"}],"mentions":{},"annotations":{}},"id":"675257507451961344","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-11T10:15:10.000Z","conversation_id":"675257507451961344","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"EPAR out for #Elocta (#efmoroctocog alfa), a #medicine to treat bleeding in patients with #haemophilia A: https://t.co/dyMavhMhMP","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/mpDLIzcxuY","expanded_url":"https://youtu.be/sLgQ-bIlCjE","display_url":"youtu.be/sLgQ-bIlCjE"}],"hashtags":{},"mentions":{},"annotations":[{"start":19,"end":28,"probability":0.621,"type":"Person","normalized_text":"Guido Rasi"}]},"id":"674911734973513728","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-10T11:21:11.000Z","conversation_id":"674911734973513728","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Executive Director Guido Rasi outlines vision for his 5-year mandate. Watch the press briefing https://t.co/mpDLIzcxuY","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/VHnCawwJQa","expanded_url":"http://bit.ly/1OSUI3U","display_url":"bit.ly/1OSUI3U"}],"hashtags":[{"start":32,"end":43,"tag":"Pemetrexed"},{"start":99,"end":105,"tag":"NSCLC"}],"mentions":{},"annotations":{}},"id":"674884159005925376","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-10T09:31:36.000Z","conversation_id":"674884159005925376","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Assessment report published for #Pemetrexed medac, a generic medicine for pleural mesothelioma and #NSCLC: https://t.co/VHnCawwJQa","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/MyJYtHV4RA","expanded_url":"http://bit.ly/1lutQvY","display_url":"bit.ly/1lutQvY"},{"start":116,"end":139,"url":"https://t.co/GqXC94SYQa","expanded_url":"https://twitter.com/EMA_News/status/674627963334352898/photo/1","display_url":"pic.twitter.com/GqXC94SYQa"}],"hashtags":{},"mentions":{},"annotations":[{"start":42,"end":51,"probability":0.9936,"type":"Person","normalized_text":"Guido Rasi"}]},"id":"674627963334352898","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-09T16:33:35.000Z","conversation_id":"674627963334352898","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":6,"quote_count":0},"lang":"en","text":"\"EMA ready to address challenges ahead\" - Guido Rasi outlines vision for his 5-year mandate https://t.co/MyJYtHV4RA https://t.co/GqXC94SYQa","attachments":{"media_keys":["3_674623823958958082"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/xNOnN1iICq","expanded_url":"http://bit.ly/1m8k9TU","display_url":"bit.ly/1m8k9TU"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":42,"end":53,"tag":"veterinary"},{"start":75,"end":80,"tag":"CVMP"}],"mentions":{},"annotations":{}},"id":"674223716063137792","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-08T13:47:15.000Z","conversation_id":"674223716063137792","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #agenda of this week's meeting of our #veterinary medicines committee (#CVMP) is available : https://t.co/xNOnN1iICq","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/dLVa4VuANe","expanded_url":"http://bit.ly/1XVS1Pv","display_url":"bit.ly/1XVS1Pv"}],"hashtags":[{"start":32,"end":41,"tag":"Blincyto"},{"start":43,"end":56,"tag":"blinatumomab"}],"mentions":{},"annotations":{}},"id":"673874752390475781","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-07T14:40:35.000Z","conversation_id":"673874752390475781","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Assessment report published for #Blincyto (#blinatumomab), an orphan medicine for acute lymphoblastic leukaemia https://t.co/dLVa4VuANe","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/XeJ01lD5te","expanded_url":"http://bit.ly/1lBdjWn","display_url":"bit.ly/1lBdjWn"}],"hashtags":[{"start":20,"end":38,"tag":"Pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"672753181445791744","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-04T12:23:52.000Z","conversation_id":"672753181445791744","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Find out about our  #Pharmacovigilance Risk Assessment Committee's (PRAC) ongoing safety reviews: https://t.co/XeJ01lD5te","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/voi2Vyx1IA","expanded_url":"http://bit.ly/1Q0WHEH","display_url":"bit.ly/1Q0WHEH"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":111,"end":127,"tag":"advancedtherapy"}],"mentions":{},"annotations":{}},"id":"672111015115554817","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-02T17:52:07.000Z","conversation_id":"672111015115554817","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #minutes of our committee for advanced therapies (CAT) in October: https://t.co/voi2Vyx1IA #advancedtherapy","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/NjnjAIYzvm","expanded_url":"http://bit.ly/1NldU4Y","display_url":"bit.ly/1NldU4Y"}],"hashtags":[{"start":22,"end":33,"tag":"Pemetrexed"},{"start":91,"end":97,"tag":"NSCLC"}],"mentions":{},"annotations":{}},"id":"671731061928435713","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-01T16:42:19.000Z","conversation_id":"671731061928435713","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Assessment report for #Pemetrexed Hospira, a generic medicine for pleural mesothelioma and #NSCLC, is available: https://t.co/NjnjAIYzvm","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/2RF00rIdAI","expanded_url":"http://bit.ly/1MUoZgb","display_url":"bit.ly/1MUoZgb"}],"hashtags":[{"start":5,"end":12,"tag":"agenda"},{"start":43,"end":61,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"671730021229293568","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-01T16:38:11.000Z","conversation_id":"671730021229293568","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"This #agenda of this week's meeting of our #pharmacovigilance committee (PRAC) is available: https://t.co/2RF00rIdAI","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/BMqTd5z55r","expanded_url":"http://bit.ly/1N1b7yz","display_url":"bit.ly/1N1b7yz"}],"hashtags":[{"start":30,"end":38,"tag":"Orkambi"},{"start":40,"end":51,"tag":"lumacaftor"},{"start":52,"end":62,"tag":"ivacaftor"},{"start":128,"end":140,"tag":"RareDisease"}],"mentions":{},"annotations":{}},"id":"671663562620870656","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-01T12:14:06.000Z","conversation_id":"671663562620870656","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"See the assessment report for #Orkambi (#lumacaftor/#ivacaftor), an orphan medicine for cystic fibrosis https://t.co/BMqTd5z55r #RareDisease","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/NnHbfpwMtX","expanded_url":"http://bit.ly/1XunhdF","display_url":"bit.ly/1XunhdF"}],"hashtags":[{"start":26,"end":35,"tag":"Entresto"},{"start":37,"end":48,"tag":"sacubitril"},{"start":49,"end":59,"tag":"valsartan"},{"start":68,"end":77,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"671649974950748160","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-01T11:20:07.000Z","conversation_id":"671649974950748160","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"The assessment report for #Entresto (#sacubitril/#valsartan), a new #medicine to treat heart failure, is available: https://t.co/NnHbfpwMtX","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":82,"end":105,"url":"https://t.co/VK9NWuzicv","expanded_url":"http://bit.ly/1Jj38gQ","display_url":"bit.ly/1Jj38gQ"}],"hashtags":[{"start":68,"end":71,"tag":"IT"},{"start":106,"end":113,"tag":"ITjobs"}],"mentions":{},"annotations":{}},"id":"671649130746404864","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-01T11:16:46.000Z","conversation_id":"671649130746404864","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":14,"quote_count":0},"lang":"en","text":"Apply now for our Solution Architect/Technical Lead position in our #IT Division: https://t.co/VK9NWuzicv #ITjobs","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/ovejNrvSNe","expanded_url":"http://bit.ly/1Xul1mK","display_url":"bit.ly/1Xul1mK"}],"hashtags":[{"start":32,"end":43,"tag":"Veterinary"},{"start":44,"end":54,"tag":"Medicines"}],"mentions":{},"annotations":{}},"id":"671645416786665472","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-01T11:02:00.000Z","conversation_id":"671645416786665472","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're recruiting a Head for our #Veterinary #Medicines Department. Deadline to apply: 4 January: https://t.co/ovejNrvSNe","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/ON7LlH12Hc","expanded_url":"http://bit.ly/1NnjVCE","display_url":"bit.ly/1NnjVCE"}],"hashtags":[{"start":26,"end":35,"tag":"Praxbind"},{"start":71,"end":85,"tag":"anticoagulant"},{"start":86,"end":94,"tag":"Pradaxa"}],"mentions":{},"annotations":{}},"id":"671643847194255360","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-01T10:55:46.000Z","conversation_id":"671643847194255360","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"The assessment report for #Praxbind (idarucizumab), an antidote to the #anticoagulant #Pradaxa, is available: https://t.co/ON7LlH12Hc","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":117,"url":"https://t.co/egTzT4ajkR","expanded_url":"http://bit.ly/1RiLizu","display_url":"bit.ly/1RiLizu"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":118,"end":131,"tag":"rarediseases"}],"mentions":{},"annotations":{}},"id":"671627179999019008","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-12-01T09:49:32.000Z","conversation_id":"671627179999019008","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #agenda of next week's meeting of our committee for orphan medicines (COMP) is available: https://t.co/egTzT4ajkR #rarediseases","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/pzGQimRIRs","expanded_url":"http://bit.ly/1IedDVB","display_url":"bit.ly/1IedDVB"}],"hashtags":[{"start":121,"end":131,"tag":"medicines"},{"start":132,"end":137,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"670240691734360064","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-27T14:00:08.000Z","conversation_id":"670240691734360064","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"See this month’s list of opinions on accelerated assessment, annual re-assessments and renewals: https://t.co/pzGQimRIRs #medicines #CHMP","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/enSahm3lmb","expanded_url":"http://bit.ly/1OuNTnb","display_url":"bit.ly/1OuNTnb"}],"hashtags":[{"start":107,"end":117,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"670222379650580480","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-27T12:47:22.000Z","conversation_id":"670222379650580480","public_metrics":{"retweet_count":13,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"Check out a new webpage and good practice guide to help prevent medication errors: https://t.co/enSahm3lmb #medicines","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/clmawWqESk","expanded_url":"http://bit.ly/1Ta4jCu","display_url":"bit.ly/1Ta4jCu"}],"hashtags":[{"start":19,"end":30,"tag":"Cinacalcet"},{"start":40,"end":48,"tag":"generic"},{"start":49,"end":58,"tag":"medicine"},{"start":63,"end":77,"tag":"hypercalcemia"},{"start":81,"end":88,"tag":"cancer"},{"start":93,"end":113,"tag":"hyperparathyroidism"}],"mentions":{},"annotations":{}},"id":"670220342229606400","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-27T12:39:16.000Z","conversation_id":"670220342229606400","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"EPAR published for #Cinacalcet Mylan, a #generic #medicine for #hypercalcemia in #cancer and #hyperparathyroidism: https://t.co/clmawWqESk","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/PwCVMbBBbK","expanded_url":"http://bit.ly/1lNKDtT","display_url":"bit.ly/1lNKDtT"}],"hashtags":[{"start":13,"end":26,"tag":"Aripiprazole"},{"start":27,"end":34,"tag":"Accord"},{"start":38,"end":46,"tag":"generic"},{"start":47,"end":56,"tag":"medicine"},{"start":61,"end":69,"tag":"bipolar"},{"start":85,"end":99,"tag":"schizophrenia"}],"mentions":{},"annotations":{}},"id":"670190811158609921","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-27T10:41:55.000Z","conversation_id":"670190811158609921","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"EPAR out for #Aripiprazole #Accord, a #generic #medicine for #bipolar I disorder and #schizophrenia: https://t.co/PwCVMbBBbK","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/WsSYnwLl1J","expanded_url":"http://bit.ly/1jlxTZs","display_url":"bit.ly/1jlxTZs"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"}],"mentions":{},"annotations":{}},"id":"669922137671602176","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-26T16:54:18.000Z","conversation_id":"669922137671602176","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"The #minutes from the October meeting of our orphan medicines committee (COMP) are now available: https://t.co/WsSYnwLl1J","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":57,"end":80,"url":"https://t.co/Virq2pfyBW","expanded_url":"http://bit.ly/1jjFmbu","display_url":"bit.ly/1jjFmbu"}],"hashtags":[{"start":28,"end":33,"tag":"CHMP"},{"start":81,"end":91,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"669548822847188992","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-25T16:10:53.000Z","conversation_id":"669548822847188992","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The minutes of last month's #CHMP meeting are available: https://t.co/Virq2pfyBW #medicines","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/MtI3KPSn1x","expanded_url":"http://bit.ly/1MCJmyl","display_url":"bit.ly/1MCJmyl"}],"hashtags":[{"start":84,"end":95,"tag":"paediatric"}],"mentions":{},"annotations":{}},"id":"669547470020571136","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-25T16:05:31.000Z","conversation_id":"669547470020571136","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Check out the opinions on paediatric \ninvestigation plans adopted this month by our #paediatric committee (PDCO) https://t.co/MtI3KPSn1x","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":61,"end":84,"url":"https://t.co/zu5EdtBEdI","expanded_url":"http://bit.ly/1N9DJsY","display_url":"bit.ly/1N9DJsY"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"668855804250955777","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-23T18:17:05.000Z","conversation_id":"668855804250955777","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Further guidance on EMA adaptive pathways pilot is released: https://t.co/zu5EdtBEdI","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/mdbCIhVNii","expanded_url":"http://bit.ly/1QDQWwC","display_url":"bit.ly/1QDQWwC"}],"hashtags":[{"start":13,"end":20,"tag":"Obizur"},{"start":22,"end":33,"tag":"susoctocog"},{"start":43,"end":52,"tag":"medicine"},{"start":104,"end":116,"tag":"haemophilia"}],"mentions":{},"annotations":{}},"id":"668802003800313856","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-23T14:43:18.000Z","conversation_id":"668802003800313856","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"EPAR out for #Obizur (#susoctocog alfa), a #medicine to treat bleeding episodes in adults with acquired #haemophilia:https://t.co/mdbCIhVNii","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/68CqHwg3ck","expanded_url":"http://bit.ly/1NL0P5E","display_url":"bit.ly/1NL0P5E"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":57,"end":72,"tag":"EudraVigilance"},{"start":73,"end":84,"tag":"veterinary"},{"start":115,"end":133,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"668740408260878337","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-23T10:38:32.000Z","conversation_id":"668740408260878337","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"fr","text":"#Consultation open on recommendation for surveillance of #EudraVigilance #veterinary data: https://t.co/68CqHwg3ck #pharmacovigilance","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/XUGMBy9w8j","expanded_url":"http://bit.ly/21cgSDp","display_url":"bit.ly/21cgSDp"}],"hashtags":[{"start":42,"end":50,"tag":"Ebymect"},{"start":52,"end":66,"tag":"dapagliflozin"},{"start":69,"end":79,"tag":"metformin"},{"start":84,"end":93,"tag":"diabetes"},{"start":94,"end":103,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"668733121601380353","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-23T10:09:35.000Z","conversation_id":"668733121601380353","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Ebymect (#dapagliflozin  /#metformin ) a #diabetes #medicine: https://t.co/XUGMBy9w8j","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/4rVkTqfuOP","expanded_url":"http://bit.ly/1OKp19S","display_url":"bit.ly/1OKp19S"}],"hashtags":[{"start":82,"end":97,"tag":"anticoagulants"},{"start":123,"end":138,"tag":"cardiovascular"}],"mentions":{},"annotations":{}},"id":"668713526349963264","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-23T08:51:43.000Z","conversation_id":"668713526349963264","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"We are broadcasting now our workshop on PK/PD measurements in the clinical use of #anticoagulants: https://t.co/4rVkTqfuOP #cardiovascular","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":102,"end":125,"url":"https://t.co/w7Sdqhg9Ew","expanded_url":"http://bit.ly/1NfNbJO","display_url":"bit.ly/1NfNbJO"}],"hashtags":[{"start":85,"end":100,"tag":"cardiovascular"}],"mentions":{},"annotations":{}},"id":"667723052332003328","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-20T15:15:56.000Z","conversation_id":"667723052332003328","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Workshop on PK/PD measurements for anticoagulants is broadcast live on Monday 23 Nov #cardiovascular \nhttps://t.co/w7Sdqhg9Ew","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":7,"username":"109118","id":"294902446"}],"annotations":{}},"id":"667695785786646528","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-20T13:27:35.000Z","conversation_id":"667695785786646528","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@109118  Thank you for alerting us. We are currently working to fix the problem.","attachments":{"media_keys":{}},"referenced_tweets":{},"in_reply_to_user_id":"294902446"},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/ry87GGtGMn","expanded_url":"http://bit.ly/1X2p4X4","display_url":"bit.ly/1X2p4X4"}],"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":47,"end":51,"tag":"HPV"},{"start":52,"end":61,"tag":"vaccines"}],"mentions":{},"annotations":{}},"id":"667678672585924608","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-20T12:19:35.000Z","conversation_id":"667678672585924608","public_metrics":{"retweet_count":17,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"#CHMP confirms: evidence does not support that #HPV #vaccines cause CRPS or POTS\nhttps://t.co/ry87GGtGMn","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":71,"end":94,"url":"https://t.co/e97VFeSvVq","expanded_url":"http://bit.ly/1PE3O5O","display_url":"bit.ly/1PE3O5O"}],"hashtags":[{"start":15,"end":24,"tag":"medicine"},{"start":59,"end":70,"tag":"narcolepsy"}],"mentions":{},"annotations":{}},"id":"667676541732696064","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-20T12:11:07.000Z","conversation_id":"667676541732696064","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"First-in-class #medicine recommended for approval to treat #narcolepsy https://t.co/e97VFeSvVq","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":64,"end":87,"url":"https://t.co/7xSlxgt9OW","expanded_url":"http://bit.ly/1lyoQGd","display_url":"bit.ly/1lyoQGd"},{"start":88,"end":111,"url":"https://t.co/XHp4kbMPAi","expanded_url":"https://twitter.com/EMA_News/status/667675962876760064/photo/1","display_url":"pic.twitter.com/XHp4kbMPAi"}],"hashtags":[{"start":7,"end":17,"tag":"medicines"},{"start":46,"end":51,"tag":"CHMP"}],"mentions":{},"annotations":{}},"id":"667675962876760064","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-20T12:08:49.000Z","conversation_id":"667675962876760064","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"10 new #medicines recommended for approval by #CHMP this month: https://t.co/7xSlxgt9OW https://t.co/XHp4kbMPAi","attachments":{"media_keys":["3_667675799554826240"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/3mqyuPymUt","expanded_url":"http://bit.ly/1PDYFKP","display_url":"bit.ly/1PDYFKP"}],"hashtags":{},"mentions":[{"start":0,"end":16,"username":"booksnowandthen","id":"2354848216"}],"annotations":[{"start":17,"end":19,"probability":0.4206,"type":"Organization","normalized_text":"EMA"}]},"id":"667663472805720064","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-20T11:19:11.000Z","conversation_id":"667654304510144513","public_metrics":{"retweet_count":1,"reply_count":4,"like_count":0,"quote_count":0},"lang":"en","text":"@booksnowandthen EMA conducts robust and fair selection procedures to fill all of its vacancies - https://t.co/3mqyuPymUt","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"667655594086649857"}],"in_reply_to_user_id":"2354848216"},{"source":"TweetDeck","entities":{"urls":[{"start":71,"end":94,"url":"https://t.co/EWUdDfVJ0e","expanded_url":"http://bit.ly/1lygzlN","display_url":"bit.ly/1lygzlN"}],"hashtags":[{"start":10,"end":18,"tag":"vacancy"},{"start":26,"end":37,"tag":"accounting"},{"start":95,"end":100,"tag":"jobs"},{"start":101,"end":113,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"667654304510144513","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-20T10:42:45.000Z","conversation_id":"667654304510144513","public_metrics":{"retweet_count":1,"reply_count":2,"like_count":0,"quote_count":0},"lang":"en","text":"We have a #vacancy for an #accounting assistant - apply by 20 Dec 2015\nhttps://t.co/EWUdDfVJ0e #jobs #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/QUauEy2Eq9","expanded_url":"http://ec.europa.eu/growth/smes/cosme/","display_url":"ec.europa.eu/growth/smes/co…"}],"hashtags":[{"start":19,"end":25,"tag":"COSME"},{"start":65,"end":74,"tag":"business"},{"start":117,"end":129,"tag":"eusmeweek15"}],"mentions":[{"start":3,"end":13,"username":"EU_Growth","id":"109241118"}],"annotations":{}},"id":"667647370792968192","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-20T10:15:12.000Z","conversation_id":"667647370792968192","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Growth: Our #COSME programme helps create more favourable #business conditions. Info: https://t.co/QUauEy2Eq9 #eusmeweek15 https://t…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"667646370803765248"}]},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/vbtyLu5fDT","expanded_url":"http://bit.ly/1QS6DPY","display_url":"bit.ly/1QS6DPY"}],"hashtags":[{"start":66,"end":71,"tag":"SMEs"},{"start":124,"end":133,"tag":"EDJF2015"}],"mentions":[{"start":3,"end":19,"username":"DigitalAgendaEU","id":"2894539229"},{"start":89,"end":99,"username":"EU_Growth","id":"109241118"}],"annotations":{}},"id":"667640850994851840","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-20T09:49:17.000Z","conversation_id":"667640850994851840","public_metrics":{"retweet_count":51,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @DigitalAgendaEU: What are the most pressing problems European #SMEs face? Answers by @EU_Growth https://t.co/vbtyLu5fDT #EDJF2015 https…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"667632487992946688"}]},{"source":"TweetDeck","entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/Gicu2ZDceI","expanded_url":"http://bit.ly/1OQJcXQ","display_url":"bit.ly/1OQJcXQ"}],"hashtags":[{"start":68,"end":81,"tag":"rarediseases"}],"mentions":{},"annotations":{}},"id":"667634661036851200","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-20T09:24:41.000Z","conversation_id":"667634661036851200","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"17 medicines recommended for orphan designation by COMP in November #rarediseases \nhttps://t.co/Gicu2ZDceI","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/Hk9tMBJOvx","expanded_url":"http://bit.ly/1FWr5J2","display_url":"bit.ly/1FWr5J2"}],"hashtags":[{"start":22,"end":32,"tag":"guideline"},{"start":94,"end":105,"tag":"rheumatoid"}],"mentions":{},"annotations":{}},"id":"667309526085824512","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-19T11:52:43.000Z","conversation_id":"667309526085824512","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Consultation closing: #guideline on clinical investigation of medicines other than NSAIDs for #rheumatoid arthritis: https://t.co/Hk9tMBJOvx","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/utYY9PVgPW","expanded_url":"http://bit.ly/1OQJC0s","display_url":"bit.ly/1OQJC0s"}],"hashtags":[{"start":26,"end":37,"tag":"veterinary"}],"mentions":{},"annotations":{}},"id":"667051403144241153","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-18T18:47:02.000Z","conversation_id":"667051403144241153","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The 2016 work plan of our #veterinary medicines committee (CVMP) antimicrobials working party is available: https://t.co/utYY9PVgPW","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/Gicu2ZDceI","expanded_url":"http://bit.ly/1OQJcXQ","display_url":"bit.ly/1OQJcXQ"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"667049679159500800","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-18T18:40:11.000Z","conversation_id":"667049679159500800","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":3,"quote_count":0},"lang":"en","text":"Check out the 17 positive opinions for orphan designations from this month's orphan medicines committee meeting: https://t.co/Gicu2ZDceI","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":86,"end":109,"url":"https://t.co/6NErTUlAPk","expanded_url":"http://bit.ly/1LlIwlE","display_url":"bit.ly/1LlIwlE"},{"start":116,"end":139,"url":"https://t.co/CSkIV9rpRU","expanded_url":"https://twitter.com/EMA_News/status/666969310510850050/photo/1","display_url":"pic.twitter.com/CSkIV9rpRU"}],"hashtags":[{"start":40,"end":61,"tag":"AntibioticResistance"},{"start":110,"end":115,"tag":"EAAD"}],"mentions":{},"annotations":{}},"id":"666969310510850050","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-18T13:20:49.000Z","conversation_id":"666969310510850050","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":12,"quote_count":0},"lang":"en","text":"Find out how EMA protects patients from #AntibioticResistance in our new infographic: https://t.co/6NErTUlAPk #EAAD https://t.co/CSkIV9rpRU","attachments":{"media_keys":["3_666969115987484672"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/I06Jjpahoc","expanded_url":"http://bit.ly/1PvSo3Y","display_url":"bit.ly/1PvSo3Y"}],"hashtags":[{"start":102,"end":107,"tag":"EAAD"}],"mentions":[{"start":0,"end":11,"username":"WHO_Europe","id":"125403342"},{"start":12,"end":27,"username":"PaulineCastres","id":"2828136269"}],"annotations":{}},"id":"666964835532447744","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-18T13:03:03.000Z","conversation_id":"666961357187731456","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@WHO_Europe @PaulineCastres ESVAC monitors sales of veterinary antibiotics to support responsible use #EAAD https://t.co/I06Jjpahoc","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"666963963259822083"}],"in_reply_to_user_id":"125403342"},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/I06Jjpahoc","expanded_url":"http://bit.ly/1PvSo3Y","display_url":"bit.ly/1PvSo3Y"}],"hashtags":[{"start":134,"end":139,"tag":"EAAD"}],"mentions":{},"annotations":[{"start":63,"end":78,"probability":0.3551,"type":"Organization","normalized_text":"EU Member States"}]},"id":"666963332512030720","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-18T12:57:04.000Z","conversation_id":"666962225467379716","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@Daavision We monitor consumption of antibiotics in animals in EU Member States as part of the ESVAC project: https://t.co/I06Jjpahoc #EAAD","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"666962225467379716"}],"in_reply_to_user_id":"3898054312"},{"source":"TweetDeck","entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/DKQ2SqLZrf","expanded_url":"http://bit.ly/1PxKG9B","display_url":"bit.ly/1PxKG9B"}],"hashtags":[{"start":65,"end":86,"tag":"AntibioticResistance"},{"start":129,"end":134,"tag":"EAAD"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.5437,"type":"Organization","normalized_text":"EMA"},{"start":23,"end":32,"probability":0.7725,"type":"Person","normalized_text":"Guido Rasi"}]},"id":"666957171058450432","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-18T12:32:35.000Z","conversation_id":"666957171058450432","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"EMA Executive Director Guido Rasi on how to tackle challenges of #AntibioticResistance. Watch the video: https://t.co/DKQ2SqLZrf #EAAD","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":129,"end":134,"tag":"EAAD"}],"mentions":{},"annotations":[{"start":19,"end":30,"probability":0.8061,"type":"Person","normalized_text":"Radu Botgros"},{"start":51,"end":64,"probability":0.5464,"type":"Person","normalized_text":"Zoltan Kunsagi"}]},"id":"666950413183262720","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-18T12:05:44.000Z","conversation_id":"666950413183262720","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Scientific experts Radu Botgros (human medicine) &amp; Zoltan Kunsagi (veterinary medicine) stand ready to answer your questions #EAAD","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/I06Jjpahoc","expanded_url":"http://bit.ly/1PvSo3Y","display_url":"bit.ly/1PvSo3Y"},{"start":115,"end":138,"url":"https://t.co/19owbI6Jt2","expanded_url":"https://twitter.com/EMA_News/status/666939008958734336/photo/1","display_url":"pic.twitter.com/19owbI6Jt2"}],"hashtags":[{"start":49,"end":60,"tag":"veterinary"},{"start":61,"end":73,"tag":"antibiotics"},{"start":109,"end":114,"tag":"EAAD"}],"mentions":{},"annotations":[{"start":77,"end":82,"probability":0.9889,"type":"Place","normalized_text":"Europe"}]},"id":"666939008958734336","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-18T11:20:25.000Z","conversation_id":"666939008958734336","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Check out ESVAC interactive database on sales of #veterinary #antibiotics in Europe: https://t.co/I06Jjpahoc #EAAD https://t.co/19owbI6Jt2","attachments":{"media_keys":["3_666938828326871040"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":31,"end":43,"tag":"TwitterChat"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":65,"end":76,"username":"WHO_Europe","id":"125403342"},{"start":77,"end":87,"username":"EU_Health","id":"606325697"}],"annotations":{}},"id":"666909468337283072","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-18T09:23:02.000Z","conversation_id":"666909468337283072","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ECDC_EU: Join the European #TwitterChat today, 1300 CET with @WHO_Europe @EU_Health @EFSA_live @EMA_News #EAAD https://t.co/Cl56vt6YVi","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"666901872381452288"}]},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/yZ2Mtv9iWS","expanded_url":"http://oe.cd/1be","display_url":"oe.cd/1be"}],"hashtags":[{"start":13,"end":34,"tag":"AntibioticResistance"},{"start":51,"end":63,"tag":"antibiotics"},{"start":87,"end":92,"tag":"OECD"}],"mentions":[{"start":3,"end":11,"username":"OECDgov","id":"2278865772"}],"annotations":{}},"id":"666673965683843072","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-17T17:47:14.000Z","conversation_id":"666673965683843072","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @OECDgov: #AntibioticResistance - Graph showing #antibiotics prescription volume in #OECD 2002-2012 https://t.co/yZ2Mtv9iWS https://t.co…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"666650419259645952"}]},{"source":"TweetDeck","entities":{"urls":[{"start":90,"end":113,"url":"https://t.co/Z6toOMMci8","expanded_url":"http://bit.ly/1SVt59Y","display_url":"bit.ly/1SVt59Y"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":27,"end":38,"tag":"veterinary"},{"start":74,"end":89,"tag":"antimicrobials"},{"start":114,"end":119,"tag":"EAAD"},{"start":120,"end":124,"tag":"AMR"}],"mentions":{},"annotations":{}},"id":"666590893030449152","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-17T12:17:08.000Z","conversation_id":"666590893030449152","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation opens on our #veterinary committee’s (CVMP) new strategy on #antimicrobials https://t.co/Z6toOMMci8 #EAAD #AMR","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":77,"end":100,"url":"https://t.co/DKQ2SqLZrf","expanded_url":"http://bit.ly/1PxKG9B","display_url":"bit.ly/1PxKG9B"}],"hashtags":[{"start":51,"end":65,"tag":"antimicrobial"},{"start":101,"end":106,"tag":"EAAD"},{"start":107,"end":111,"tag":"AMR"}],"mentions":{},"annotations":{}},"id":"666590152924528641","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-17T12:14:11.000Z","conversation_id":"666590152924528641","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Find out about our activities in the fight against #antimicrobial resistance https://t.co/DKQ2SqLZrf #EAAD #AMR","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/s1A4snCuQg","expanded_url":"http://bit.ly/1j50nqf","display_url":"bit.ly/1j50nqf"}],"hashtags":[{"start":27,"end":37,"tag":"guideline"},{"start":67,"end":77,"tag":"medicines"},{"start":125,"end":140,"tag":"cardiovascular"}],"mentions":{},"annotations":{}},"id":"666579656372568064","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-17T11:32:29.000Z","conversation_id":"666579656372568064","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Consultation open on draft #guideline on clinical investigation of #medicines for prevention of VTE: https://t.co/s1A4snCuQg #cardiovascular","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/as5bRqjasn","expanded_url":"https://twitter.com/EMA_News/status/666548213147688961/photo/1","display_url":"pic.twitter.com/as5bRqjasn"}],"hashtags":{},"mentions":{},"annotations":[{"start":45,"end":54,"probability":0.7968,"type":"Person","normalized_text":"Guido Rasi"},{"start":70,"end":95,"probability":0.3196,"type":"Organization","normalized_text":"CHMP Chair Tomas Salmonson"}]},"id":"666548213147688961","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-17T09:27:32.000Z","conversation_id":"666548213147688961","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":9,"quote_count":0},"lang":"en","text":"Second day in office: EMA Executive Director Guido Rasi is greeted by CHMP Chair Tomas Salmonson https://t.co/as5bRqjasn","attachments":{"media_keys":["3_666547426497568768"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":20,"end":32,"tag":"antibiotics"},{"start":44,"end":49,"tag":"EAAD"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":77,"end":85,"username":"ECDC_EU","id":"204752573"},{"start":86,"end":97,"username":"WHO_Europe","id":"125403342"},{"start":99,"end":109,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":50,"end":56,"probability":0.4232,"type":"Product","normalized_text":"Twitter"}]},"id":"666302963921629184","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-16T17:13:00.000Z","conversation_id":"666302963921629184","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Keep #antibiotics effective: #EAAD Twitter chat, 18 Nov, 1 PM @ECDC_EU @WHO_Europe, @EU_Health @EFSA_live @EMA_News https://…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"666266082240569348"}]},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":36,"end":60,"tag":"antimicrobialresistance"},{"start":113,"end":123,"tag":"OneHealth"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":{}},"id":"666253121040052224","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-16T13:54:57.000Z","conversation_id":"666253121040052224","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAAD_EU: EU Action Plan against #antimicrobialresistance requires actions on both human &amp; animal sector, #OneHealth, says @V_Andriukait…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"666245975699255296"}]},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":122,"end":125,"tag":"EU"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":16,"end":31,"username":"V_Andriukaitis","id":"575269517"}],"annotations":{}},"id":"666252938294272000","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-16T13:54:13.000Z","conversation_id":"666252938294272000","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: .@V_Andriukaitis: The implementation of actions to fight antimicrobial resistance is the responsibility of #EU Member States…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"666247944182628352"}]},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":15,"end":29,"tag":"Certification"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":[{"start":58,"end":61,"probability":0.6553,"type":"Organization","normalized_text":"CEPs"}]},"id":"666252766873038848","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-16T13:53:32.000Z","conversation_id":"666252766873038848","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: #Certification report gives key figures on CEPs and inspections. See our latest report for October 2015 https://t.co/jb1H6pf…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"666249925928353793"}]},{"source":"TweetDeck","entities":{"urls":[{"start":57,"end":80,"url":"https://t.co/XlFYC0tzjf","expanded_url":"http://bit.ly/1kAakO7","display_url":"bit.ly/1kAakO7"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"}],"mentions":{},"annotations":{}},"id":"666251265169620992","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-16T13:47:34.000Z","conversation_id":"666251265169620992","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week's CHMP meeting: https://t.co/XlFYC0tzjf","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/VK9NWuzicv","expanded_url":"http://bit.ly/1Jj38gQ","display_url":"bit.ly/1Jj38gQ"}],"hashtags":[{"start":115,"end":127,"tag":"recruitment"},{"start":128,"end":135,"tag":"ITjobs"}],"mentions":{},"annotations":{}},"id":"666198808552939521","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-16T10:19:07.000Z","conversation_id":"666198808552939521","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Apply until 30 Nov for a job as Solution Architect/Technical Lead, Information Technology: https://t.co/VK9NWuzicv #recruitment #ITjobs","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/DdvmJpEZl9","expanded_url":"http://bit.ly/1WVhzRU","display_url":"bit.ly/1WVhzRU"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.9729,"type":"Person","normalized_text":"Guido Rasi"},{"start":39,"end":63,"probability":0.5578,"type":"Organization","normalized_text":"European Medicines Agency"}]},"id":"666196353639391232","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-16T10:09:22.000Z","conversation_id":"666196353639391232","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"Guido Rasi takes office as head of the European Medicines Agency today: https://t.co/DdvmJpEZl9","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/92MHRcDDtp","expanded_url":"https://twitter.com/EAAD_EU/status/665148144607436800/photo/1","display_url":"pic.twitter.com/92MHRcDDtp"}],"hashtags":[{"start":33,"end":45,"tag":"antibiotics"},{"start":87,"end":108,"tag":"AntibioticResistance"},{"start":109,"end":114,"tag":"EAAD"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"}],"annotations":{}},"id":"665148533071355904","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-13T12:45:42.000Z","conversation_id":"665148533071355904","public_metrics":{"retweet_count":57,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAAD_EU: Join us! Talk about #antibiotics - a 24-hour global conversation, 18 Nov. #AntibioticResistance #EAAD https://t.co/92MHRcDDtp","attachments":{"media_keys":["3_665147505378766848"]},"referenced_tweets":[{"type":"retweeted","id":"665148144607436800"}]},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/Hk9tMBsdDZ","expanded_url":"http://bit.ly/1FWr5J2","display_url":"bit.ly/1FWr5J2"}],"hashtags":[{"start":22,"end":32,"tag":"guideline"},{"start":62,"end":72,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"665148449873088512","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-13T12:45:22.000Z","conversation_id":"665148449873088512","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"2 weeks to comment on #guideline on clinical investigation of #medicines other than NSAIDs for rheumatoid arthritis: https://t.co/Hk9tMBsdDZ","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":105,"end":128,"url":"https://t.co/71GgksqtRR","expanded_url":"http://goo.gl/1WyXp5","display_url":"goo.gl/1WyXp5"}],"hashtags":[{"start":71,"end":92,"tag":"AntibioticResistance"}],"mentions":[{"start":3,"end":11,"username":"WHOatEU","id":"3042231323"},{"start":66,"end":70,"username":"WHO","id":"14499829"}],"annotations":[{"start":30,"end":64,"probability":0.5998,"type":"Other","normalized_text":"1st World Antibiotic Awareness Week"}]},"id":"665136621105373184","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-13T11:58:22.000Z","conversation_id":"665136621105373184","public_metrics":{"retweet_count":65,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHOatEU: Next week is the 1st World Antibiotic Awareness Week @WHO #AntibioticResistance. More info: https://t.co/71GgksqtRR https://t.…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"665105602771832832"}]},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":55,"end":59,"tag":"CEP"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"id":"665135203648716800","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-13T11:52:44.000Z","conversation_id":"665135203648716800","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: Do you know how to prepare a successful #CEP application? Our online webinar will answer all of your questions https://t.co/…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"665108800425316352"}]},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":18,"end":30,"tag":"antibiotics"},{"start":42,"end":47,"tag":"EAAD"}],"mentions":[{"start":3,"end":11,"username":"EAAD_EU","id":"1725283578"},{"start":75,"end":83,"username":"ECDC_EU","id":"204752573"},{"start":84,"end":95,"username":"WHO_Europe","id":"125403342"},{"start":97,"end":107,"username":"EU_Health","id":"606325697"},{"start":108,"end":116,"username":"EFSA_EU","id":"84582815"},{"start":117,"end":126,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":48,"end":54,"probability":0.4374,"type":"Product","normalized_text":"Twitter"}]},"id":"664385832711667712","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-11T10:15:00.000Z","conversation_id":"664385832711667712","public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EAAD_EU: Keep #antibiotics effective: #EAAD Twitter chat, 18 Nov, 1 PM @ECDC_EU @WHO_Europe, @EU_Health @EFSA_EU @EMA_News https://t.co…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"664375503109775360"}]},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/XreF0QnpMG","expanded_url":"http://bit.ly/1iROT9m","display_url":"bit.ly/1iROT9m"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":42,"end":53,"tag":"paediatric"}],"mentions":{},"annotations":{}},"id":"664139457788928000","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-10T17:56:00.000Z","conversation_id":"664139457788928000","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"The #agenda of this week's meeting of our #paediatric committee (PDCO) is available: https://t.co/XreF0QnpMG","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/5QrXjH9NAS","expanded_url":"http://bit.ly/1PmoT4p","display_url":"bit.ly/1PmoT4p"}],"hashtags":[{"start":34,"end":44,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"664059968958533633","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-10T12:40:08.000Z","conversation_id":"664059968958533633","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Check out our updated list of new #medicines for human use under EMA evaluation: https://t.co/5QrXjH9NAS","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/vejORXXm8A","expanded_url":"http://bit.ly/1RICr8j","display_url":"bit.ly/1RICr8j"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":36,"end":47,"tag":"veterinary"},{"start":48,"end":58,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"663762961278877696","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-09T16:59:56.000Z","conversation_id":"663762961278877696","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the #minutes of our #veterinary #medicines committee in October: https://t.co/vejORXXm8A","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/2Lt1ppx2nH","expanded_url":"http://bit.ly/1Ozm3ZZ","display_url":"bit.ly/1Ozm3ZZ"}],"hashtags":[{"start":54,"end":65,"tag":"veterinary"},{"start":66,"end":76,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"663735960757280768","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-09T15:12:39.000Z","conversation_id":"663735960757280768","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the meeting highlights of last week's #veterinary #medicines committee (CVMP): https://t.co/2Lt1ppx2nH","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":121,"url":"https://t.co/ItFfYsiszi","expanded_url":"http://goo.gl/NiYrvQ","display_url":"goo.gl/NiYrvQ"}],"hashtags":[{"start":9,"end":30,"tag":"AntibioticResistance"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"annotations":{}},"id":"663691610606170112","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-09T12:16:25.000Z","conversation_id":"663691610606170112","public_metrics":{"retweet_count":545,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO: #AntibioticResistance→ Only take antibiotics a health professional has prescribed TO YOU https://t.co/ItFfYsiszi\nhttps://t.co/pAvK…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"663676921012600833"}]},{"source":"Mobile Web","entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/teTfkRhYxa","expanded_url":"https://youtu.be/6viX0xkhZ0A","display_url":"youtu.be/6viX0xkhZ0A"}],"hashtags":[{"start":54,"end":61,"tag":"safety"},{"start":65,"end":69,"tag":"HPV"},{"start":70,"end":79,"tag":"vaccines"}],"mentions":{},"annotations":[{"start":10,"end":12,"probability":0.4062,"type":"Organization","normalized_text":"EMA"}]},"id":"662681312466239488","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-06T17:21:51.000Z","conversation_id":"662681312466239488","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":6,"quote_count":0},"lang":"en","text":"Watch the EMA’s virtual press briefing confirming the #safety of #HPV #vaccines in relation to CRPS and POTS https://t.co/teTfkRhYxa","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":102,"end":125,"url":"https://t.co/t5tvHN8sGM","expanded_url":"http://bit.ly/1LVhJ3f","display_url":"bit.ly/1LVhJ3f"}],"hashtags":[{"start":92,"end":100,"tag":"studies"}],"mentions":{},"annotations":{}},"id":"662645637809381376","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-06T15:00:06.000Z","conversation_id":"662645637809381376","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Submit comments on our draft guidance for design&amp;conduct of post-authorisation efficacy #studies \nhttps://t.co/t5tvHN8sGM","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/NosrnVNzN0","expanded_url":"http://bit.ly/1PcZdHt","display_url":"bit.ly/1PcZdHt"}],"hashtags":[{"start":17,"end":24,"tag":"safety"},{"start":28,"end":32,"tag":"HPV"},{"start":33,"end":42,"tag":"vaccines"},{"start":97,"end":113,"tag":"medicinessafety"}],"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.4248,"type":"Person","normalized_text":"EMA"}]},"id":"662321977173147649","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-05T17:33:59.000Z","conversation_id":"662321977173147649","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":6,"quote_count":0},"lang":"en","text":"EMA confirms the #safety of #HPV #vaccines in relation to CRPS and POTS: https://t.co/NosrnVNzN0 #medicinessafety","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/UL0HgOGtpj","expanded_url":"http://bit.ly/1FWu5Zt","display_url":"bit.ly/1FWu5Zt"}],"hashtags":[{"start":115,"end":127,"tag":"recruitment"}],"mentions":{},"annotations":[{"start":58,"end":88,"probability":0.7408,"type":"Organization","normalized_text":"Veterinary Medicines Department"}]},"id":"661857805465337856","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-04T10:49:32.000Z","conversation_id":"661857805465337856","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to apply for our vacancy for a Head of our Veterinary Medicines Department: https://t.co/UL0HgOGtpj #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":80,"end":103,"url":"https://t.co/4x63JNQm1S","expanded_url":"http://bit.ly/1Q3PT8R","display_url":"bit.ly/1Q3PT8R"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":27,"end":38,"tag":"veterinary"}],"mentions":{},"annotations":{}},"id":"661582824542232580","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-11-03T16:36:51.000Z","conversation_id":"661582824542232580","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #agenda of this week's #veterinary medicines committee (CVMP) is available: https://t.co/4x63JNQm1S","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/VL7JNIOFhh","expanded_url":"http://bit.ly/1GBiC29","display_url":"bit.ly/1GBiC29"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":63,"end":81,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"660131865936986112","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-30T16:31:16.000Z","conversation_id":"660131865936986112","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the #minutes from the September meeting of our #pharmacovigilance committee (PRAC): https://t.co/VL7JNIOFhh","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/24e13dN6av","expanded_url":"http://bit.ly/1cw2ZdQ","display_url":"bit.ly/1cw2ZdQ"}],"hashtags":[{"start":45,"end":55,"tag":"guideline"},{"start":101,"end":111,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"660035107894378498","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-30T10:06:47.000Z","conversation_id":"660035107894378498","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Deadline approaching to comment on our draft #guideline on clinical development of fixed combination #medicines: https://t.co/24e13dN6av","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/1iIOswTVgZ","expanded_url":"http://bit.ly/1MkmKQ2","display_url":"bit.ly/1MkmKQ2"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":53,"end":63,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"659707022590484480","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-29T12:23:05.000Z","conversation_id":"659707022590484480","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #minutes from the September meeting of our human #medicines committee (CHMP) are now available: https://t.co/1iIOswTVgZ","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/yNca5Hyqbo","expanded_url":"http://bit.ly/1KCoH9l","display_url":"bit.ly/1KCoH9l"}],"hashtags":[{"start":27,"end":33,"tag":"PhEur"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"id":"659343254681473024","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-28T12:17:36.000Z","conversation_id":"659343254681473024","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: 8th Edition #PhEur – Looking for advice on the different subscriptions &amp; versions available:  https://t.co/yNca5Hyqbo","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"659339203780747264"}]},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/JA9BB3JTzv","expanded_url":"http://bit.ly/1GvgXuV","display_url":"bit.ly/1GvgXuV"}],"hashtags":[{"start":96,"end":106,"tag":"guideline"}],"mentions":[{"start":0,"end":6,"username":"kgapo","id":"187453356"}],"annotations":{}},"id":"659336046757486592","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-28T11:48:58.000Z","conversation_id":"659313161275908096","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"@kgapo We are broadcasting our two-day workshop on product lifecycle management and the ICH Q12 #guideline: https://t.co/JA9BB3JTzv","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"659313161275908096"}],"in_reply_to_user_id":"187453356"},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":136,"url":"https://t.co/tEZmNGzmsk","expanded_url":"http://bit.ly/1PpVIw2","display_url":"bit.ly/1PpVIw2"}],"hashtags":[{"start":90,"end":100,"tag":"guideline"}],"mentions":{},"annotations":{}},"id":"659333905154220032","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-28T11:40:27.000Z","conversation_id":"659333905154220032","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Follow the live broadcast of our workshop on product lifecycle management and the ICH Q12 #guideline, 28-29 Oct: https://t.co/tEZmNGzmsk","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":83,"end":98,"tag":"drugregulation"},{"start":99,"end":115,"tag":"drugdevelopment"}],"mentions":[{"start":3,"end":12,"username":"ICH_news","id":"305434870"}],"annotations":{}},"id":"659037172956274690","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-27T16:01:21.000Z","conversation_id":"659037172956274690","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ICH_news: Reforms to ICH build on 25 years success in harmonising guidelines - #drugregulation #drugdevelopment of medicines https://t.…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"659035437646921728"}]},{"source":"TweetDeck","entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/aqBzTdcNwX","expanded_url":"http://bit.ly/1WfNv2Z","display_url":"bit.ly/1WfNv2Z"}],"hashtags":[{"start":92,"end":107,"tag":"EudraVigilance"}],"mentions":{},"annotations":{}},"id":"659034622597181440","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-27T15:51:12.000Z","conversation_id":"659034622597181440","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"We have published a change management plan to help stakeholders prepare for improvements to #EudraVigilance: https://t.co/aqBzTdcNwX","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/JA9BB3JTzv","expanded_url":"http://bit.ly/1GvgXuV","display_url":"bit.ly/1GvgXuV"}],"hashtags":[{"start":69,"end":79,"tag":"guideline"}],"mentions":{},"annotations":{}},"id":"659013790487461889","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-27T14:28:26.000Z","conversation_id":"659013790487461889","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"How to improve product lifecycle management: EMA workshop on ICH Q12 #guideline to be broadcast live on 28-29 Oct: https://t.co/JA9BB3JTzv","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/DzskvdXDAR","expanded_url":"http://bit.ly/1XvDuM4","display_url":"bit.ly/1XvDuM4"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":30,"tag":"herbal"},{"start":45,"end":57,"tag":"Pelargonium"},{"start":77,"end":89,"tag":"Pelargonium"}],"mentions":{},"annotations":[{"start":100,"end":103,"probability":0.5543,"type":"Person","normalized_text":"Curt"}]},"id":"658938176623525888","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-27T09:27:58.000Z","conversation_id":"658938176623525888","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#Consultation on draft #herbal monograph for #Pelargonium sidoides DC and/or #Pelargonium reniforme Curt.: https://t.co/DzskvdXDAR","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/6Os1gCfCqs","expanded_url":"http://europa.eu/!MV96JY","display_url":"europa.eu/!MV96JY"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":72,"end":82,"username":"EU_Health","id":"606325697"},{"start":92,"end":101,"username":"ICH_news","id":"305434870"}],"annotations":{}},"id":"658688611601268736","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-26T16:56:17.000Z","conversation_id":"658688611601268736","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Harmonizing technical requirements 4 medicinal products: @EU_Health welcomes @ICH_news reforms https://t.co/6Os1gCfCqs #medi…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"658671143856001024"}]},{"source":"TweetDeck","entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/eeeAbvPEXu","expanded_url":"http://bit.ly/1H4dHkT","display_url":"bit.ly/1H4dHkT"}],"hashtags":[{"start":62,"end":77,"tag":"drugregulation"},{"start":78,"end":94,"tag":"drugdevelopment"}],"mentions":[{"start":3,"end":12,"username":"ICH_news","id":"305434870"}],"annotations":{}},"id":"658623041321246721","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-26T12:35:44.000Z","conversation_id":"658623041321246721","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @ICH_news: ICH reforms, now better equipped to face global #drugregulation #drugdevelopment challenges https://t.co/eeeAbvPEXu https://t…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"658593504600444928"}]},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/s5cZnUa8Sf","expanded_url":"http://bit.ly/1WdwK38","display_url":"bit.ly/1WdwK38"}],"hashtags":[{"start":20,"end":26,"tag":"PRIME"},{"start":74,"end":84,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"658606664141176832","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-26T11:30:39.000Z","conversation_id":"658606664141176832","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Comments invited on #PRIME new scheme to optimise development of priority #medicines and facilitate patients' access:https://t.co/s5cZnUa8Sf","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/pB6Z7JEFal","expanded_url":"http://crs.edqm.eu/","display_url":"crs.edqm.eu"}],"hashtags":[{"start":37,"end":56,"tag":"referencestandards"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"id":"657557845517430784","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-23T14:03:01.000Z","conversation_id":"657557845517430784","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: Did you know that our #referencestandards Database is updated daily? https://t.co/pB6Z7JEFal","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"657542203884072960"}]},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/jeFNbLK6XN","expanded_url":"http://bit.ly/1PKXRm8","display_url":"bit.ly/1PKXRm8","status":403,"unwound_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/10/news_detail_002421.jsp&mid=WC0b01ac058004d5c1"}],"hashtags":[{"start":32,"end":41,"tag":"medicine"},{"start":76,"end":85,"tag":"melanoma"}],"mentions":{},"annotations":{}},"id":"657515885104648192","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-23T11:16:17.000Z","conversation_id":"657515885104648192","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"First-in-class advanced therapy #medicine recommended for approval to treat #melanoma: https://t.co/jeFNbLK6XN","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":56,"end":79,"url":"https://t.co/2WfrXQZhpP","expanded_url":"http://bit.ly/1jYe3Ec","display_url":"bit.ly/1jYe3Ec"},{"start":91,"end":114,"url":"https://t.co/KveKtZOZGo","expanded_url":"https://twitter.com/EMA_News/status/657515217107202048/photo/1","display_url":"pic.twitter.com/KveKtZOZGo"}],"hashtags":[{"start":80,"end":90,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"657515217107202048","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-23T11:13:38.000Z","conversation_id":"657515217107202048","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Check out the highlights of our CHMP meeting this week: https://t.co/2WfrXQZhpP #medicines https://t.co/KveKtZOZGo","attachments":{"media_keys":["3_657514889057951744"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/yfz7o9Bcdl","expanded_url":"http://ow.ly/THReC","display_url":"ow.ly/THReC"}],"hashtags":[{"start":72,"end":79,"tag":"TATFAR"},{"start":80,"end":84,"tag":"AMR"},{"start":85,"end":93,"tag":"1health"},{"start":94,"end":106,"tag":"antibiotics"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"id":"657118151092621312","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-22T08:55:50.000Z","conversation_id":"657118151092621312","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: International taskforce battles antimicrobial resistance #TATFAR #AMR #1health #antibiotics https://t.co/yfz7o9Bcdl https://…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"657112831138074624"}]},{"source":"TweetDeck","entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/PXIKAnRU3w","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"hashtags":{},"mentions":[{"start":0,"end":10,"username":"ex_journo","id":"3298501179"}],"annotations":{}},"id":"657109000895512577","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-22T08:19:28.000Z","conversation_id":"654310882080653313","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@ex_journo Please send us your questions so that we can respond in full: https://t.co/PXIKAnRU3w","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"657039456151732225"}],"in_reply_to_user_id":"3298501179"},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":110,"url":"https://t.co/q2I9euSbfv","expanded_url":"http://bit.ly/1hQg9Vq","display_url":"bit.ly/1hQg9Vq"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":36,"end":47,"tag":"paediatric"}],"mentions":{},"annotations":{}},"id":"656488063258877953","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-20T15:12:05.000Z","conversation_id":"656488063258877953","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #minutes of our #paediatric committee (PDCO) meeting in September: https://t.co/q2I9euSbfv","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/l6060qLjFW","expanded_url":"http://bit.ly/1W0wrs9","display_url":"bit.ly/1W0wrs9"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"}],"mentions":{},"annotations":{}},"id":"656086159433469952","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-19T12:35:04.000Z","conversation_id":"656086159433469952","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week's CHMP meeting:\nhttp://t.co/l6060qLjFW","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/w7Sdqhg9Ew","expanded_url":"http://bit.ly/1NfNbJO","display_url":"bit.ly/1NfNbJO"}],"hashtags":[{"start":119,"end":134,"tag":"cardiovascular"}],"mentions":{},"annotations":{}},"id":"654983042080067584","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-16T11:31:40.000Z","conversation_id":"654983042080067584","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"lang":"en","text":"Sign up for our workshop on PK/PD measurements in the clinical use of anticoagulants on 23 Nov: http://t.co/w7Sdqhg9Ew #cardiovascular","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/a5qA2clv7D","expanded_url":"http://bit.ly/1PwJamM","display_url":"bit.ly/1PwJamM"}],"hashtags":[{"start":0,"end":13,"tag":"consultation"},{"start":35,"end":45,"tag":"guideline"}],"mentions":{},"annotations":{}},"id":"654965247200075777","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-16T10:20:58.000Z","conversation_id":"654965247200075777","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#consultation opens on revision of #guideline on the assessment of clinical safety and efficacy of herbal medicines: http://t.co/a5qA2clv7D","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/zW42ZozGPd","expanded_url":"http://bit.ly/1QwCenT","display_url":"bit.ly/1QwCenT"},{"start":115,"end":137,"url":"http://t.co/zBdExfe59x","expanded_url":"https://twitter.com/EMA_News/status/654691354891542528/photo/1","display_url":"pic.twitter.com/zBdExfe59x"}],"hashtags":[{"start":37,"end":43,"tag":"ESVAC"},{"start":61,"end":72,"tag":"veterinary"},{"start":73,"end":85,"tag":"antibiotics"},{"start":110,"end":114,"tag":"AMR"}],"mentions":{},"annotations":{}},"id":"654691354891542528","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-15T16:12:37.000Z","conversation_id":"654691354891542528","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Interactive tool for tailored use of #ESVAC data on sales of #veterinary #antibiotics: http://t.co/zW42ZozGPd #AMR http://t.co/zBdExfe59x","attachments":{"media_keys":["3_654691261845147650"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/tIwmN32bHH","expanded_url":"http://bit.ly/1VU9o2a","display_url":"bit.ly/1VU9o2a"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"654670598128332802","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-15T14:50:08.000Z","conversation_id":"654670598128332802","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Check out the 16 positive opinions for orphan designations from this month's orphan medicines committee meeting: http://t.co/tIwmN32bHH","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/zW42ZoRidN","expanded_url":"http://bit.ly/1QwCenT","display_url":"bit.ly/1QwCenT"},{"start":108,"end":130,"url":"http://t.co/WZUQil2R6A","expanded_url":"https://twitter.com/EMA_News/status/654645263773106176/photo/1","display_url":"pic.twitter.com/WZUQil2R6A"}],"hashtags":[{"start":4,"end":10,"tag":"ESVAC"},{"start":30,"end":41,"tag":"veterinary"},{"start":42,"end":54,"tag":"antibiotics"},{"start":103,"end":107,"tag":"AMR"}],"mentions":{},"annotations":[{"start":58,"end":63,"probability":0.9936,"type":"Place","normalized_text":"Europe"}]},"id":"654645263773106176","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-15T13:09:28.000Z","conversation_id":"654645263773106176","public_metrics":{"retweet_count":26,"reply_count":0,"like_count":8,"quote_count":0},"lang":"en","text":"New #ESVAC report on sales of #veterinary #antibiotics in Europe now published: http://t.co/zW42ZoRidN #AMR http://t.co/WZUQil2R6A","attachments":{"media_keys":["3_654644218498035717"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/PXIKAnRU3w","expanded_url":"http://bit.ly/176ZhkW","display_url":"bit.ly/176ZhkW"}],"hashtags":{},"mentions":[{"start":0,"end":10,"username":"ex_journo","id":"3298501179"}],"annotations":{}},"id":"654592593356038144","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-15T09:40:10.000Z","conversation_id":"654310882080653313","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@ex_journo Please send us your questions for a complete response: http://t.co/PXIKAnRU3w","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"654380027031781376"}],"in_reply_to_user_id":"3298501179"},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":10,"username":"ex_journo","id":"3298501179"}],"annotations":{}},"id":"654327165559959552","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-14T16:05:27.000Z","conversation_id":"654310882080653313","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"lang":"en","text":"@ex_journo We will provide information in our assessment report once the procedure is concluded","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"654310882080653313"}],"in_reply_to_user_id":"3298501179"},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/jkSAoJZPpU","expanded_url":"http://bit.ly/1jyhrFJ","display_url":"bit.ly/1jyhrFJ"}],"hashtags":{},"mentions":[{"start":0,"end":8,"username":"lilylai","id":"19620821"}],"annotations":{}},"id":"654324178384986112","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-14T15:53:35.000Z","conversation_id":"654297574292254720","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"@lilylai We are encouraging all interested parties to contribute. More information on our website: http://t.co/jkSAoJZPpU","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"654297574292254720"}],"in_reply_to_user_id":"19620821"},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/uHzw6UCoHI","expanded_url":"http://bit.ly/1NcM0Lp","display_url":"bit.ly/1NcM0Lp"}],"hashtags":[{"start":96,"end":106,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"654314193949167617","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-14T15:13:55.000Z","conversation_id":"654314193949167617","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"Check out our monthly statistics on the evaluation of marketing authorisation applications for  #medicines: http://t.co/uHzw6UCoHI","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/fwmTJdH8La","expanded_url":"http://bit.ly/1K8vrvf","display_url":"bit.ly/1K8vrvf"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":36,"end":47,"tag":"veterinary"},{"start":48,"end":58,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"654271674221752321","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-14T12:24:57.000Z","conversation_id":"654271674221752321","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #minutes of our #veterinary #medicines committee (CVMP) meeting in September: http://t.co/fwmTJdH8La","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/c3GJveryrD","expanded_url":"http://bit.ly/1LkabVe","display_url":"bit.ly/1LkabVe"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":23,"end":30,"tag":"herbal"},{"start":45,"end":57,"tag":"Helichrysum"}],"mentions":{},"annotations":{}},"id":"654250549823569921","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-14T11:01:01.000Z","conversation_id":"654250549823569921","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation on draft #herbal monograph for #Helichrysum arenarium (Sandy everlasting): http://t.co/c3GJveryrD","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/jkSAoJZPpU","expanded_url":"http://bit.ly/1jyhrFJ","display_url":"bit.ly/1jyhrFJ"}],"hashtags":[{"start":67,"end":74,"tag":"herbal"}],"mentions":{},"annotations":{}},"id":"654228470277521409","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-14T09:33:16.000Z","conversation_id":"654228470277521409","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've launched a call for scientific data to support the review of #herbal monographs: http://t.co/jkSAoJZPpU","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/KXAGis0y8X","expanded_url":"http://bit.ly/1LLxUmQ","display_url":"bit.ly/1LLxUmQ"}],"hashtags":[{"start":38,"end":56,"tag":"Pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"653952796694310912","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-13T15:17:51.000Z","conversation_id":"653952796694310912","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Check out our quarterly update on our #Pharmacovigilance Programme: http://t.co/KXAGis0y8X","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/3h4a10Fdz2","expanded_url":"http://bit.ly/1ju7lFJ","display_url":"bit.ly/1ju7lFJ"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.9894,"type":"Person","normalized_text":"Guido Rasi"},{"start":60,"end":78,"probability":0.6826,"type":"Organization","normalized_text":"European Parliament"},{"start":82,"end":95,"probability":0.4651,"type":"Organization","normalized_text":"ENVI Committee"}]},"id":"653837312888057856","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-13T07:38:57.000Z","conversation_id":"653837312888057856","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Guido Rasi, EMA nominated Executive Director, speaks now at European Parliament’s ENVI Committee. Listen here:  http://t.co/3h4a10Fdz2","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/WAaKeYNJ4X","expanded_url":"http://bit.ly/1hA6XEv","display_url":"bit.ly/1hA6XEv"}],"hashtags":[{"start":42,"end":62,"tag":"medicinedevelopment"}],"mentions":{},"annotations":{}},"id":"653581171922702336","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-12T14:41:08.000Z","conversation_id":"653581171922702336","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"How to extrapolate efficacy and safety in #medicinedevelopment? Workshop 17-18 May, registration opens 10 December: http://t.co/WAaKeYNJ4X","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/6SoN5n0Tme","expanded_url":"http://bit.ly/1Mn1sl0","display_url":"bit.ly/1Mn1sl0"}],"hashtags":[{"start":80,"end":98,"tag":"patientregistries"}],"mentions":{},"annotations":{}},"id":"653550552656314369","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-12T12:39:28.000Z","conversation_id":"653550552656314369","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":8,"quote_count":0},"lang":"en","text":"Collecting high-quality information on medicines in clinical use, initiative on #patientregistries launched: http://t.co/6SoN5n0Tme","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/iBwYbxm4T4","expanded_url":"http://bit.ly/1R2nGwe","display_url":"bit.ly/1R2nGwe"}],"hashtags":[{"start":44,"end":55,"tag":"veterinary"}],"mentions":{},"annotations":{}},"id":"652499079008780289","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-09T15:01:17.000Z","conversation_id":"652499079008780289","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published highlights from this week's #veterinary committee (CVMP) meeting: http://t.co/iBwYbxm4T4","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/bRXIrwHOXO","expanded_url":"http://bit.ly/1PkICjT","display_url":"bit.ly/1PkICjT"}],"hashtags":[{"start":19,"end":37,"tag":"Pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"652443076166856704","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-09T11:18:45.000Z","conversation_id":"652443076166856704","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Find out about our #Pharmacovigilance Risk Assessment Committee's (PRAC) ongoing safety reviews: http://t.co/bRXIrwHOXO","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/e0qKI9daIc","expanded_url":"http://bit.ly/1KRtjPm","display_url":"bit.ly/1KRtjPm"}],"hashtags":[{"start":123,"end":135,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"652409998857891840","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-09T09:07:19.000Z","conversation_id":"652409998857891840","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to apply for a job as Toxicology and Environmental Risk Assessment (ERA) Specialist: \nhttp://t.co/e0qKI9daIc #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/k6mTGFRLb8","expanded_url":"http://Bit.ly/1F2hynb","display_url":"Bit.ly/1F2hynb"}],"hashtags":[{"start":115,"end":127,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"652409283330580480","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-09T09:04:28.000Z","conversation_id":"652409283330580480","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"One week to go to apply for a job as Risk Management Officer in Human Medicines Evaluation: http://t.co/k6mTGFRLb8 #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/lW8KqIv7bu","expanded_url":"http://bit.ly/1bvqBPe","display_url":"bit.ly/1bvqBPe"}],"hashtags":[{"start":39,"end":49,"tag":"guideline"},{"start":112,"end":125,"tag":"consultation"}],"mentions":{},"annotations":{}},"id":"652407639041777664","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-09T08:57:56.000Z","conversation_id":"652407639041777664","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to comment on our draft #guideline on the chemistry of active substances: http://t.co/lW8KqIv7bu #consultation","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":119,"end":141,"url":"http://t.co/uTKDvLLLPx","expanded_url":"http://bit.ly/1L1FrKK","display_url":"bit.ly/1L1FrKK"}],"hashtags":[{"start":13,"end":21,"tag":"Innovax"}],"mentions":{},"annotations":[{"start":99,"end":103,"probability":0.7666,"type":"Person","normalized_text":"Marek"}]},"id":"652133161426554881","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-08T14:47:16.000Z","conversation_id":"652133161426554881","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"EPAR out for #Innovax-ILT a veterinary vaccine for chickens against infectious laryngotracheitis &amp; Marek’s disease:http://t.co/uTKDvLLLPx","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/w915Ztsimu","expanded_url":"http://bit.ly/1FZs1zU","display_url":"bit.ly/1FZs1zU"}],"hashtags":[{"start":47,"end":54,"tag":"agenda"},{"start":120,"end":139,"tag":"medicinesshortages"}],"mentions":{},"annotations":{}},"id":"652128712545181696","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-08T14:29:35.000Z","conversation_id":"652128712545181696","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":3,"quote_count":1},"lang":"en","text":"How to proactively prevent medicine shortages? #agenda for tomorrow’s stakeholder meeting is out:http://t.co/w915Ztsimu #medicinesshortages","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/l3p7fGCC4U","expanded_url":"http://bit.ly/1VEUOeO","display_url":"bit.ly/1VEUOeO"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":58,"end":69,"tag":"paediatric"}],"mentions":{},"annotations":{}},"id":"651783888914771968","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-07T15:39:23.000Z","conversation_id":"651783888914771968","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week's meeting of our #paediatric committee (PDCO):\nhttp://t.co/l3p7fGCC4U","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/zeThhIfPoa","expanded_url":"http://bit.ly/1RtP33c","display_url":"bit.ly/1RtP33c"}],"hashtags":[{"start":28,"end":38,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"651782072038727680","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-07T15:32:10.000Z","conversation_id":"651782072038727680","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Check out our update on new #medicines for human use under EMA evaluation: http://t.co/zeThhIfPoa","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/QgkwGu6E3b","expanded_url":"http://bit.ly/1OkBGSZ","display_url":"bit.ly/1OkBGSZ"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":109,"end":113,"tag":"ICH"}],"mentions":{},"annotations":{}},"id":"651691952962990080","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-07T09:34:04.000Z","conversation_id":"651691952962990080","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"#Consultation on Common technical document for the registration of pharmaceuticals for human use – Efficacy, #ICH: http://t.co/QgkwGu6E3b","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/nLXad9A2SO","expanded_url":"http://bit.ly/1VElFrr","display_url":"bit.ly/1VElFrr"},{"start":114,"end":136,"url":"http://t.co/qUATw59i2l","expanded_url":"https://twitter.com/EMA_News/status/651682748298563584/photo/1","display_url":"pic.twitter.com/qUATw59i2l"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":12,"probability":0.9962,"type":"Person","normalized_text":"Bruno Sepodes"},{"start":18,"end":30,"probability":0.9948,"type":"Person","normalized_text":"Lesley Greene"}]},"id":"651682748298563584","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-07T08:57:29.000Z","conversation_id":"651682748298563584","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"Bruno Sepodes and Lesley Greene re-elected to chair our orphan medicines committee (COMP): http://t.co/nLXad9A2SO http://t.co/qUATw59i2l","attachments":{"media_keys":["3_651682167576207360"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/UL0HgOY4NT","expanded_url":"http://bit.ly/1FWu5Zt","display_url":"bit.ly/1FWu5Zt"}],"hashtags":[{"start":113,"end":125,"tag":"recruitment"}],"mentions":{},"annotations":[{"start":31,"end":61,"probability":0.744,"type":"Organization","normalized_text":"Veterinary Medicines Department"}]},"id":"651680289790521344","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-07T08:47:43.000Z","conversation_id":"651680289790521344","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"We're recruiting a Head of our Veterinary Medicines Department, deadline to apply 18 Nov: http://t.co/UL0HgOY4NT #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/udPKcRoOFm","expanded_url":"http://bit.ly/1Lfrw0z","display_url":"bit.ly/1Lfrw0z"}],"hashtags":[{"start":42,"end":50,"tag":"Intuniv"},{"start":52,"end":63,"tag":"guanfacine"},{"start":68,"end":77,"tag":"medicine"},{"start":82,"end":87,"tag":"ADHD"}],"mentions":{},"annotations":{}},"id":"651420582903476224","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-06T15:35:44.000Z","conversation_id":"651420582903476224","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":5,"quote_count":1},"lang":"en","text":"We've published the assessment report for #Intuniv (#guanfacine), a #medicine for #ADHD: http://t.co/udPKcRoOFm","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"Twitter Web Client","entities":{"urls":{},"hashtags":[{"start":50,"end":54,"tag":"CHM"},{"start":79,"end":87,"tag":"Nursing"},{"start":88,"end":106,"tag":"GeriatricMedicine"},{"start":107,"end":120,"tag":"Toxicologist"}],"mentions":[{"start":3,"end":18,"username":"appointmentsDH","id":"2967800469"}],"annotations":{}},"id":"651419106554609665","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-06T15:29:52.000Z","conversation_id":"651419106554609665","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @appointmentsDH: Commission on Human Medicines #CHM seeking 3 commissioners #Nursing #GeriatricMedicine #Toxicologist Closes 20 Oct http…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"649581962504613888"}]},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/xGe6ACY6KJ","expanded_url":"http://bit.ly/1LeMEUC","display_url":"bit.ly/1LeMEUC"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":44,"end":59,"tag":"bioequivalence"},{"start":66,"end":75,"tag":"guidance"}],"mentions":{},"annotations":{}},"id":"651375437730455552","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-06T12:36:20.000Z","conversation_id":"651375437730455552","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation open on five product-specific #bioequivalence draft #guidance, comments invited until 1 Jan 2016: http://t.co/xGe6ACY6KJ","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/6bxqcoWqnT","expanded_url":"http://bit.ly/1QW72OO","display_url":"bit.ly/1QW72OO"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":58,"end":69,"tag":"veterinary"},{"start":70,"end":80,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"651345821175291904","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-06T10:38:39.000Z","conversation_id":"651345821175291904","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week's meeting of our #veterinary #medicines committee (CVMP): http://t.co/6bxqcoWqnT","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/bEVhpBoBiY","expanded_url":"http://bit.ly/1jaLoMm","display_url":"bit.ly/1jaLoMm"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"651344234507862017","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-06T10:32:21.000Z","conversation_id":"651344234507862017","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Find out about the main highlights from last week's Management Board meeting: http://t.co/bEVhpBoBiY","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/mKhFKF2ZJG","expanded_url":"http://bit.ly/1IbZh16","display_url":"bit.ly/1IbZh16"}],"hashtags":[{"start":119,"end":131,"tag":"recruitment"},{"start":132,"end":139,"tag":"ITjobs"}],"mentions":{},"annotations":{}},"id":"651320491790200832","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-06T08:58:00.000Z","conversation_id":"651320491790200832","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Deadline extended to 3 Nov to apply for a job as  Enterprise Architect, Information Technology  http://t.co/mKhFKF2ZJG #recruitment #ITjobs","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/uGjr8L9Fqo","expanded_url":"http://bit.ly/1Pw9TNR","display_url":"bit.ly/1Pw9TNR"}],"hashtags":[{"start":117,"end":129,"tag":"recruitment"},{"start":130,"end":137,"tag":"ITjobs"}],"mentions":{},"annotations":{}},"id":"651319968538198016","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-06T08:55:56.000Z","conversation_id":"651319968538198016","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Apply until 3 Nov for a job as Extract, Transform and Load Developer, Information Technology: http://t.co/uGjr8L9Fqo #recruitment #ITjobs","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/9k9wqY6CHk","expanded_url":"http://bit.ly/1JwAPNi","display_url":"bit.ly/1JwAPNi"}],"hashtags":[{"start":111,"end":123,"tag":"recruitment"},{"start":124,"end":131,"tag":"ITjobs"}],"mentions":{},"annotations":{}},"id":"651318712369303552","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-06T08:50:56.000Z","conversation_id":"651318712369303552","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Deadline extended to 3 Nov to apply for a job as Data Architect, Information Technology http://t.co/9k9wqY6CHk #recruitment #ITjobs","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/mbhYYjqbWK","expanded_url":"http://bit.ly/1Rr1jkX","display_url":"bit.ly/1Rr1jkX"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"651080977972920321","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-05T17:06:16.000Z","conversation_id":"651080977972920321","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Get prepared for downtime of EMA IT systems between 30 October and 3 November: http://t.co/mbhYYjqbWK","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/NymEW9Odb9","expanded_url":"http://bit.ly/1QUxska","display_url":"bit.ly/1QUxska"}],"hashtags":[{"start":41,"end":59,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"651080138667356160","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-05T17:02:56.000Z","conversation_id":"651080138667356160","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The agenda of this week’s meeting of our #pharmacovigilance committee (PRAC) is now available: http://t.co/NymEW9Odb9","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":67,"end":89,"url":"http://t.co/GPw8l1bJA5","expanded_url":"http://bit.ly/1JOjue8","display_url":"bit.ly/1JOjue8"}],"hashtags":[{"start":31,"end":42,"tag":"NobelPrize"},{"start":56,"end":65,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"650994786275618816","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-05T11:23:46.000Z","conversation_id":"650994786275618816","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":10,"quote_count":0},"lang":"en","text":"Congratulations to this year's #NobelPrize laureates in #medicine: http://t.co/GPw8l1bJA5","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/fZpP6wBRnt","expanded_url":"http://bit.ly/1Rku4zF","display_url":"bit.ly/1Rku4zF"}],"hashtags":[{"start":28,"end":39,"tag":"sufentanil"},{"start":44,"end":51,"tag":"hybrid"},{"start":52,"end":61,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"649980687349600257","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-02T16:14:06.000Z","conversation_id":"649980687349600257","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"EPAR published for Zalviso (#sufentanil), a #hybrid #medicine to treat pain occurring in adults after an operation: http://t.co/fZpP6wBRnt","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/IQ7SUfeTiQ","expanded_url":"http://bit.ly/1iRkZSZ","display_url":"bit.ly/1iRkZSZ"}],"hashtags":[{"start":42,"end":53,"tag":"Pemetrexed"},{"start":63,"end":71,"tag":"generic"},{"start":72,"end":81,"tag":"medicine"}],"mentions":{},"annotations":[{"start":54,"end":58,"probability":0.522,"type":"Person","normalized_text":"Lilly"}]},"id":"649978957874495488","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-02T16:07:14.000Z","conversation_id":"649978957874495488","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Pemetrexed Lilly, a #generic #medicine for two types of lung cancer: http://t.co/IQ7SUfeTiQ","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/3AlTcI1JIR","expanded_url":"http://bit.ly/1VsKtb5","display_url":"bit.ly/1VsKtb5"}],"hashtags":[{"start":32,"end":43,"tag":"Pemetrexed"},{"start":54,"end":62,"tag":"generic"},{"start":63,"end":72,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"649978598804299776","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-02T16:05:48.000Z","conversation_id":"649978598804299776","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Assessment report published for #Pemetrexed Sandoz, a #generic #medicine for two types of lung cancer: http://t.co/3AlTcI1JIR","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/C8KAippKjy","expanded_url":"http://bit.ly/1GomoGe","display_url":"bit.ly/1GomoGe"}],"hashtags":[{"start":19,"end":27,"tag":"Fexeric"},{"start":31,"end":40,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"649974988024496128","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-02T15:51:27.000Z","conversation_id":"649974988024496128","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"EPAR published for #Fexeric, a #medicine to control hyperphosphataemia in adults with long-term kidney disease: http://t.co/C8KAippKjy","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/cNghrOZqdv","expanded_url":"http://bit.ly/1JJEP8x","display_url":"bit.ly/1JJEP8x"}],"hashtags":[{"start":20,"end":28,"tag":"minutes"}],"mentions":{},"annotations":{}},"id":"649950537186676736","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-02T14:14:18.000Z","conversation_id":"649950537186676736","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We’ve published the #minutes from the July meeting of our committee for advanced therapies (CAT): http://t.co/cNghrOZqdv","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/tD4zbQemCJ","expanded_url":"http://bit.ly/1MJQetD","display_url":"bit.ly/1MJQetD"}],"hashtags":[{"start":30,"end":48,"tag":"pharmacovigilance"},{"start":86,"end":94,"tag":"webradr"}],"mentions":[{"start":0,"end":7,"username":"imi_ju","id":"1473203261469790214"},{"start":8,"end":16,"username":"WEBRADR","id":"2797520425"}],"annotations":{}},"id":"649884361555357696","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-02T09:51:20.000Z","conversation_id":"649884361555357696","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"@IMI_JU @WEBRADR Improving EU #pharmacovigilance through new technologies. EMA-hosted #webradr workshop, report out: http://t.co/tD4zbQemCJ","attachments":{"media_keys":{}},"referenced_tweets":{},"in_reply_to_user_id":"153741027"},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/71nw8zy9ai","expanded_url":"http://bit.ly/1N7DQGS","display_url":"bit.ly/1N7DQGS"}],"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":48,"end":58,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"649876587547131905","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-02T09:20:27.000Z","conversation_id":"649876587547131905","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"The #minutes from the July meeting of our human #medicines committee (CHMP) are now available: http://t.co/71nw8zy9ai","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/e0qKI9daIc","expanded_url":"http://bit.ly/1KRtjPm","display_url":"bit.ly/1KRtjPm"}],"hashtags":[{"start":123,"end":135,"tag":"recruitment"}],"mentions":{},"annotations":[{"start":37,"end":80,"probability":0.3671,"type":"Other","normalized_text":"Toxicology and Environmental Risk Assessment"}]},"id":"649869113700040706","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-02T08:50:45.000Z","conversation_id":"649869113700040706","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two weeks left to apply for a job as Toxicology and Environmental Risk Assessment (ERA) Specialist:\nhttp://t.co/e0qKI9daIc #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/k6mTGFRLb8","expanded_url":"http://Bit.ly/1F2hynb","display_url":"Bit.ly/1F2hynb"}],"hashtags":[{"start":113,"end":125,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"649864184507797504","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-02T08:31:10.000Z","conversation_id":"649864184507797504","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to apply for a job as Risk Management Officer, Human Medicines Evaluation: http://t.co/k6mTGFRLb8 #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/Shrc9e03Er","expanded_url":"http://bit.ly/1KWjg5u","display_url":"bit.ly/1KWjg5u"}],"hashtags":[{"start":0,"end":5,"tag":"CHMP"},{"start":28,"end":36,"tag":"malaria"},{"start":45,"end":55,"tag":"Mosquirix"}],"mentions":{},"annotations":{}},"id":"649594328252305409","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-01T14:38:51.000Z","conversation_id":"649594328252305409","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"#CHMP assessment report for #malaria vaccine #Mosquirix is published\nhttp://t.co/Shrc9e03Er","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/Lu8hs9EjRa","expanded_url":"http://bit.ly/1N4yzQa","display_url":"bit.ly/1N4yzQa"}],"hashtags":[{"start":14,"end":19,"tag":"CHMP"},{"start":29,"end":41,"tag":"cholesterol"}],"mentions":{},"annotations":{}},"id":"649591986278793217","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-01T14:29:33.000Z","conversation_id":"649591986278793217","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Check out how #CHMP assessed #cholesterol treatment Repatha\nhttp://t.co/Lu8hs9EjRa","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/4uXUPFY6Hw","expanded_url":"http://bit.ly/1WA5Vbp","display_url":"bit.ly/1WA5Vbp"},{"start":92,"end":114,"url":"http://t.co/f9S7C1vxjy","expanded_url":"https://twitter.com/EMA_News/status/649572217857134592/photo/1","display_url":"pic.twitter.com/f9S7C1vxjy"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.9874,"type":"Person","normalized_text":"Guido Rasi"}]},"id":"649572217857134592","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-01T13:10:59.000Z","conversation_id":"649572217857134592","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"Guido Rasi nominated as Executive Director. These are the next steps http://t.co/4uXUPFY6Hw http://t.co/f9S7C1vxjy","attachments":{"media_keys":["3_649564406733500417"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/rQHtjOTvnn","expanded_url":"http://bit.ly/1GkfRMF","display_url":"bit.ly/1GkfRMF"},{"start":107,"end":129,"url":"http://t.co/0yfXzHGb4l","expanded_url":"https://twitter.com/EMA_News/status/649563152699510784/photo/1","display_url":"pic.twitter.com/0yfXzHGb4l"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.6404,"type":"Person","normalized_text":"Kent Woods"},{"start":53,"end":62,"probability":0.9943,"type":"Person","normalized_text":"Guido Rasi"}]},"id":"649563152699510784","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-01T12:34:58.000Z","conversation_id":"649563152699510784","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":5,"quote_count":0},"lang":"en","text":"Kent Woods, Chair of Management Board, congratulates Guido Rasi on nomination as ED http://t.co/rQHtjOTvnn http://t.co/0yfXzHGb4l","attachments":{"media_keys":["3_649563119275143168"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/rQHtjOTvnn","expanded_url":"http://bit.ly/1GkfRMF","display_url":"bit.ly/1GkfRMF"},{"start":99,"end":121,"url":"http://t.co/K42JlQZOGU","expanded_url":"https://twitter.com/EMA_News/status/649559522986590208/photo/1","display_url":"pic.twitter.com/K42JlQZOGU"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":9,"probability":0.9872,"type":"Person","normalized_text":"Guido Rasi"}]},"id":"649559522986590208","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-01T12:20:33.000Z","conversation_id":"649559522986590208","public_metrics":{"retweet_count":39,"reply_count":0,"like_count":11,"quote_count":0},"lang":"en","text":"Guido Rasi nominated as Executive Director of the European Medicines Agency http://t.co/rQHtjOTvnn http://t.co/K42JlQZOGU","attachments":{"media_keys":["3_649558726609911808"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/WAEzdXBkId","expanded_url":"http://bit.ly/1FK5Ptf","display_url":"bit.ly/1FK5Ptf"}],"hashtags":[{"start":66,"end":76,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"649521113354108932","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-01T09:47:55.000Z","conversation_id":"649521113354108932","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Detect, assess &amp; manage unwanted immune response with biotech #medicines; draft guideline open for comments\nhttp://t.co/WAEzdXBkId","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/KHG9QAZx9X","expanded_url":"http://bit.ly/1KUtrro","display_url":"bit.ly/1KUtrro"}],"hashtags":[{"start":34,"end":47,"tag":"civilsociety"}],"mentions":{},"annotations":{}},"id":"649517618957811713","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-10-01T09:34:02.000Z","conversation_id":"649517618957811713","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Interested to join PRAC or CAT as #civilsociety member? Apply by 18 October http://t.co/KHG9QAZx9X","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/G54z1kUN4F","expanded_url":"http://bit.ly/1P5rDBX","display_url":"bit.ly/1P5rDBX"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"}],"mentions":{},"annotations":{}},"id":"649214604179021824","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-30T13:29:58.000Z","conversation_id":"649214604179021824","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"The #agenda of next week's meeting of our committee for orphan medicines (COMP) is available: http://t.co/G54z1kUN4F","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/mKhFKF2ZJG","expanded_url":"http://bit.ly/1IbZh16","display_url":"bit.ly/1IbZh16"}],"hashtags":[{"start":108,"end":120,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"648862796923465728","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-29T14:12:00.000Z","conversation_id":"648862796923465728","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We're seeking an Enterprise Architect, Information Technology. Deadline in one week: http://t.co/mKhFKF2ZJG #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/uGjr8L9Fqo","expanded_url":"http://bit.ly/1Pw9TNR","display_url":"bit.ly/1Pw9TNR"}],"hashtags":[{"start":123,"end":135,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"648862214770806784","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-29T14:09:41.000Z","conversation_id":"648862214770806784","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to go to apply for a job as Extract, Transform and Load Developer, Information Technology: http://t.co/uGjr8L9Fqo #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/9k9wqY6CHk","expanded_url":"http://bit.ly/1JwAPNi","display_url":"bit.ly/1JwAPNi"}],"hashtags":[{"start":123,"end":135,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"648860401879384064","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-29T14:02:29.000Z","conversation_id":"648860401879384064","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to apply for a job as Data Architect, Information Technology. Details on our website: http://t.co/9k9wqY6CHk #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":36,"end":39,"tag":"EU"},{"start":108,"end":117,"tag":"medicine"},{"start":129,"end":140,"tag":"EUPharma50"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":26,"end":35,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":15,"end":24,"probability":0.9607,"type":"Person","normalized_text":"Guido Rasi"}]},"id":"648502989372702720","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-28T14:22:15.000Z","conversation_id":"648502989372702720","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Guido Rasi @EMA_News #EU network of regulatory agencies best placed to address challenges in #medicine regulation #EUPharma50","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"648502437465165824"}]},{"source":"TweetDeck","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/XjdyKhzxiF","expanded_url":"http://bit.ly/1GcfnZb","display_url":"bit.ly/1GcfnZb"}],"hashtags":[{"start":67,"end":79,"tag":"antibiotics"},{"start":104,"end":108,"tag":"AMR"}],"mentions":{},"annotations":{}},"id":"648502821202100224","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-28T14:21:35.000Z","conversation_id":"648502821202100224","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"We're inviting comments on new guidance to speed up development of #antibiotics  http://t.co/XjdyKhzxiF #AMR","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/nuh2s97GUu","expanded_url":"http://bit.ly/1LXjhqN","display_url":"bit.ly/1LXjhqN"}],"hashtags":[{"start":42,"end":51,"tag":"Strensiq"},{"start":69,"end":78,"tag":"medicine"},{"start":126,"end":139,"tag":"rarediseases"}],"mentions":{},"annotations":{}},"id":"648493970520186880","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-28T13:46:25.000Z","conversation_id":"648493970520186880","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We've published the assessment report for #Strensiq (asfotase alfa), #medicine for a rare bone disease http://t.co/nuh2s97GUu #rarediseases","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":115,"end":128,"tag":"transparency"},{"start":129,"end":140,"tag":"EUPharma50"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":30,"end":39,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":15,"end":28,"probability":0.9569,"type":"Person","normalized_text":"Stefano Marino"}]},"id":"648450642164482048","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-28T10:54:15.000Z","conversation_id":"648450642164482048","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Stefano Marino @EMA_News We welcome feedback from stakeholders &amp; we will do more in the area of #transparency #EUPharma50 #m…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"648450266841382912"}]},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/TrnnpIvpod","expanded_url":"http://bit.ly/1FCDVzx","display_url":"bit.ly/1FCDVzx"}],"hashtags":[{"start":38,"end":52,"tag":"certification"},{"start":118,"end":133,"tag":"chemicalpurity"},{"start":134,"end":138,"tag":"cep"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"annotations":{}},"id":"648432202804535297","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-28T09:40:59.000Z","conversation_id":"648432202804535297","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @edqm_news: The EDQM has revised a #certification guideline, applicable from September 2015 http://t.co/TrnnpIvpod #chemicalpurity #cep","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"648431625890603008"}]},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/5G836iSBre","expanded_url":"http://europa.eu/!nF67dj","display_url":"europa.eu/!nF67dj"}],"hashtags":[{"start":78,"end":89,"tag":"EUPharma50"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"id":"648421320095592448","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-28T08:57:44.000Z","conversation_id":"648421320095592448","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Risk regulation - what is the appropriate level? - 1st session #EUPharma50 conference. Live http://t.co/5G836iSBre #medicine…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"648420935922528256"}]},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/u4msmIdqL7","expanded_url":"http://bit.ly/1KF2vPl","display_url":"bit.ly/1KF2vPl"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":72,"end":79,"tag":"herbal"}],"mentions":{},"annotations":{}},"id":"648416930911682560","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-28T08:40:17.000Z","conversation_id":"648416930911682560","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week's meeting of our committee for #herbal medicines (HMPC): http://t.co/u4msmIdqL7","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/5G836iSBre","expanded_url":"http://europa.eu/!nF67dj","display_url":"europa.eu/!nF67dj"}],"hashtags":[{"start":61,"end":64,"tag":"EU"},{"start":65,"end":72,"tag":"pharma"},{"start":85,"end":96,"tag":"EUPharma50"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"id":"648411998372405248","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-28T08:20:41.000Z","conversation_id":"648411998372405248","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Live coverage tday 10:00 CET from 50 years of #EU #pharma legislation #EUPharma50 Webstreaming http://t.co/5G836iSBre http:/…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"648384362891845632"}]},{"source":"TweetDeck","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/mrtT5WeeXv","expanded_url":"https://twitter.com/EU_Health/status/648410080132657153/photo/1","display_url":"pic.twitter.com/mrtT5WeeXv"}],"hashtags":[{"start":28,"end":39,"tag":"EUPharma50"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":[{"start":54,"end":61,"probability":0.99,"type":"Place","normalized_text":"Brussels"}]},"id":"648411668465254400","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-28T08:19:23.000Z","conversation_id":"648411668465254400","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Full room at #EUPharma50 conference in Brussels, we are getting ready to start http://t.co/mrtT5WeeXv","attachments":{"media_keys":["3_648410070124904448"]},"referenced_tweets":[{"type":"retweeted","id":"648410080132657153"}]},{"source":"TweetDeck","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/buaqQu26BG","expanded_url":"http://bit.ly/1NYF9Ie","display_url":"bit.ly/1NYF9Ie"}],"hashtags":[{"start":63,"end":72,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"647447141934321664","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-25T16:26:42.000Z","conversation_id":"647447141934321664","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":4,"quote_count":0},"lang":"en","text":"Assessment report published for Aripiprazole Sandoz,\na generic #medicine for schizophrenia and bipolar 1 disorder: http://t.co/buaqQu26BG","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":72,"end":94,"url":"http://t.co/XQMu9cKxLM","expanded_url":"http://bit.ly/1JthKGY","display_url":"bit.ly/1JthKGY"}],"hashtags":[{"start":4,"end":13,"tag":"medicine"},{"start":62,"end":70,"tag":"myeloma"},{"start":95,"end":108,"tag":"rarediseases"}],"mentions":{},"annotations":{}},"id":"647371463775883264","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-25T11:25:59.000Z","conversation_id":"647371463775883264","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":2,"quote_count":0},"lang":"en","text":"New #medicine fast-tracked for approval for relapsed multiple #myeloma: http://t.co/XQMu9cKxLM #rarediseases","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/08bWKN954Z","expanded_url":"http://bit.ly/1YF5iPS","display_url":"bit.ly/1YF5iPS"}],"hashtags":[{"start":4,"end":13,"tag":"medicine"},{"start":48,"end":61,"tag":"heartfailure"}],"mentions":{},"annotations":{}},"id":"647370683199176704","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-25T11:22:53.000Z","conversation_id":"647370683199176704","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"New #medicine recommended for approval to treat #heartfailure: http://t.co/08bWKN954Z","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/etygBsaN77","expanded_url":"http://bit.ly/1Fl2VeH","display_url":"bit.ly/1Fl2VeH"}],"hashtags":[{"start":12,"end":26,"tag":"anticoagulant"},{"start":27,"end":35,"tag":"Pradaxa"}],"mentions":{},"annotations":{}},"id":"647369511927193600","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-25T11:18:13.000Z","conversation_id":"647369511927193600","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Antidote to #anticoagulant #Pradaxa fast-tracked for approval in emergency situations: http://t.co/etygBsaN77","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":72,"end":94,"url":"http://t.co/lnWP9tnw2x","expanded_url":"http://bit.ly/1Oy4Ejs","display_url":"bit.ly/1Oy4Ejs"},{"start":95,"end":117,"url":"http://t.co/Dn901P0ZqV","expanded_url":"https://twitter.com/EMA_News/status/647368290944319489/photo/1","display_url":"pic.twitter.com/Dn901P0ZqV"}],"hashtags":[{"start":16,"end":26,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"647368290944319489","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-25T11:13:22.000Z","conversation_id":"647368290944319489","public_metrics":{"retweet_count":18,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"A record 19 new #medicines recommended for approval this month by CHMP: http://t.co/lnWP9tnw2x http://t.co/Dn901P0ZqV","attachments":{"media_keys":["3_647363504664641536"]},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/e4pERNNJDK","expanded_url":"http://bit.ly/1O1ABzA","display_url":"bit.ly/1O1ABzA"}],"hashtags":[{"start":123,"end":135,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"647320246408355840","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-25T08:02:28.000Z","conversation_id":"647320246408355840","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to go to apply for a job as quality specialist in our human medicines evaluation division: http://t.co/e4pERNNJDK #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/TwO4smE5na","expanded_url":"http://bit.ly/1JDxFUn","display_url":"bit.ly/1JDxFUn"}],"hashtags":[{"start":119,"end":131,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"647319635474448384","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-25T08:00:02.000Z","conversation_id":"647319635474448384","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Deadline in 1 week to apply as Risk Management Specialist, Human Medicines Evaluation Division: http://t.co/TwO4smE5na #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/f3IW37EMi9","expanded_url":"http://bit.ly/1EF7IHE","display_url":"bit.ly/1EF7IHE"}],"hashtags":[{"start":107,"end":119,"tag":"recruitment"},{"start":120,"end":134,"tag":"ITspecialists"}],"mentions":{},"annotations":{}},"id":"647319074683375616","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-25T07:57:48.000Z","conversation_id":"647319074683375616","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to go to apply for a position as Business Analyst, Information Technology: http://t.co/f3IW37EMi9 #recruitment #ITspecialists","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/Kt7mqNPD6V","expanded_url":"http://bit.ly/1Ogbw1D","display_url":"bit.ly/1Ogbw1D"}],"hashtags":[{"start":101,"end":113,"tag":"recruitment"}],"mentions":{},"annotations":[{"start":36,"end":75,"probability":0.637,"type":"Organization","normalized_text":"EU Institutional Liaison Support Officer"}]},"id":"647318616623443968","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-25T07:55:59.000Z","conversation_id":"647318616623443968","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week left to apply for a job as EU Institutional Liaison Support Officer: http://t.co/Kt7mqNPD6V #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/dvKkQjJGoF","expanded_url":"https://youtu.be/tH179ToqeIU","display_url":"youtu.be/tH179ToqeIU"}],"hashtags":[{"start":97,"end":105,"tag":"EHR2015"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"annotations":[{"start":81,"end":95,"probability":0.5322,"type":"Place","normalized_text":"European Region"}]},"id":"647058862839885824","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-24T14:43:49.000Z","conversation_id":"647058862839885824","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @WHO_Europe: Video of key findings of health situation across 53 countries in European Region #EHR2015 https://t.co/dvKkQjJGoF","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"646956270457606144"}]},{"source":"TweetDeck","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/QJTu5d9MVP","expanded_url":"http://bit.ly/1LHABo3","display_url":"bit.ly/1LHABo3"}],"hashtags":[{"start":98,"end":109,"tag":"hepatitisE"}],"mentions":{},"annotations":{}},"id":"646626668363255808","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-23T10:06:26.000Z","conversation_id":"646626668363255808","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"7 days left to comment on draft paper on viral safety of plasma-derived medicines with respect to #hepatitisE virus: http://t.co/QJTu5d9MVP","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/ca65O9Czj5","expanded_url":"http://bit.ly/1Hbg1u7","display_url":"bit.ly/1Hbg1u7"}],"hashtags":[{"start":29,"end":39,"tag":"guideline"},{"start":73,"end":78,"tag":"tick"},{"start":85,"end":90,"tag":"flea"}],"mentions":{},"annotations":{}},"id":"646626356265095168","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-23T10:05:11.000Z","conversation_id":"646626356265095168","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"1 week to go to comment on a #guideline on treatment &amp; prevention of #tick &amp; #flea infestation in dogs and cats: http://t.co/ca65O9Czj5","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/sxlLjnIUgi","expanded_url":"http://bit.ly/1IMQl8r","display_url":"bit.ly/1IMQl8r"}],"hashtags":[{"start":47,"end":62,"tag":"cardiovascular"}],"mentions":{},"annotations":{}},"id":"646626120364912640","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-23T10:04:15.000Z","conversation_id":"646626120364912640","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"7 more days to comment on a paper on assessing #cardiovascular risk of cardiovascular &amp; metabolic disease medicines: http://t.co/sxlLjnIUgi","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/8VO5l7jQqQ","expanded_url":"http://bit.ly/1IyDS2K","display_url":"bit.ly/1IyDS2K"}],"hashtags":[{"start":55,"end":62,"tag":"sodium"}],"mentions":{},"annotations":{}},"id":"646625872594796544","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-23T10:03:16.000Z","conversation_id":"646625872594796544","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"1 more week to comment on our questions and answers on #sodium in product information for human medicines: http://t.co/8VO5l7jQqQ","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/GuSgIA8KbF","expanded_url":"http://bit.ly/1j98S4h","display_url":"bit.ly/1j98S4h"}],"hashtags":[{"start":0,"end":8,"tag":"Minutes"},{"start":81,"end":99,"tag":"Pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"646608780139077632","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-23T08:55:21.000Z","conversation_id":"646608780139077632","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Minutes of the July meeting of the PRAC just published  \nhttp://t.co/GuSgIA8KbF #Pharmacovigilance","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/OoMyoOLwXb","expanded_url":"http://bit.ly/1KuqBME","display_url":"bit.ly/1KuqBME"}],"hashtags":[{"start":12,"end":23,"tag":"paediatric"},{"start":50,"end":60,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"646607592756760576","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-23T08:50:38.000Z","conversation_id":"646607592756760576","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"PDCO agrees #paediatric investigation plans for 9 #medicines. Check the September monthly report http://t.co/OoMyoOLwXb","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/XE5luwMRTi","expanded_url":"http://bit.ly/1Ktg702","display_url":"bit.ly/1Ktg702"}],"hashtags":[{"start":79,"end":93,"tag":"consultations"}],"mentions":{},"annotations":{}},"id":"646369669633302528","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-22T17:05:12.000Z","conversation_id":"646369669633302528","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Publication of clinical data: Summaries and presentations from two stakeholder #consultations now available http://t.co/XE5luwMRTi","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/mKhFKELol6","expanded_url":"http://bit.ly/1IbZh16","display_url":"bit.ly/1IbZh16"}],"hashtags":[{"start":119,"end":131,"tag":"recruitment"}],"mentions":{},"annotations":[{"start":34,"end":77,"probability":0.3928,"type":"Organization","normalized_text":"Enterprise Architect, Information Technology"}]},"id":"646327423697465344","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-22T14:17:20.000Z","conversation_id":"646327423697465344","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Application deadline for a job as Enterprise Architect, Information Technology is in two weeks: http://t.co/mKhFKELol6 #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/uGjr8KS41O","expanded_url":"http://bit.ly/1Pw9TNR","display_url":"bit.ly/1Pw9TNR"}],"hashtags":[{"start":124,"end":136,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"646327017651068931","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-22T14:15:43.000Z","conversation_id":"646327017651068931","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks to go to apply for a job as Extract, Transform and Load Developer, Information Technology: http://t.co/uGjr8KS41O #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/9k9wqXP1iK","expanded_url":"http://bit.ly/1JwAPNi","display_url":"bit.ly/1JwAPNi"}],"hashtags":[{"start":109,"end":121,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"646326777451704320","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-22T14:14:46.000Z","conversation_id":"646326777451704320","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two more weeks to apply for our vacancy for a Data Architect, Information Technology: http://t.co/9k9wqXP1iK #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/Ec6XTKvdDN","expanded_url":"http://bit.ly/1KJZQoQ","display_url":"bit.ly/1KJZQoQ"}],"hashtags":[{"start":75,"end":82,"tag":"health"}],"mentions":[{"start":1,"end":15,"username":"EU_Commission","id":"157981564"},{"start":25,"end":29,"username":"WHO","id":"14499829"}],"annotations":{}},"id":"646271417621680128","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-22T10:34:47.000Z","conversation_id":"646271417621680128","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":".@EU_Commission, EMA and @WHO step up cooperation to better protect public #health: http://t.co/Ec6XTKvdDN","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/1zE5cwFb6v","expanded_url":"http://bit.ly/1Jl4JiK","display_url":"bit.ly/1Jl4JiK"}],"hashtags":[{"start":32,"end":43,"tag":"Ivabradine"}],"mentions":{},"annotations":{}},"id":"645996302908715009","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-21T16:21:35.000Z","conversation_id":"645996302908715009","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Assessment report published for #Ivabradine Anpharm, a medicine to treat the symptoms of long-term stable angina: http://t.co/1zE5cwFb6v","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":45,"end":67,"url":"http://t.co/vtwAJI95wt","expanded_url":"http://bit.ly/1LIa6u7","display_url":"bit.ly/1LIa6u7"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":14,"probability":0.9933,"type":"Person","normalized_text":"Tomas Salmonson"}]},"id":"645938699033817089","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-21T12:32:41.000Z","conversation_id":"645938699033817089","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Tomas Salmonson is re-elected as CHMP Chair: http://t.co/vtwAJI95wt","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/YIPTnm5vid","expanded_url":"http://bit.ly/1isH4r1","display_url":"bit.ly/1isH4r1"}],"hashtags":[{"start":16,"end":23,"tag":"agenda"}],"mentions":{},"annotations":{}},"id":"645936460772868096","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-21T12:23:47.000Z","conversation_id":"645936460772868096","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"CHMP has a busy #agenda this week - Find out more here: http://t.co/YIPTnm5vid","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/9103W5xUBs","expanded_url":"http://bit.ly/1OjuIPp","display_url":"bit.ly/1OjuIPp"}],"hashtags":[{"start":32,"end":43,"tag":"Pregabalin"},{"start":60,"end":69,"tag":"medicine"},{"start":74,"end":83,"tag":"epilepsy"}],"mentions":{},"annotations":{}},"id":"644892820176785409","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-18T15:16:44.000Z","conversation_id":"644892820176785409","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Assessment report published for #Pregabalin Accord, generic #medicine for #epilepsy and generalised anxiety disorder: http://t.co/9103W5xUBs","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/z0XSdOynvU","expanded_url":"http://bit.ly/1KkTQkJ","display_url":"bit.ly/1KkTQkJ"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":63,"end":74,"tag":"paediatric"}],"mentions":{},"annotations":{}},"id":"644869759490785280","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-18T13:45:06.000Z","conversation_id":"644869759490785280","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"#Consultation now open on a draft qualification opinion on the #paediatric ulcerative colitis activity index: http://t.co/z0XSdOynvU","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/ITz7iplKUS","expanded_url":"http://bit.ly/1KlhX0G","display_url":"bit.ly/1KlhX0G"}],"hashtags":[{"start":0,"end":13,"tag":"Consultation"}],"mentions":{},"annotations":{}},"id":"644795815425409024","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-18T08:51:16.000Z","conversation_id":"644795815425409024","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"#Consultation on concept paper on requirements for the production and control of allergen products for use in animals http://t.co/ITz7iplKUS","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/l78NOSSohd","expanded_url":"http://bit.ly/1haYHL8","display_url":"bit.ly/1haYHL8"}],"hashtags":[{"start":99,"end":111,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"644794072016797696","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-18T08:44:21.000Z","conversation_id":"644794072016797696","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"One week to go to apply for a job as human resources management specialist: http://t.co/l78NOSSohd #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/e4pERNNJDK","expanded_url":"http://bit.ly/1O1ABzA","display_url":"bit.ly/1O1ABzA"}],"hashtags":[{"start":123,"end":135,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"644792959704170496","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-18T08:39:55.000Z","conversation_id":"644792959704170496","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two weeks left to apply for a job as quality specialist in our human medicines evaluation division: http://t.co/e4pERNNJDK #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/TwO4smE5na","expanded_url":"http://bit.ly/1JDxFUn","display_url":"bit.ly/1JDxFUn"}],"hashtags":[{"start":120,"end":132,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"644792123959734272","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-18T08:36:36.000Z","conversation_id":"644792123959734272","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Deadline in 2 weeks to apply as Risk Management Specialist, Human Medicines Evaluation Division: http://t.co/TwO4smE5na #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/f3IW37EMi9","expanded_url":"http://bit.ly/1EF7IHE","display_url":"bit.ly/1EF7IHE"}],"hashtags":[{"start":108,"end":120,"tag":"recruitment"},{"start":121,"end":135,"tag":"ITspecialists"}],"mentions":{},"annotations":{}},"id":"644791227318169600","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-18T08:33:02.000Z","conversation_id":"644791227318169600","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks to go to apply for a position as Business Analyst, Information Technology: http://t.co/f3IW37EMi9 #recruitment #ITspecialists","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/Kt7mqNPD6V","expanded_url":"http://bit.ly/1Ogbw1D","display_url":"bit.ly/1Ogbw1D"}],"hashtags":[{"start":102,"end":114,"tag":"recruitment"}],"mentions":{},"annotations":[{"start":37,"end":76,"probability":0.6731,"type":"Organization","normalized_text":"EU Institutional Liaison Support Officer"}]},"id":"644790463770308608","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-18T08:30:00.000Z","conversation_id":"644790463770308608","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two weeks left to apply for a job as EU Institutional Liaison Support Officer: http://t.co/Kt7mqNPD6V #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/h8xAmSbnPG","expanded_url":"http://bit.ly/1Mt3g18","display_url":"bit.ly/1Mt3g18"}],"hashtags":[{"start":40,"end":50,"tag":"idebenone"},{"start":54,"end":63,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"644557086395899906","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-17T17:02:39.000Z","conversation_id":"644557086395899906","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Assessment report published for Raxone (#idebenone) a #medicine used to treat rare inherited visual impairment: http://t.co/h8xAmSbnPG","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/ca65O9Czj5","expanded_url":"http://bit.ly/1Hbg1u7","display_url":"bit.ly/1Hbg1u7"}],"hashtags":[{"start":29,"end":39,"tag":"guideline"},{"start":73,"end":78,"tag":"tick"},{"start":85,"end":90,"tag":"flea"}],"mentions":{},"annotations":{}},"id":"644490540277452800","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-17T12:38:13.000Z","conversation_id":"644490540277452800","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":4,"quote_count":0},"lang":"en","text":"14 days left to comment on a #guideline on treatment &amp; prevention of #tick &amp; #flea infestation in dogs and cats: http://t.co/ca65O9Czj5","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/sxlLjnIUgi","expanded_url":"http://bit.ly/1IMQl8r","display_url":"bit.ly/1IMQl8r"}],"hashtags":[{"start":48,"end":63,"tag":"cardiovascular"}],"mentions":{},"annotations":{}},"id":"644480395032043520","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-17T11:57:54.000Z","conversation_id":"644480395032043520","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"14 more days to comment on a paper on assessing #cardiovascular risk of cardiovascular &amp; metabolic disease medicines: http://t.co/sxlLjnIUgi","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/8VO5l7jQqQ","expanded_url":"http://bit.ly/1IyDS2K","display_url":"bit.ly/1IyDS2K"}],"hashtags":[{"start":58,"end":65,"tag":"sodium"}],"mentions":{},"annotations":{}},"id":"644477873932369920","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-17T11:47:53.000Z","conversation_id":"644477873932369920","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"Two more weeks to comment on our questions and answers on #sodium in product information for human medicines: http://t.co/8VO5l7jQqQ","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/QJTu5d9MVP","expanded_url":"http://bit.ly/1LHABo3","display_url":"bit.ly/1LHABo3"}],"hashtags":[{"start":99,"end":110,"tag":"hepatitisE"}],"mentions":{},"annotations":{}},"id":"644475039673393152","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-17T11:36:37.000Z","conversation_id":"644475039673393152","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"14 days left to comment on draft paper on viral safety of plasma-derived medicines with respect to #hepatitisE virus: http://t.co/QJTu5d9MVP","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":{},"hashtags":[{"start":120,"end":133,"tag":"substitution"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"annotations":{}},"id":"644452470337486848","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-17T10:06:56.000Z","conversation_id":"644452470337486848","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_ECHA: Learn how to reduce the impact of hazardous chemicals on human health &amp; environment.Visit our pages on #substitution http://t.…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"644451621162889216"}]},{"source":"TweetDeck","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/vMIxSJlvlW","expanded_url":"http://bit.ly/1W4EQgf","display_url":"bit.ly/1W4EQgf"}],"hashtags":[{"start":49,"end":59,"tag":"docetaxel"},{"start":63,"end":71,"tag":"generic"},{"start":72,"end":81,"tag":"medicine"}],"mentions":{},"annotations":[{"start":19,"end":46,"probability":0.2248,"type":"Other","normalized_text":"Docetaxel Hospira UK Limited"}]},"id":"644451868349988864","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-17T10:04:33.000Z","conversation_id":"644451868349988864","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"EPAR published for Docetaxel Hospira UK Limited (#docetaxel) a #generic #medicine for certain types of cancer: http://t.co/vMIxSJlvlW","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/iWms020K0r","expanded_url":"http://bit.ly/1KqfOEr","display_url":"bit.ly/1KqfOEr"}],"hashtags":[{"start":32,"end":42,"tag":"Respreeza"},{"start":50,"end":57,"tag":"alpha1"},{"start":82,"end":91,"tag":"medicine"}],"mentions":{},"annotations":{}},"id":"644198306483163136","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-16T17:16:59.000Z","conversation_id":"644198306483163136","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Assessment report published for #Respreeza (human #alpha1-proteinase inhibitor) a #medicine for an inherited disorder:http://t.co/iWms020K0r","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/Kg1joPWuqV","expanded_url":"http://bit.ly/1gqD5da","display_url":"bit.ly/1gqD5da"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"644161291880386560","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-16T14:49:54.000Z","conversation_id":"644161291880386560","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Consultation open on draft qualification opinion on a biomarker to measure patient adherence to medication in trials: http://t.co/Kg1joPWuqV","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/e0qKI9daIc","expanded_url":"http://bit.ly/1KRtjPm","display_url":"bit.ly/1KRtjPm"}],"hashtags":[{"start":118,"end":130,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"644086848323764224","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-16T09:54:05.000Z","conversation_id":"644086848323764224","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"We're looking for a Toxicology and Environmental Risk Assessment (ERA) Specialist. Apply now: \nhttp://t.co/e0qKI9daIc #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/k6mTGFRLb8","expanded_url":"http://Bit.ly/1F2hynb","display_url":"Bit.ly/1F2hynb"}],"hashtags":[{"start":111,"end":123,"tag":"recruitment"}],"mentions":{},"annotations":{}},"id":"644085425963954176","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-16T09:48:26.000Z","conversation_id":"644085425963954176","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Apply now for our position for a Risk Management Officer in human medicines evaluation: http://t.co/k6mTGFRLb8 #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/01df7PJYyO","expanded_url":"http://europa.eu/!Qt96XR","display_url":"europa.eu/!Qt96XR"}],"hashtags":[{"start":69,"end":84,"tag":"antimicrobials"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"id":"643392216312979456","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-14T11:53:52.000Z","conversation_id":"643392216312979456","public_metrics":{"retweet_count":29,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Commission publishes guidelines on the prudent use of #antimicrobials in veterinary medicine - http://t.co/01df7PJYyO","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"642330318859599872"}]},{"source":"TweetDeck","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/O0gMkgIla7","expanded_url":"http://bit.ly/1iiYFSK","display_url":"bit.ly/1iiYFSK"}],"hashtags":[{"start":48,"end":59,"tag":"veterinary"}],"mentions":{},"annotations":{}},"id":"642341963992276992","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-11T14:20:33.000Z","conversation_id":"642341963992276992","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"We've published the highlights from this week's #veterinary committee (CVMP) meeting: http://t.co/O0gMkgIla7","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/dryatLyjVC","expanded_url":"http://bit.ly/1KIMmLX","display_url":"bit.ly/1KIMmLX"}],"hashtags":[{"start":6,"end":24,"tag":"pharmacovigilance"},{"start":95,"end":107,"tag":"fusafungine"}],"mentions":{},"annotations":{}},"id":"642340534271508480","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-11T14:14:52.000Z","conversation_id":"642340534271508480","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"EMA’s #pharmacovigilance committee (PRAC) starts a review of nasal and mouth sprays containing #fusafungine: http://t.co/dryatLyjVC","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/FqwifqTsTS","expanded_url":"http://bit.ly/1UH4Uke","display_url":"bit.ly/1UH4Uke"}],"hashtags":[{"start":32,"end":40,"tag":"Farydak"}],"mentions":{},"annotations":{}},"id":"642337569632579585","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-11T14:03:05.000Z","conversation_id":"642337569632579585","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"lang":"en","text":"Assessment report published for #Farydak (# panobinostat) a medicine for multiple myeloma (cancer of the bone marrow):http://t.co/FqwifqTsTS","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/l78NOSSohd","expanded_url":"http://bit.ly/1haYHL8","display_url":"bit.ly/1haYHL8"}],"hashtags":[{"start":108,"end":120,"tag":"recruitment"}],"mentions":{},"annotations":[{"start":46,"end":82,"probability":0.5304,"type":"Organization","normalized_text":"Human Resources Management Specialist"}]},"id":"642264578336923649","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-11T09:13:02.000Z","conversation_id":"642264578336923649","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"Two more weeks to apply for our vacancy for a Human Resources Management Specialist: http://t.co/l78NOSSohd #recruitment","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/Rp1fVtm3Wy","expanded_url":"http://bit.ly/1iBEQpq","display_url":"bit.ly/1iBEQpq"}],"hashtags":[{"start":40,"end":47,"tag":"SGLT2s"}],"mentions":[{"start":0,"end":12,"username":"Sarah_Finer","id":"3437733083"}],"annotations":{}},"id":"642258567362412544","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-11T08:49:09.000Z","conversation_id":"642083335293042688","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@Sarah_Finer EMA is currently reviewing #SGLT2s, see here for full details including timetable: http://t.co/Rp1fVtm3Wy","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"642083335293042688"}],"in_reply_to_user_id":"3437733083"},{"source":"TweetDeck","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":14,"username":"traybakequeen","id":"44080641"}],"annotations":{}},"id":"642006985169354752","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-10T16:09:27.000Z","conversation_id":"641985632626167808","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"lang":"en","text":"@traybakequeen Your presence was very valuable and we thank you very much for the contribution you made today.","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"641985632626167808"}],"in_reply_to_user_id":"44080641"},{"source":"TweetDeck","entities":{"urls":[{"start":70,"end":92,"url":"http://t.co/DKhS0Beawq","expanded_url":"http://bit.ly/1OCTAi7","display_url":"bit.ly/1OCTAi7"}],"hashtags":[{"start":24,"end":34,"tag":"medicines"}],"mentions":{},"annotations":{}},"id":"641999495149023233","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-10T15:39:42.000Z","conversation_id":"641999495149023233","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Check our update on new #medicines for human use under EMA evaluation http://t.co/DKhS0Beawq","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/3JKu11Jva4","expanded_url":"http://bit.ly/1Of7zfW","display_url":"bit.ly/1Of7zfW"}],"hashtags":[{"start":40,"end":50,"tag":"medicines"},{"start":55,"end":68,"tag":"rarediseases"}],"mentions":{},"annotations":{}},"id":"641944292802605057","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-10T12:00:20.000Z","conversation_id":"641944292802605057","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":6,"quote_count":0},"lang":"en","text":"How to apply for orphan designation for #medicines for #rarediseases: see our new sponsors' guide http://t.co/3JKu11Jva4","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/ZFJwG5catG","expanded_url":"http://bit.ly/1OcIl1P","display_url":"bit.ly/1OcIl1P"}],"hashtags":{},"mentions":{},"annotations":{}},"id":"641596637052334080","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-09T12:58:53.000Z","conversation_id":"641596637052334080","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":3,"quote_count":0},"lang":"en","text":"Find out about the 20 positive opinions for orphan designations from this month's orphan medicines committee meeting: http://t.co/ZFJwG5catG","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/PhIKt6n7uQ","expanded_url":"http://bit.ly/1iwqG99","display_url":"bit.ly/1iwqG99"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":58,"end":69,"tag":"paediatric"}],"mentions":{},"annotations":{}},"id":"641545418296434688","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-09T09:35:21.000Z","conversation_id":"641545418296434688","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week's meeting of our #paediatric committee (PDCO): http://t.co/PhIKt6n7uQ","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/jSkvFVSoUb","expanded_url":"http://bit.ly/1JPwOQx","display_url":"bit.ly/1JPwOQx"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"patfan198010","id":"468887029"}],"annotations":[{"start":70,"end":71,"probability":0.9038,"type":"Place","normalized_text":"UK"}]},"id":"641255392404742145","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-08T14:22:54.000Z","conversation_id":"641243404693843968","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"@patfan198010 The PRAC outcomes will be published this Friday at noon UK time and will be available here: http://t.co/jSkvFVSoUb","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"replied_to","id":"641250895980818432"}],"in_reply_to_user_id":"468887029"},{"source":"TweetDeck","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/t9mWbPGF7J","expanded_url":"http://bit.ly/1K5kEa1","display_url":"bit.ly/1K5kEa1"}],"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":27,"end":38,"tag":"veterinary"}],"mentions":{},"annotations":{}},"id":"641244467098480640","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-08T13:39:29.000Z","conversation_id":"641244467098480640","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"lang":"en","text":"The #agenda of this week's #veterinary medicines committee (CVMP) is available: http://t.co/t9mWbPGF7J","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/XArcJNnMJZ","expanded_url":"http://bit.ly/1JPqF78","display_url":"bit.ly/1JPqF78"}],"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":58,"end":76,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"id":"641243404693843968","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-08T13:35:16.000Z","conversation_id":"641243404693843968","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"lang":"en","text":"We've published the #agenda of this week's meeting of our #pharmacovigilance committee (PRAC) : http://t.co/XArcJNnMJZ","attachments":{"media_keys":{}},"referenced_tweets":{}},{"source":"TweetDeck","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/chwHgh0qh0","expanded_url":"http://europa.eu/!MR67JQ","display_url":"europa.eu/!MR67JQ"}],"hashtags":[{"start":58,"end":61,"tag":"EU"},{"start":62,"end":69,"tag":"public"},{"start":70,"end":77,"tag":"health"},{"start":78,"end":87,"tag":"consumer"},{"start":88,"end":95,"tag":"safety"},{"start":96,"end":108,"tag":"environment"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"annotations":{}},"id":"641234299358969856","author_id":"116716199","possibly_sensitive":false,"created_at":"2015-09-08T12:59:05.000Z","conversation_id":"641234299358969856","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"lang":"en","text":"RT @EU_Health: Scientist? Join our Scientific Committees! #EU #public #health #consumer #safety #environment http://t.co/chwHgh0qh0 http://…","attachments":{"media_keys":{}},"referenced_tweets":[{"type":"retweeted","id":"641185659542196224"}]}]
